A proteomic analysis of Raf-1 signalling pathways by von Kriegsheim, Alexander F
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
A Proteomic Analysis of Raf-1 signalling Pathways
Alexander F  von Kriegsheim, DipLChem.
July 2005
This thesis is submitted to the University of Glasgow in accordance with the 
requirements for the degree of Doctor of Philosophy
Beatson Institute for Cancer Research IBLS/Biochemistry
Garscube Estate University of Glasgow
Switchback Road Glasgow
Bearsden, Glasgow
ProQuest Number: 10646806
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10646806
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
4GLASGOW 
VERSJTY 
( A R Y
Abstract
Raf-1 is an integral part of the Ras/RafTVIEK/ERK signalling pathway that relays 
mitogenic and survival signals to the nucleus, leading to suppression of apoptosis, growth 
and proliferation. The ability of Raf-1 to fulfil these diverse functions is likely to require its 
ability to form multiple complexes which are regulated by phosphorylation and sub- 
cellular localisation. The aim of the work described in this thesis was to develop proteomic 
approaches to study dynamic changes in Raf-1 signalling complexes in vivo.
Recent studies have indicated that Raf-1 not only plays a crucial role in relaying growth 
signals through the MAPK pathway but it also has a kinase independent function in 
protecting cells from apoptosis. To characterise this anti-apoptotic role of Raf-1, DIGE 
(different gel electrophoresis) was used to determine changes in protein expression 
resulting from the reconstitution of Raf-T " fibroblasts with kinase-dead or wild-type Raf- 
1. Numerous pro- and anti-apoptotic proteins were differentially expressed between these 
three cell lines. Furthermore levels of several potential Raf-1 binding proteins and proteins 
involved in actin dynamics and motility were altered. The changes in protein expression 
identified by proteomic analysis are consistent with the hypersensitivity of Raf-1'' 
fibroblasts to apoptotic stimuli and the alterations in their actin cytoskeleton and motility.
In addition to examining global protein changes by DIGE, we developed a gel-less, mass 
spectrometry based two-dimensional liquid chromatography approach to analyse protein 
samples of medium complexity and successfully adapted it to identify Raf-1 protein 
complexes. We identified over 100 potential Raf-1 interacting partners, some of which 
required the presence of S259 site to bind to Raf-1 whereas others interacted only when 
cells were induced with mitogens or apoptotic insults. Two of these interactions (protein 
phosphatase 5 and SIPl) were verified by co-immunoprecipitations and functional analysis 
was performed on one of these proteins. Furthermore we developed a highly sensitive and
4robust method for phosphorylation site mapping and demonstrated its potential by 
identifying phosphorylation sites of proteins present in Raf-1 complexes.
Raf-1 activation is a complex process in vvhich phosphorylation plays a key role. While 
several kinases have been shown to phosphorylate Raf-1, only one phosphatase, PP2A, has 
been identified to regulate Raf-1 activity in vivo by dephosphorylating serine 259 upon 
activation with mitogens. We identified protein phosphatase 5 (PP5) as a potential Raf-1 
interacting protein. This interaction was validated by co-immunoprecipitation of 
endogenous Raf-1 with PP5 in COS-1 cells. PP5 dissociated from Raf-1 upon stimulation 
with EOF and specifically dephosphorylated a crucial activation site, S338, in-vivo and in- 
vitro. Furthermore we provide evidence that cross talk between the MAPK pathway and 
the G a l2 pathway is regulated by PP5.
The results presented here show that we have developed robust proteomic methods 
enabling us to analyse protein complexes as well as changes in protein expression and 
phosphorylation with high sensitivity and accuracy.
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1.1 Raf isoforms
Mitogen activated protein kinase (MAPK) pathways play an integral part in relaying 
extracellular signals to the nucleus and other intracellular destinations. MAPK pathways 
can be found in all eukaryotic organisms and consist of kinase modules organised in a 
three-tiered cascade (reviewed in (Garrington and Johnson, 1999; Schaeffer and Weber, 
1999; Widmann et al., 1999). This setup not only ensures the amplification of the signal 
but additionally facilitates regulation and fine-tuning of the signal outcome, by providing 
interfaces for additional regulation of signal duration, amplitude and kinetics. The basic 
module consists of a small G-protein located at the membrane that upon activation recruits 
and induces activation of a MAP kinase kinase kinase (MAPKKK) which then itself binds 
to a MAP kinase kinase (MAPKK) and activates it through phosphorylation. MAPKK then 
phosphorylates MAP kinase (MAPK). Raf is a MAPKKK and functions downstream of 
Ras as the G-protein and upstream of MEK as MAPKK and ERK as MAPK. The 
Ras/Raf/MEK/ERK pathway mainly regulates proliferation and differentiation pathways 
through activation of ERK which itself has the ability to phosphorylate either cytoplasmic 
substrates, such as RSK, or can translocate to the nucleus where it can activate 
transcription factors. Not surprisingly hyperactivation of this pathway leads to unchecked 
proliferation and differentiation, and occurs in approximately 30% of human tumours 
(reviewed in (Bos, 1989; Katz and McCormick, 1997; Lowy and Willumsen, 1993) 
Consistent with this observation mutational activation of members of this cascade can 
induce transformation of cells in tissue culture.
Evolution provided mammalian organisms with three distinctive Raf isoforms compared 
with only one in Drosophila and C. elegans. All three isoforms A-Raf, B-Raf and Raf-1 
share a common structure and large parts of the proteins are conserved throughout the 
isoforms; see (Kolch, 2000; Wellbrock et al., 2004) for reviews. The conserved structure
18
consists of the conserved regions, CRl, CR2 and CR3. CRl and CR2 lie in the regulatory 
domain and CR3 encodes the C-terminal kinase domain. The regulatory domain also 
includes the Ras binding domain (RBD) and a cysteine rich domain (CRD) both of which 
are essential for Raf/Ras binding. The CRD has been shown to bind to a multitude of 
proteins in a large scale yeast-two-hybrid screen, making this domain an important hub for 
protein-protein interactions (Yuryev and Wennogle, 2003). Remarkably, despite the high 
degree of conservation in this domain several isoform-specific interactions were found.
Raf proteins have been found to be strongly regulated by multisite phosphorylation. 
Several of these sites are conserved throughout the family, suggesting a common 
regulatory mechanism, while others are not conserved suggesting at least a degree of 
differential regulation. B-Raf is subject to multiple splicing resulting in the expression of 
iso forms with a mass range of 70 to 95 kDa (Bamier et ah, 1995), whereas no alternative 
splice variants of A-Raf and Raf-1 have been reported. A-Raf has a molecular weight of 
68kDa and Raf-1 of 75kDa. mRNA studies suggested that Raf-1 is ubiquitously expressed, 
while A-Raf and B-Raf showed are more restricted expression pattern (Storm et al., 1990). 
B-Raf has been found expressed at high levels in neuronal cells but lower levels of B-Raf 
are expressed in wide range of other tissues. A-Raf mRNA is especially high in urogenital 
organs, although protein expression studies have shown that it is fairly ubiquitous in all 
tissues (Luckett et al., 2000).
All three isoforms share Ras as a common activator and all three can activate MEK, 
although with varying efficiencies. B-Raf is by far the best MEK kinase followed by Raf-1 
and A-Raf (Papin et al., 1996). Despite having a common activator and substrate all three 
isoforms are essential for mouse development. A-Raf deficient mice are bom but, 
depending on the background, die because of intestinal and neurological defects (Pritchard 
et al., 1996). Raf-1 knock-out mice die in midgestation due to massive apoptosis in the 
liver and placenta (Huser et al., 2001; Mikula et al., 2001) and B-Raf knock-outs die of
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vascular defects in midgestation (Wojnowski et ai., 1997). Interestingly MEK and ERK 
activation in response to mitogens in not impaired in either the A-Raf or the Raf-1 knock­
out, whereas MEK activation is severely impaired in the B-Raf knock-out mice. This 
finding indicates that B-Raf might be the main activator of the MEK/ERK pathway 
whereas Raf-1 and A-Raf may perform other tasks. The phenotype of the Raf-1 knock-out 
mice and newly discovered anti-apoptotic fimctions of Raf indicate that Raf-1’s main 
fimction may not be MEK activation, but protection from apoptosis (see Raf and apoptosis) 
(Baccarini, 2002).
1.2 Activation of the Raf-1 pathway
Raf proteins are activated by numerous mitogens and growth factors such as EGF, serum, 
PDGF and NGF. Activation of the pathway occurs upon binding of the mitogens to 
specific cell surface receptors. In the case of receptor tyrosine kinases this induces 
oligomerisation that results in activation of their tyrosine kinase activity through inter 
molecular tyrosine phosphorylation. These tyrosine phosphorylations sites create protein- 
protein docking sites for adaptor proteins containing SH2 and SH3 domains (Li et al., 
1993; Rozakis-Adcock et al., 1993). These newly attached adaptor proteins, such as Grb-2, 
have the ability to recruit RasGEFs (Guanosine nucleotide Exchange Factors) such as SOS, 
Cdc25 and RasGRF (Guanosine nucleotide Release Factor) to the membrane, which 
stimulate the release of bound GDP on Ras, thus creating a binding pocket for either GTP 
or GDP (Egan et al., 1993). Due to the much higher concentrations of GTP in the cell, GTP 
binding is favoured. It induces a conformational change in the effector binding region of 
Ras facilitating the interaction with effectors such as Raf-1 and so initiating a signalling 
cascade resulting in phosphorylation of ERK (Wittinghofer and Nassar, 1996). Active 
ERK can then in turn terminate Ras activation by phosphorylating the GEF SOS resulting 
in disassembly of the Grb-2/GEF complex and release of SOS back into the cytosol, thus 
terminating the activation of Ras (Buday et al., 1995; Chemiack et al., 1995; Waters et al..
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1995a; Waters et al., 1995b) . Beside ERK other kinases that are regulated by MAPK- 
signalling have also been identified to exert a similar negative feed-back effect on SOS. 
RSK-2, a kinase downstream of ERK, has been reported to phosphorylate SOS in PC 12 
cells in response to EGF activation (Douville and Downward, 1997).
Raf-1 recruitment to the membrane by RasGTP is initiated by the binding of the RBD and 
the CRD to Ras. Point mutation in either one of the RBD and CRD disrupt the membrane 
localisation of Raf, suggesting that both domains are needed for the successful 
translocation and Ras binding in fibroblasts (Bondeva et al., 2002). RBD binding to Ras is 
dependent on the GTP-induced conformational change in Ras, whereas the CRD binds 
either conformation. Membrane localisation of Raf-1 is only the initial event that leads to 
full activation. In order to achieve full activation a complex set of steps that involves 
sequential dephosphorylation, phosphorylation and conformational changes is needed to 
fully activate Raf-1. Targeting Raf-1 to the plasma membrane by fusing the famesylation 
sequence of Ras to the C-terminus of Raf-1 (Raf-CAAX) is sufficient to activate Raf-1 
constitutively and seemingly independent of Ras (Stokoe et al., 1994). However Raf- 
CAAX is not fully active and its kinase activity can be further increased by mitogens and 
RasGTP. Recent reports even suggested that mutationally activated Ras is able to enhance 
Raf-CAAX activity by direct binding (Mineo et al., 1997), possibly by initiating Raf 
dimérisation or by forcing the release of the kinase from the regulatory domain, indicating 
that Ras does more than merely recruiting Raf-1 to the membrane. Although most reports 
suggest that Ras/Raf binding is essential for Raf-1, activation studies using a Raf-1 mutant 
that is deficient in Ras binding showed that this mutant could still be activated by EGF, 
TPA and during mitosis, suggesting that at least part of the activation process might not be 
dependent on the Ras/Raf interaction (Mischak et al., 1996; Ziogas et al., 1998).
The activation of A-Raf is less well studied, but seems to be similar to Raf-1. In contrast, 
B-Raf activation is simpler, as Ras binding alone suffices to activate B-Raf. This seems to
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be due to the fact that B-Raf exists in an already pre-activated form. In B-raf two crucial 
tyrosines (Y447 and Y448, equivalent to Y340 and Y341 in Raf-1) are replaced by 
phosphomimetic aspartic acid residues, and the adjacent S445 and S446 (equivalent to 
S338 and S339 in Raf-1), whose phosphorylation is required for activation, are already 
constitutively phosphorylated (Kolch, 2000; Wellbrock et al., 2004).
1.3 Regulation of Raf-1 by phosphorylation
Phosphorylation of Raf-1 plays a key role in regulating its activity, subcellular localisation, 
and its interaction with other proteins. In resting cells Raf-1 is phosphorylated on S43, 
S259 and S621 (Morrison et al., 1993). Upon stimulation with growth factors S338 and 
possibly Y341 phosphorylation is induced as well as phosphorylations of T491 and S494 
in the activation loop (Kolch, 2000; Wellbrock et al., 2004). The basal S259 
phosphorylation site is assumed to be mainly an inhibitory site, whereas the latter sites are 
phosphorylated in conjunction with increasing Raf-1 activity, therefore assumed to be 
activating (Figure 1.1).
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Figure 1.1: C artoon  of Raf-1 dom ains and phosphory lation  sites
Raf-1 is phosphorylated on both S621 and S259 in its inactive cytoplasmic confirmation 
although the stochiometry of these phosphorylations is not known (Dhillon et al., 2002a; 
Michaud et al., 1995; Tzivion et al., 1998). These phosphorylations create two 14-3-3
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interaction sites. This interaction can stabilise Raf-1 in its inactive conformation, where the 
regulatory domain shields the kinase domain, preventing access to substrates and activating 
kinases. Upon stimulation with mitogens the dephosphorylation of pS259 is one of the 
early events necessary for full activation of Raf-1 and the inhibition of this crucial 
dephosphorylation step inhibits the subsequent activation. It has been reported that Raf-1 
binding to Ras-GTP destabilises the 14-3-3/pS259 interaction, thus releasing 14-3-3 and 
making this site accessible to phosphatases localised at the plasma membrane (Rommel et 
al., 1996). Treatment with okadaic acid and other phosphatase inhibitors have suggested 
that PP2A and PPl both can dephosphorylate pS259 (Abraham et al., 2000; Jaumot and 
Hancock, 2001; Mitsuhashi et al., 2003). Inhibition of these phosphatases increases pS259 
and 14-3-3 bound to Raf-1 at the membrane, thus increasing the proportion of inactive Raf 
at the membrane. Consequently the dephosphorylation of pS259 impedes the reassembly of 
the 14-3-3 dimer with the Ras/Raf complex, thus releasing the kinase domain form the 
regulatory domain. 14-3-3 is thought to remain bound to pS621 and disruption of this 
interaction leads to the loss of kinase activity. Confirmation of the proposed inhibitory role 
of S259 phosphorylation was obtained by mutational analysis as Raf-1 S259 mutants have 
an increased basal kinase activity that can be further increased by growth factor 
stimulation. This indicates that pS259 dephosphorylation is essential for activation, but 
itself is not sufficient, suggesting that these mutants resemble an intermediate 
conformation. The kinases Akt and PKA have been identified as the enzymes that can 
phosphorylate S259, although the kinase which is responsible for the basal S259 
phosphorylation remains elusive. In some cell types, including muscle cells and breast 
cancer cells, the activation of Akt via PI3-kinase is sufficient to block Raf-1 activity and 
to impair signalling through the MAPK pathway (Moelling et al., 2002; Rommel et al., 
1999; Zimmermann and Moelling, 1999). This cross-talk between the Akt and Raf-1 
signalling pathway can change the outcome of the stimulation such as shifting the cellular 
response from cell cycle arrest caused by Raf-1 hyperactivity to proliferation in breast
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cancer cell lines. The occurrence of the Raf/Akt cross-talk seems to be highly dependent 
on the cell type and differentiation stage, suggesting that Akt might not be the sole kinase 
responsible for the S259 phosphorylation or that accessory proteins are involved.
PKA has also been shown to phosphorylate S259. Activation of PKA via cAMP was 
reported to inhibit MAPK activation induced by EGF and this has been correlated with 
increases in phosphorylation on S43,S233, S259 and S621 (Chuang et al., 1994; Wu et al., 
1993). Mutation of these sites suggested that the S259 is the major site involved in PKA 
mediated Raf-1 inhibition (Dhillon et ah, 2002b), although another report suggested that all 
sites involved have to be mutated to abolish cAMP initiated inhibition of Raf-1 signalling 
(Dumaz et ah, 2002).
Upon activation and translocation to the membrane several inducible, activating 
phosphorylations events take place. Two crucial phosphorylation sites, T491 and S494, lay 
both within the activation loop and are essential for Raf-1 activation. Mutation of both sites 
to alanines blocks Raf-1 activation by mitogens and by active Ras. The corresponding 
mutation to phosphomimetic amino acids on the other hand does not activate Raf-1, quite 
in contrast to B-Raf, and additional mitogen stimulation is essential for Raf-1 activation 
(Chong et ah, 2001; Zhang and Guan, 2000). This confirms that the phosphorylations in 
the activation loop are essential, but not sufficient for full Raf-1 activation. So far, the 
kinases responsible for phosphorylating these two sites have not been identified.
Finally, phosphorylation of two more sites is essential for Raf-1 activation. S338 and Y341 
both are located in the CR3 region and have been shown to be induced by mitogens. S33 8 
is conserved throughout the Raf isoforms, but it has been suggested that it is constitutively 
phosphorylated in B-Raf, whereas it is strongly induced in Raf-1 (Diaz et al., 1997; Mason 
et al., 1999). Mutation of S338 and the adjacent S339 to alanines severely impedes the 
transformation ability of membrane targeted Raf-CAAX and severely reduces Ras
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dependent activation. Mutation to acidic amino acids on the other hand only increases the 
kinase activity mildly, once again suggesting that this sites are essential for activation but 
not sufficient. Initial studies identified Pak3 as the kinase that is responsible for 
phosphorylating S338, but subsequent studies indicated that Pak2 is probably the kinase 
involved (Chaudhary et al., 2000; King et al., 1998; Sun et al., 2000). The Pak family 
kinases are cytosolic serine/threonine kinases that are regulated by the Rho family of small 
GTPases, specifically CDC42 and Rac. Ras can activate Rac via a PI3-kinase dependent 
mechanism possibly explaining how active Ras can induce pS338 phosphorylation on Raf- 
1. pS338 appears to be important not only for Raf-1 activity, but may also serve as a 
platform for integrating signals from CDC42 and Rac into ERK signalling. More recently 
the involvement of Paks in phosphorylating S338 residue has been disputed (Chiloeches et 
al., 2001), as inhibition of the PI3-kinase pathway with chemical inhibitors did not 
influence pS338 phosphorylation levels and Pak3 kinase activity did not correlate with 
S3 38 phosphorylation. This contradicted earlier publications suggesting that chemical 
inhibitors of PI3-kinase signalling were able to inhibit pS338 phosphorylation (Sun et al., 
2000). A possible explanation for this discrepancy is that the inhibitors can inhibit Ras at 
high unspecific concentrations and therefore can reduce pS338 phosphorylation by 
inhibiting Ras instead of reducing Pak activity. However, studies on the physical 
interactions between Raf-1 and Pakl have supported the role of this Pak isoform as a S33 8 
kinase (Zang et al., 2002). Thus, the role of Pak as the physiological regulator of S33 8 
remains unresolved.
Tyrosine 341 is the fourth site essential for Raf-1 activation. It is conserved in A-Raf and 
Raf-1 but is replaced by a phosphomimetic acid amino acid in B-Raf. The exchange in B- 
Raf in conjunction with the constitutive phosphorylation S445, the equivalent of S338 in 
Raf-1, explains why B-Raf has a higher activity than Raf-1 and is more readily stimulated 
by mitogens, as it only requires membrane translocation and two phosphorylations in the 
activation loop. Tyrosine 340/341 site on Raf on the other hand is strongly phosphorylated
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by active Src (Marais et al., 1997), which may explain why active Src and Ras synergise in 
activating Raf-1.
Although co-expression assays have established that active Src is capable of 
phosphorylating tyrosines 340 and 341 (Fabian et al., 1993; Jelinek et al., 1996; Marais et 
al., 1995), the importance of tyrosine phosphorylation in the physiological activation of 
Raf-1 remains disputed, mainly because tyrosine phosphorylation of Raf-1 by mitogen 
stimulation occurs on a low level and is difficult to detect both by phospho-peptide 
mapping of in vivo labelled Raf-1 or by western blotting with phosphospecific antibodies. 
More recently a report suggested that distinctive growth factor stimulations could not only 
phosphorylate the Y341 and S338 residues, but were selective for either one of these 
residues. In human endothelial cells vascular endothelial growth factor (VEGF) and basic 
fibroblast growth factor (bFGF) induced either tyrosine phosphorylation on 340/341 or 
serine phosphorylation on S338/339 (Alavi et al., 2003). More interestingly, pY340/341 
was linked to Raf-1 mediated protection from extrinsic apoptotic stimuli, whereas serine 
338 phosphorylation protected the cells from intrinsically induced apoptosis (Alavi et al., 
2003) (also see Raf and apoptosis).
Although the processes that lead to Raf-1 activation have been extensively studied, little is 
known how Raf-1 is deactivated. Taking into account that only a small fraction of the Raf 
pool is active at any given time and is localised at the membrane very little is known how 
Raf relocalises from the membrane back to the cytosol. Recent studies suggest binding of 
Raf-1 to 14-3-3 may play an important role in this process (Roy et al., 1998; Dhillon et al., 
2002; Light et al., 2002). In addition, déphosphorylation of activating Raf-1 sites is likely 
to be a crucial step in the inactivation of Raf-1. To date no phosphatases have been 
identified that dephosphorylate either of the activating sites and identifying the players in 
this game will certainly help to clarify the mechanisms involved in inactivating Raf-1.
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1.4 Regulation of Raf-1 signalling by protein-protein interactions
In addition to Ras, 14-3-3 and MEK, Raf-1 has been reported to interact with several other 
proteins. The core of the Raf-1 complex is formed by an assembly of chaperones and 14-3- 
3 proteins that keep Raf-1 in conformations required for its functions. HSP90, HSP70, 
CDC37, FKBP65 and Bag-1 all are chaperones that have been reported to bind to Raf-1 
(Coss et al., 1998; Grammatikakis et al., 1999; Silverstein et al., 1998; Wang et al., 1996b). 
Disruption of the interaction between Raf-1 and the chaperone complex renders Raf-1 
insoluble and prone to degradation. This is exemplified by treating cells with 
geldanamycin or radicicol, both drugs which interfere with HSP90 function. Upon 
treatment with these drugs Raf-1 protein levels drop and Raf-1 becomes undetectable 
within a few hours, demonstrating their crucial role in stabilising Raf-1 (Schulte et al., 
1997; Schulte et al., 1995; Soga et al., 1998). Apart from merely stabilising and correctly 
folding Raf, chaperones have been shown to be crucial for regulating Raf membrane 
localisation and its activity. For example, HSP70 and Bag-1 have been found to regulate 
Raf-1 activity and the subsequent activation of ERK in concert (Song et al., 2001). Upon 
heat-shock, HSP70 levels increase and displace Bag-1 from Raf-1. This exchange 
antagonizes Raf-1 activity thus reducing signalling through the MAPK pathway and 
halting DNA synthesis. Bag-1 mutants deficient in HSP70 binding constitutively activate 
Raf-1, whereas HSP70 mutants that cannot bind Bag-1 do not inhibit Raf-1 activity.
As chaperones ensure correct folding of Raf-1, scaffolding proteins ensure that individual 
signalling modules maintain their specificity and fidelity of signalling by facilitating the 
physical interaction of the proteins involved in the cascade in a spatially and temporally 
restricted manner.
Sur-8 is a scaffold proposed to act at the Ras/Raf level. Sur-8 was identified in a 
Caenorhabditis elegans loss of function screen as a protein that when mutated could 
suppress an active Ras phenotype. Sur-8 was shown to function upstream of Raf, at the
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level of Ras (Sieburth et aL, 1998). Sur-8 interacted with Ras, but did not bind to a 
dominant negative mutant. Human Sur-8 was found to have similar functions. 
Overexpression of Sur-8 did not activate the MAPK pathway per se, but enhanced ERK 
and Raf-1 activity induced by mitogens and active Ras. Sur-8 was found to bind not only 
to Ras and active Ras mutants, but also Raf-1 and was present in ternary complex 
consisting of Ras/Sur-8/Raf-l. The enhancement of Ras signalling seems to be Raf specific 
as Sur-8 was not able to enhance signalling through P13-kinase/Akt or JNK (Li et a l, 
2000), suggesting that Sur-8 is indeed a Ras/Raf specific scaffold that organises and 
enhances signalling through the MAPK pathway.
Connector enhancer of KSR (CNK or MAGUIN) in another scaffold regulating the 
Ras/Raf interaction and was identified in a Drosophila melanogaster genetic screen as a 
gene which interfered with the rough-eye phenotype caused by expression of dominant 
negative KSR (Therrien et a l, 1998). Drosophila CNK is a multidomain protein with no 
apparent enzymatic function but comprises several protein-protein interaction domains, 
indicating that its main purpose is to assemble protein complexes. Genetic studies 
suggested that CNK functioned in the Ras pathway either upstream or in parallel of Raf. A 
subsequent biochemical analysis in Schneider insect cells revealed that the interaction with 
Raf was mediated by two N-terminal domains and a short C-terminal domain, whereas the 
C-terminus binds to Ras. When Ras is inactive the interaction of the C-terminus with Raf 
inhibited its catalytic function, whereas it changes into a potent activator upon Ras 
activation by interacting with the N-terminal domains (Douziech et a l, 2003). The 
functions of CNK in mammalian system remains sketchy. Human CNK2 interacted with 
Raf-1 in a manner not dependent of Raf-1 activity and its overexpression inhibited MAPK 
activation by mitogens (Lanigan et a l, 2003). The other human homologue CNKl has 
been recently found to be involved in Rho mediated transcription but did not affect Rho- 
dependent stress fibre formation (Jaffe et a l, 2004). Moreover it was found to augment 
proapoptotic Ras signalling through RASSFIA/C and MSTl/2 (Rabizadeh et a l, 2004).
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Clearly the functions of CNK in the mammalian system are more complex than the studies 
in Drosophila suggested and more work is needed to fully characterise the functions of the 
mammalian homologues of CNK.
Kinase suppressor of Ras (KSR) is another scaffold involved in regulating MAPK 
signalling. KSR was also identified in genetic screens in worms and flies (Komfeld et al., 
1995; Sundaram and Han, 1995; Therrien et al., 1995) as a protein that was able to reverse 
the phenotype of mutationally activated Ras. KSR is a multidomain protein containing five 
conserved domains and has a high degree of similarity to Raf kinases. The CAl region is a 
40 amino acid stretch unique to KSR proteins, CA2 is a proline rich region, CA3 is a 
cysteine rich domain, CA4 is a serine/threonine rich region and CA5 is a putative kinase 
domain. Although the name, the similarity to Raf and the presence o f kinase domain 
suggested an enzymatic function, so far only few reports have found the kinase domain to 
be active (Wang and Studzinski, 2001; Xing et al., 2004; Xing and Kolesnick, 2001; Xing 
et al., 2000; Zhang et al., 1997) and identified Raf-1 as a potential substrate. Other studies 
challenged the proposed kinase function as they failed to detect kinase activity (Michaud et 
al., 1997; Stewart et al., 1999). Furthermore, the essential lysine involved it the phospho- 
transfer reaction in the kinase domain of KSR is exchanged for an arginine, indicating that 
this protein might not be able to utilise ATP. Moreover the expression of a truncation 
mutant of KSR that contains the C-terminal kinase domain inhibited MAPK signalling 
(Joneson et al., 1998; Yu et al., 1998), in contrast to Raf, where the equivalent deletion 
produces a constitutively active kinase.
It is now widely accepted that KSR functions as a scaffold in MAPK signalling 
independently of its proposed kinase function. The idea of KSR being a scaffold emerged 
when it was found to bind to several proteins involved in MAPK signalling. It was found 
to bind to Raf-1, MEK and ERK (Denouel-Galy et al., 1998; Yu et al., 1998) and 
mutations in protein-protein binding domains of KSR render it functionally inactive (Roy
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et al., 2002). KSR’s interaction with MEK is constitutive and mutations that disrupt this 
interaction disrupt KSR function (Muller et al., 2000; Stewart et al., 1999). Raf-1 and ERK 
binding on the other hand is not constitutive and is induced by Ras activation (Jacobs et 
al., 1999). Raf-1/KSR binding seems to be limited to the membrane and does not require 
either MEK or Ras to be present in the complex (Roy et al., 2002; Therrien et al., 1996; 
Xing et al., 1997). Interestingly forcing the interaction between Raf and MEK is sufficient 
for Raf-mediated MEK phosphorylation (Roy et al., 2002). The proposed function of KSR 
as a molecular scaffold coordinating the Raf/MEK interaction was further confirmed by 
mouse knock-out studies. Although the mice were bom alive and no phenotypical 
deficiencies were detectable, ERK activation was impaired upon stimulation by mitogens, 
indicating that KSR potentates MAPK signalling (Nguyen et al., 2002). Gel filtration of 
mouse lysates showed that MEK, ERK and KSR are present in high molecular protein 
complexes, whose size was reduced in the knock-out mice, further supporting the 
scaffolding function of KSR.
The similarity between KSR and Raf not only occurs at the stmctural level but also at the 
level of regulation. Like Raf, 14-3-3, CDC37 and HSP90 bind to KSR and control its 
conformation and solubility. One particularly intriguing similarity between Raf and KSR 
is their regulation by 14-3-3 binding. KSR is phosphorylated in resting cells on S297 and 
S392 which enables binding to 14-3-3 proteins (Cacace et al., 1999). Upon activation, 
these sites are dephosphorylated by PP2A, enabling membrane translocation of KSR. The 
inhibition of this dephosphorylation step prevents the membrane localisation of KSR, thus 
preventing MAPK activation (Cry et al., 2003). Thus the similarity o f Raf and KSR 
regulation by PP2A and 14-3-3 is remarkable.
As scaffolding proteins organise and facilitate Raf interactions, other proteins inhibit the 
formation of the active signalling complex. Raf kinase inhibitory protein (RKIP) was 
initially identified in a yeast-two-hybrid screen for proteins interacting with the C-terminal
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kinase domain of Raf-1 (Yeung et aL, 1999). RKIP interacts not only with Raf-1 but also 
with MEK and ERK, but fails to interact with Ras. This is similar to KSR but the function 
of RKIP is quite the opposite. RKIP inhibits Raf dependent phosphorylation of MEK in- 
vitro and in-vivo, but does not affect ERK phosphorylation by constitutively active MEK 
mutants in-vitro or in-vivo, suggesting that RKIP functions at the Raf/MEK interface. 
Furthermore the inhibitory function of RKIP is very specific to MEK phosphorylation by 
Raf as it does not reduce the kinase activity of Raf-1 per se, and RKIP does not inhibit 
MEK phosphorylation by MEKKl. RKIP acts by specifically disrupting the physical 
interaction between Raf-1 and MEK, thus behaving like a competitive inhibitor. 
Interestingly, the Raf-1 domains needed for MEK and RKIP binding and the MEK 
domains needed for Raf and RKIP interaction do not overlap, suggesting that RKIP does 
not function as a straightforward competitor but reduces the affinity of Raf towards MEK 
by either inducing a conformational change or by steric hindrance (Yeung et al., 2000). In 
accordance with these findings, RKIP-bound Raf-1 is unable to bind to MEK and vice 
versa, whereas MEK and ERK are able to bind to RKIP simultaneously. Upon activation 
with mitogens, RKIP can be phosphorylated by protein kinase C (PKC) which causes it to 
dissociate from Raf-1 (Corbit et al., 2003; Lorenz et al., 2003). RKIP is phosphorylated by 
PKC on serine 153, which reduces its affinity for Raf-1, but enables it to bind and inhibit 
G-protein-coupled receptor kinase 2 (GRK-2). This inhibits receptor internalisation and 
enhances signalling through both G-protein-coupled receptors and the ERK pathway 
(Lorenz et al., 2003). PKC phosphorylation of RKIP explains the widely observed RKIP 
dissociation from Raf-1 upon stimulation with mitogens, although it cannot be excluded 
that other kinases or mechanisms, such as direct modifications of Raf, contribute to this 
dissociation. More recently RKIP has been identified as a metastasis suppressor gene in 
prostate cancer (Fu et al., 2003) and malignant melanomas (Schuierer et al., 2004). RKIP 
expression and mRNA levels were widely reduced in the métastasés in comparison to the
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primary tumours. The decrease in RKIP levels correlated with increased phospho-ERK 
levels, confirming the pivotal role of RKIP in regulating MAPK signalling.
1.5 Raf-1 and apoptosis
In mice, one essential role of Raf-1 that could not be compensated by other Raf family 
members is its ability to inhibit apoptosis. Raf-1 is essential for mouse development and 
knocking out the gene resulted in a lethal phenotype (Huser et al., 2001; Mikula et al., 
2001). The mouse embryos died in mid-gestation due to massive apoptosis in the placenta 
and the liver. Apoptosis is the cellular mechanism of programmed cell death and can be 
induced by several stimuli. These stimuli can be divided into intrinsic and extrinsic insults, 
and Raf-1 has been reported to protect against both (Alavi et al., 2003). Replacement of 
wild-type Raf-1 with a mutant, Raf-1 YY340/341FF, which has impaired kinase activity 
and is not efficiently activated by Ras signalling, was sufficient to revert the apoptotic 
phenotype completely (Huser et al., 2001; Mikula et al., 2001). These results confirmed 
previous observations that Raf-1 plays a cmcial role in cell survival and that, at least part 
of this function, is seemingly independent of kinase activity and signalling through the 
MEK/ERK module. Several mechanisms have been so far proposed to explain the function 
of Raf-1 in preventing apoptosis, some of which require MEK/ERK signalling, while some 
require Raf-1 kinase activity while others require neither.
One of the first indications of an anti-apoptotic function of Raf-1 came from the 
observation that the anti-apoptotic Bcl-2 protein was able to bind to Raf-1 and recruit it to 
the mitochondria. Raf-1 was unable to phosphorylate Bcl-2 but it was suggested that it 
could phosphorylate and inactivate the pro-apoptotic protein BAD (von Gise et al., 2001; 
Wang et al., 1996a). However, no Raf-1 phosphorylation site has been detected in BAD 
and it is only a very poor in vitro substrate for Raf-1 (von Gise et al., 2001; Wang et al., 
1996a). Non-phosphorylated BAD can bind to Bcl-2 and prevent it from interacting with 
other proapoptotic BH3-domain proteins such as Bax and Bak. Phosphorylation of BAD
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causes it to bind 14-3-3, which sequesters it to the cytosol. This increases the level of free 
Bcl-2, therefore increasing Bcl-2 and Bax/Bak heterodimerisation and thus preventing 
destabilisation of the mitochondrial membrane potential and release o f cytochrome c. 
Mitochondrial targeting of activated Raf-1 by fusing it to a p70 Mas targeting sequence 
protected the cells to the same extent as over-expression of Bcl-2 and Raf-1, demonstrating 
that mitochondrial translocation and kinase activity was sufficient to inhibit apoptosis (von 
Gise et al., 2001). As kinase activity seems to be required for protection from apoptosis it 
has still to be determined how Raf-1 can be activated at the mitochondrial membrane as no 
conclusive mechanism has been found. There is data suggesting that Bag-1, a protein that 
binds to Bcl-2 and heat shock proteins, could play a role in the activation of Raf-1 at the 
mitochondria as incubation of Raf-1 with recombinant Bag-1 was sufficient to increase 
kinase activity (Wang et al., 1996b), possibly resolving this mystery.
A further potential anchor protein for mitochondrial Raf-1 has been identified as the 
voltage-dependent anion channel (VDAC), a protein crucial for mitochondrial membrane 
trafficking. VDAC was reported to bind to both Raf-1 and Bcl-2 (Le Mellay et al., 2002), 
although the interaction of Raf-1 with VDAC seemed to be Bcl-2 independent. Binding of 
kinase active Raf-1 to VDAC limited the in-vitro reconstitution of VDAC in the outer 
mitochondrial membrane thus reducing the conductivity of the ion-channel and 
cytochrome C release, but had no effect on already established VDAC pores. These reports 
indicate that the anti-apoptotic function of Raf-1 at the mitochondria requires kinase 
activity which contradicts the results obtained in the mouse knock-in studies. The reasons 
for this discrepancy are not presently clear. One possibility is that active Raf-1 at the 
mitochondria protects cells from a different set of stimuli compared to the kinase- 
independent protection mechanism.
It has been shown that Raf-1 can interact with apoptosis signal-regulating kinase 1 (ASKl) 
and prevent apoptosis induced by overexpression of ASKl (Chen et al., 2001). ASKl is an
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important mediator of apoptosis as it can relay pro-apoptotic signals induced by numerous 
insults, such as Fas, TNF-a, DNA-damage and oxidative stress. ASK-1 overexpression has 
been shown to induce mitochondrial dependent cell death. The antiapoptotic function of 
Raf-1 in these studies was MEK independent as inhibiting MEK/ERK signalling did not 
decrease the protective function of Raf-1 and more intriguingly Raf-1 kinase activity was 
not needed either. The direct interaction of Raf-1 and ASKl was essential as apoptosis 
induced by an ASKl truncation mutant that was unable to bind to Raf-1 was not inhibited 
by Raf-1. Additional confirmation of the physiological relevance o f this interaction 
emerged from cross-breeding of ASKl and Raf-1 deficient mice. Mice with a heart- 
specific deletion of Raf-1 showed heart dilatation caused by an increase in cardiomyocyte 
apoptosis . Cross-breeding these mice with ASKl knock-out reverted this phenotype 
suggesting that, at least in the heart, this interaction does prevent ASKl mediated apoptosis 
(Yamaguchi et al., 2004). Perhaps a whole-animal ASK-1/R af 1 knock-out would have 
generated more insights and possibly confirmed if this mechanism is more general.
Another, possibly more general, mechanism how Raf-1 can inhibit apoptosis has been 
identified. MST2, a proapoptotic Ste20-like kinase was found to directly bind to Raf-1. In 
Raf-1 deficient cells MST2 kinase activity was increased and could be further increased 
through Fas signalling. The apparent inhibitory effect of Raf-1 was not dependent on 
kinase activity as kinase dead Raf-1 inhibited MST2 as efficiently as wild type Raf-1. 
Further confirmation of the necessity of this interaction was the observation that a 
simultaneous knock-down o f Raf-1 and MST2 in several cell lines reverted the increased 
apoptotic sensitivity of Raf-1 knock-downs. This indicates that at least a large proportion 
of Raf-1 anti-apoptotic function is dependent on this interaction (O’Neill et al. 2004 in 
press).
Apart from these three anti-apoptotic functions of Raf-1 that are not dependent MAPK- 
signalling, Raf-1 is also involved in survival signalling relayed through MEK and ERK.
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Both MEK and ERK have been shown to have antiapoptotic functions as expression of 
active MEK or ERK is sufficient to repress cell death in several situations. Expression of 
oncogenic v-Raf did also suppress apoptosis through a MEK dependent pathway as this 
effect was nullified by co-expression of dominant negative MEK. Furthermore it was 
shown that Akt was necessary for Raf/MEK dependent cell survival (von Gise et al.,
2001). This suggests that Raf/MEK signalling activates PI 3-kinase and subsequently Akt. 
Active Akt then has the ability to inhibit apoptosis by phosphorylating several down­
stream targets. It has seen shown that phosphorylation o f BAD is Akt and ERK dependent 
(Cross et al., 1995; Flayakawa et al., 2000; Scheid and Duronio, 1998) as well as dependent 
on phosphorylation and inactivation of proapoptotic GSK-3(3 (Cross et al., 1995).
In another study using human endothelial cells, the pathways through which Raf-1 could 
protect from apoptosis were separated (Alavi et al., 2003). The authors showed that 
extrinsic apoptotic insults, such as death receptor signalling, were inhibited if Src 
dependent tyrosine phosphorylation of the 340/341 sites was induced by vascular 
endothelial growth factor (VEGF). On the other hand signalling through the S338 kinase 
(possibly Pak), stimulated by bFGF, resulted in phosphorylation of serine 338 and could 
protect from intrinsic apoptotic insults, such as starvation and DNA damage. The induction 
of phosphorylation at serine 338 resulted in mitochondrial translocation of Raf-1 and quite 
intriguingly mutation of the serine at the 338/339 position to alanines inhibited the sub- 
cellular redistribution indicating that serine 338 phosphorylation might be essential for 
mitochondrial translocation and protection form apoptosis.
Taken together, these studies provide strong evidence for a role of Raf-1 in apoptosis 
protection. Clearly, much more work is needed to clarify the physiological relevance of 
these different mechanisms by which Raf-1 is proposed to act and to determine if they 
coexist in cells or whether they are cell-type or species specific. In addition, the
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relationship, if any, between Raf-1 dependent apoptosis protection and other anti-apoptotic 
pathways (e.g. Akt) requires further investigation.
1.6 Proteomic analysis of differentially expressed proteins
1.6.1 Two-dimensional gel electrophoresis
Proteomic analysis of proteins generally requires the initial separation of the proteins in the 
sample. In less complex samples conventional one dimensional gel electrophoresis may be 
sufficient to separate the proteins but the resolution limit of this method is quickly reached 
in biological samples. Therefore more powerful methods have to be used especially if the 
samples contain hundreds to thousands of individual proteins, a complexity easily reached 
in cell lysates as an example. If the resolution of one dimensional separation is not 
sufficient a second separation that is perpendicular to the first can improve the overall 
capacity of the method. Thus, two-dimensional gel electrophoresis has been used for 
samples of medium to high complexity. The most widely used first dimension in protein 
analysis is the separation according to the isoelectric point using immobilised pH gradients 
(reviewed in (Gorg et al., 2000). Typically the sample is denatured with strong chaotropic 
reagents and solubilised using non-ionic detergents, as these do not affect the overall 
charge and hence migration of the protein. The protein mixture is then separated in an 
electric field and the proteins migrate in the pH gradient to the point where they do not 
carry any net charge, the isoelectric point. This point is not only dependent on the primary
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f  the protein, i.e. the amino acid composition, but is also strongly affected by 
posttranslational modifications. In particular, modifications that alter or introduce acidic or 
basic groups change the isoelectric point noticeably, therefore enabling the separation of 
differentially modified protein isoforms. It is therefore possible to detect changes in the 
phosphorylation status, as this modification introduces a strongly acidic group onto a less 
acidic amino acid, thus decreasing the isoelectric point of the overall protein. The second 
dimension is normally a denaturing sodium dodecylsulfate polyacrylamide gel (SDS-
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PAGE) that separates the proteins according to size resulting in a gel separated by the 
isoelectric point on the x and molecular weight on the y axis. These gels can resolve 
several thousand individual proteins into single protein spots enabling the simultaneous 
comparison of a large number of proteins in one sample.
The proteins separated by 2D gel electrophoresis are then stained by either conventional 
methods such as silver or Coomassie staining or by fluorescent dyes that either bind to the 
proteins or the SDS molecules surrounding the protein in the gel (Steinberg et al., 1996). A 
comparison between individual samples separated by 2D gels can reveal differentially 
expressed and differentially modified proteins on a large scale. The final stage of analysis 
is the identification of the differentially expressed or modified proteins, which can be 
either performed by Edman sequencing or by mass spectrometric methods (Shevchenko et 
al., 1996).
1.6.2 Soft ionisation methods and mass spectrometric analysers
The mass spectrometric analysis of proteins and peptides began in the 1960s with the 
introduction of electron impact and chemical ionisation mass spectrometry. These methods 
are limited with respect to the maximal weight of the molecules that can be analysed as 
they have to be transferred into the gas phase before ionisation can occur. This limited the 
methods to thermically stable and evaporable substances and chemical modification were 
necessary in order to analyse peptides. The introduction of ionisation methods in a 
condensed phase was able to alleviate the problems encountered in the gas-phase ionisation 
methods. Electrospray (Whitehouse et al., 1985) and matrix assisted laser desorption 
ionisation (MALDI) (Karas and Hillenkamp, 1988) are the two most widely used “soft” 
ionisation techniques used to date and have replaced other methods (Figure 1.2), such as 
fast atom bombardment and plasma desorption (Macfarlane and Torgerson, 1976; Morris 
et al., 1981). These soft methods enable ionisation of peptides and proteins directly form 
the condensed phase, so that no derivatisation is needed for thermolabile and non-volatile
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m olecules, such as pro teins and peptides. M A L D I w as in troduced  in the late 1980s and 
represents an ion isation technique suitable for peptides and pro teins. T he ion isation  is 
perform ed in solid  phase. The sam ple is m ixed  w ith  an UV absorb ing  m ixture and co ­
crystallised on a m etal target. T he ions are generated  by irrad ia ting  the sam ple/m atrix  
crystals w ith a pu lse o f  light generated  by a U V  laser. This leads to desorption  o f  m atrix 
and sam ple m olecu les and ions. The ions are then accelerated  in an electric field in a 
vacuum  and their flight tim e is m easured at the end o f  a flight tube (tim e-of-fligh t 
analyser/TO F). T he flight tim e is d irectly  proportional to their m ass over charge (m /z), 
therefore it can be translated  into m ass units w ith  the appropriate  calibration. TO F 
analysers com bine speed, w ide m ass range and ex trem e sensitiv ity  as all ions are detected  
(Figure 1.3B).
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Figure 1.2: Schem atic draw ings o f  soft ionisation m ethods. A) Electrospray ionisation: The analyte 
solution flow passes through the electrospray needle that has a high potential difference applied to it 
(typically in the range from  l-2.5kV ). This forces the spraying o f  charged droplets from  the needle with 
a surface charge o f  the sam e polarity  to the charge on the needle. The droplets are repelled from  the 
needle tow ards the source sam pling cone on the counter electrode (shown in blue). As the droplets 
traverse the space solvent evaporation occurs until the ions are left w ithout solvent. B) M atrix assisted 
laser desorption ionisation: The solid analyte/m atrix solution is irradiated w ith a UV laser beam . The 
m atrix absorbs at that w avelength and transfers the energy to the analyte resulting in the evaporation o f  
the matrix and analyte. The m atrix m olecules stabilise in the gas phase by protonating the analyte 
molecules, leading to m atrix and sam ple ions.
In contrast to M A L D I the sam ple ion isation  in ESI occurs in solution. The analyte is 
introduced to the source either loaded into a nanospray  needle (nano-flow  ES) (W ilm  and 
M ann, 1996) or w ith  a constan t flow generated  from a H PLC  pum p (LC -M S). The 
solubilised sam ple is sprayed from  a needle that carries a voltage potential. Sm all charged 
droplets are form ed and repelled  from  the needle that carries the sam e charge. T he solvent 
starts to evaporate as the droplets travel th rough the space tow ards the sam ple cone
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attached to the counter electrode and are finally sucked into the mass spectrometer. The 
solvent in the droplets surrounding the sample ions is completely evaporated whilst the 
droplet proceeds through several stages of pressure reduction until the ion is left “naked”. 
The ion is then transported to the analyser. Contrary to MALDI, ESI generated ions tend to 
carry multiple charges and peptides commonly carry more than one charge. The 
introduction of nanospray ionisation (nano ESI) decreased the sample consumption of 
electrospray ionisation, thereby increasing the sensitivity by several orders of magnitude, 
as signal intensity of electrospray ionisation is dependent on the concentration of the 
sample.
As ESI produces a steady stream of ions, quite in contrast to the pulse generated in 
MALDI sources by the laser beam, TOF analysers are not the preferred method of 
separating these ions, since TOF analysers use pulsed accelerations and are not compatible 
with constant ion currents. Most widely used in conjunction with ESI are quadrupole 
analysers because of their compactness, robustness and compatibility with a steady ion 
stream. The quadrupole consists of four metal rods that are assembled in parallel. A 
varying voltage is applied to the metal rods that results in a fluctuating electric field. At a 
certain voltage and voltage to frequency ratio (radio frequency (RF)/DC is constant) only 
ions with a specific m/z value can pass through the electric field and reach the detector. By 
varying the voltage and RF the nature of the electric field can be changed, allowing ions 
with different m/z to pass, thereby enabling scanning through the whole mass range 
(Figure 1.3 A).
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Other analysers used for ESI are ion traps. The ions, produced in the source of the 
instrument, enter into the trap through the inlet and are trapped through action of the three 
electrodes: the ring electrode and the entrance and exit endcap electrodes. The ions are 
forced into a stable trajectory by varying the potentials of these electrodes. For detection of 
the ions the potentials are varied hence destabilising the trajectories of ions with a certain 
m/z ratio. Thus these ions are released from the trap and can be detected in order of 
increasing m/z. More recently linear ion traps have been constructed (LIT), the advantage 
of these analysers is their ability to function either as a quadruple or as an ion trap, hence 
combining the versatility of the quadrupole analyser with the enhanced sensitivity of an 
ion-trap.
1.6.. 3 Mass spectrometric protein identification methods
The identification of a protein in a database by using a set o f molecular masses generated 
by proteolytic digest is called peptide mass fingerprinting. This method emerged over 10 
years ago as the first mass spectrometric method to identify proteins isolated from 2- 
dimensional gels. Before that, proteins had to be either identified by Edman sequencing, a 
time consuming and insensitive method whereas MALDI based peptide mass 
fingerprinting enabled rapid and sensitive identification of gel separated proteins in an 
automated fashion with high accuracy (Henzel et al., 1993; Mann et al., 1993; Pappin et 
al., 1993; Yates et al., 1993). Soon afterwards other methods were developed that used 
short sequence data obtained by fragmenting peptides in the mass spectrometer, so called 
peptide sequence tags (Mann and Wilm, 1994), for searching against a protein or expressed 
sequence tag (EST) database (Neubauer et a l, 1998). This method, especially if combined 
with peptide mass fingerprinting, increased the accuracy of the protein identification and 
also made it feasible to de-novo sequence at least small parts o f proteins not present in the 
database. In contrast to peptide mass fingerprinting the generation of peptide sequence tags 
is more laborious and not robustly automatable. The operator has to identify possible
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sequence fragments by hand and by experience, making large scale analyses of 
fragmentation data a daunting task. This was resolved with the advent of fully automated 
search programs that did not use amino acid sequences generated by the operator, but used 
the raw MS/MS data and by comparing the fragmentation to the theoretical fragmentation 
of peptides derived from theoretical digests of proteins present in databases (Perkins et al., 
1999; Yates et al., 1995).
The increasing size of the databases following large scale sequencing projects increases the 
chance of the protein identification as the protein is more likely to be present in the 
database. However, the expansion of the databases presented the field with new problems 
as it also increased the chances of a false positive identification, creating the need for more 
accurate and reliable methods. This need was met by the development of more advanced 
mass spectrometers with increased resolution, mass accuracy and sensitivity. Delayed 
extraction (Brown and Lennon, 1995) combined with reflectrons (Brown and Lennon,
1995) increased the mass accuracy and resolution of MALDI-TOF machines to such an 
extent that mass accuracy below 20ppm is routinely achievable with in-gel digested 
biological samples, facilitating protein identification by peptide mass fingerprinting. More 
recently new hybrid mass spectrometers have become widely available that combine high 
sensitivity and mass accuracy with the possibility to obtain fragmentation data (Brown and 
Lennon, 1995). Triple quadrupole and ion-trap mass spectrometers were the first 
generation of machines used routinely for peptide fragmentation (see Figure 1.4A for an 
example of a triple quadrupole/linear-ion trap mass spectrometer). Later on, quadrupole- 
TOF machines became available with the benefit of a high resolving, fast and sensitive 
second analyser (Figure 1.4B). More recently TOF-TOF mass spectrometers have been 
developed (Medzihradszky et al., 2000). This specific setup enables the fast generation of 
sequence data form MALDI-ionised samples, combining the speed and sensitivity of 
MALDI-TOF data acquisition with the generation o f fragmentation data that usually 
required ES ionisation techniques.
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Figure 1.4: Schem atic d raw ings a quadrupole/T O F  and a q u ad rupo le /linear ion -trap  hybrid  mass 
spectrom eter. QO is a RF-only quadrupole used to cool the ion beam, Q l can be used in selective RF/DC 
mode for product/precursor/neutral loss or a RF-only for standard MS. Q2 is an enclosed pressurised 
quadrupole used for CID. A) Q3 can be used as a standard RF/DC quadrupole for precursor/neutral loss 
scans or as a linear ion trap (LIT) for MS and MS/MS scans. B) The second analyser is a time o f flight that 
can be used for MS, MS/MS and for precursor ion scans.
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1.7 Analysis of Protein-Protein interactions
Signal transduction, the cell cycle, targeted proteolysis and gene expression are just a few 
examples of cellular events that are regulated by protein-protein interactions. These 
interactions, often regulated by interaction domains, organise enzymes, scaffolds and 
adaptors into ftmctional multiprotein signalling complexes that execute distinctive 
functions (reviewed in (Pawson and Nash, 2003). The regulation of these interactions is 
essential for the understanding of cellular regulation, as interacting proteins often link 
signalling modules from the receptors to their ultimate substrate. Typically, protein-protein 
interactions require distinctive interaction domains that regulate the assembly of the 
complexes. Some of these domains, for instance SH2 and PTB domains, require modified 
amino acids for the interaction. These domains are present in a multitude of cytoplasmic 
proteins and they directly recognise phosphorylated tyrosines, which are typically found on 
activated tyrosine kinase receptors, The phospho-tyrosine dependent assembly of 
signalling complexes at activated tyrosine kinase receptors enables the transmission of 
receptor signals to their cytoplasmic targets. Phosphoserine and threonine on the other 
hand can be recognised by WD40 repeats, 14-3-3 and FHA domains driving the assembly 
of other protein complexes as the result of reversible phosphorylation.
Because of the multitude of regulations exerted by protein-protein interactions, it is not 
surprising that a multitude of methods has been developed that address the detection of 
potential interacting proteins. Some of these are based on yeast genetics, while others are 
based on in-vitro protein interactions and on affinity purifications of complexes that are 
formed in-vivo.
1.7.1 Yeast two hybrid screens
The two hybrid system is a molecular biological tool that enables the screening for protein- 
protein interactions. Developed fifteen years ago it is probably the most widely used
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screening method for these interactions (Fields and Song, 1989). It is based on the fact that 
the DNA binding and transcriptional activation domains of transcription factors can 
function as independent modules that v\ill form a functional transcription factor even when 
artificially linked. Initially the system used the Gal4 transcription factor to assay for 
interacting proteins. One gene sequence is fused to the Gal4 binding domain and the other 
is fused to the Gal4 activating domain to produce chimeric proteins that are co-expressed 
in a yeast cell. If the two test proteins interact they reconstitute a functional transcription 
factor that can initiate Gal4 driven transcription. This transcription can then initiate the 
transcription of an essential marker gene, which usually encodes a metabolic enzyme that 
enables the colony to grow in selection medium. Refined systems usually have more than 
one marker gene with different copies of the Gal4 DNA binding motif in their promoters. 
Promoters with more binding sites are more sensitive and respond to weaker interactions 
than promoters with only one binding site, thus permitting a semiquantitative evaluation of 
the strength of the interaction. By using the protein or protein domain of interest as bait a 
library of chimeric proteins can be screened for interaction partners. The surviving 
colonies are then isolated and the chimeric proteins that interacted with the “bait” are 
identified by reisolating the expression plasmids and sequencing the gene inserts. This 
simple and powerful assay enables large library screens, and screens of complete genomes 
have been produced (Ito et al., 2001; Uetz et al., 2000), identifying a myriad of protein- 
protein interactions. Several variations of the original two-hybrid system have been 
developed more recently. A general shortcoming of the yeast two hybrid system is that it 
only detects binary interactions, and that the interactions have to take place in the nucleus 
of a yeast cell, which is a rather artificial environment for most proteins, e.g. membrane 
proteins. In order to remedy the latter shortcoming, Ras and SOS recruitment systems have 
been developed (Aronheim et al., 1997; Broder et al., 1998; Hubsman et al., 2001). Both 
are based on a different readout than the original yeast two hybrid screen and these 
methods can overcome some shortcomings of the transcriptional based selection. The
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selection is based on the activation of Ras at the membrane by bringing Ras to the vicinity 
of the SOS exchange factor through interacting proteins. In the Ras recruitment screen 
active Ras, lacking the membrane localising CAAX-box is fused to the bait proteins and 
the “prey” protein is fused with a membrane targeting sequence. If “bait” and “prey” 
interact physically, active Ras is localised at the membrane and enables the survival of the 
cell. These assays are suitable for hydrophobic membrane proteins as the bait is localised 
at the membrane and does not require nuclear localisation and solubility. Furthermore 
some basic interaction studies can be performed in mammalian systems (Maroun and 
Aronheim, 1999).
Other variants of this screen include reverse two-hybrid screens that screen for mutations 
and molecules that disrupt a pre-existing protein-protein interaction (Leanna and Hannink,
1996) and yeast-three-hybrid screens that screen for protein/protein/ RNA interactions 
(SenGupta et al., 1996; Zhang and Lautar, 1996).
1.7.2 Protein arrays
Several recent reports have used purified recombinant proteins immobilised to a matrix to 
study protein-protein interactions (Ge, 2000; MacBeath and Schreiber, 2000; 
Ramachandran et al., 2004; Zhu et al., 2001). Zhu et al. produced protein chips containing 
purified proteins derived from 5800 yeast open reading frames, enabling a genome wide 
screen for interacting proteins. The purified proteins are printed at high density onto glass 
slides and are fixed to the surface with reactive cross-linkers or by affinity interactions. 
These chips can then be used to screen for protein-protein and protein-phospholipid 
interactions. The protein-protein or protein-phospholipid interactions are formed by 
incubating the molecule that is screened with the protein-chip. The interactions are formed 
and after intensive wash steps, specifically binding molecules can be detected on the chip 
by a multitude of techniques, such as chemoluminiscence, fluorescence and radioactivity. 
So far protein microarrays have been used in “proof of principle” studies in yeast and on a
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small scale in mammalian systems. Large scale mammalian protein microarrays have still 
to be produced, but clearly the application of these chips will contribute to our knowledge 
of protein-protein interactions as well as other interactions mediated by protein domains, 
such as drug and DNA binding.
1.7.3 Protein-protein interaction screening using mass spectrometric methods 
Mass spectrometric methods have both been used to screen for interacting proteins as well 
as for determining possible interaction domains, such as antibody epitope screening. The 
analysis of interacting sequences relies on limited proteolysis of two interacting proteins 
and assaying for peptide sequences that have not been cleaved as an indication of domains 
that are not exposed in a protein complex (Suckau et al., 1990), or on the ability of the 
interacting protein to specifically affinity purify the peptides (Zhao et al., 1996). Other 
methods to detect the interacting sequences involve deuterium-hydrogen exchange 
reactions as these reactions occur more quickly on exposed amino acids (Anand et al., 
2002; Hughes et al., 2001; Mandell et al., 2001; Mandell et al., 1998). Upon formation of a 
complex the interacting sequences are not exposed to the solvent anymore, therefore the 
exchange is slower. A direct comparison of peptides derived from the digested isolated and 
the complexed protein can reveal the sequences that are involved in the interaction.
The methods involved in screening for interacting proteins are more straightforward and 
utilise the ability of mass spectrometric methods to identify proteins. Protein pull-downs 
and co-precipitations are two of the most widely used methods for proteomic interaction 
screening. Both methods have been used successfully and have distinctive advantages and 
produce complementary information when used in parallel (compare (Jin et al., 2004; 
Rubio et al., 2004) (reviewed in (Aebersold and Mann, 2003).
Protein pull-downs involve the binding of a purified recombinant protein to a matrix, 
which is then exposed to a protein lysate. Interacting proteins that bind to the bait protein
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can be identified by mass spectrometric methods after being eluted from the bait. The 
formation of complexes in pull-down assays takes place in-vitro, quite in contrast to co­
precipitation experiments. In these experiments the complex is formed in the cell and the 
intact complexes are then precipitated by binding the bait protein to an affinity matrix. As 
the success of this purification relies on enriching intact complexes it is crucial that the 
complex is not disrupted by the purification process, hence mild, non-denaturing 
conditions and speed are two crucial factors for a successful analysis.
The most common affinity purification for co-precipitations studies is antibody based, and 
some problems can arise by using this purification method. Certain protein complexes 
might not be purified because an interacting protein is masking the binding epitope of the 
antibody. Moreover certain complexes can be disrupted by the interaction of the antibody 
with the epitope, thus limiting the identification of interacting proteins.
Although immunoprécipitation of endogenous, untagged proteins is feasible, most 
purifications rely on the use of overexpressed, tagged proteins. The introduction of a tag 
into the bait protein has several advantages over protein specific immunoprécipitations. A 
specific tag can allow a very high degree of purification in a single step, as highly specific 
antibodies are commercially available. Moreover, elution can often be performed under 
mild conditions by using immunospecific peptides that preserve the complex and its 
biological activity. Importantly, the conditions for purification are generally more 
dependent on the affinity tag than on the protein to which it is attached. Purification 
methods can be optimised and standardized for a particular tag, allowing many different 
proteins or complexes to be purified by essentially similar methods.
As mentioned before the ease and reproducibility of the purification is essential for 
successful large scale screen. A single tag is often insufficient for homogeneity so several 
systems have been developed that fuse two more tags (Honey et al., 2001; Rigaut et al..
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1999) to the bait protein. The introduction of several tags allows the consecutive affinity 
purification resulting in a higher purity of the purified protein complex. These tandem 
affinity purification tags (TAP tags) have been developed in yeast but more recently tags 
compatible with mammalian expression systems have been developed. However, one 
drawback of this approach is that the two-step method increases the purification time, 
which might eliminate the identification of transient or weak interactions.
Subsequently the eluted complexes can be separated by denaturing, native or by 2D gel 
electrophoresis and then identified by MALDI or ESI. Successful identification of the 
molecular components of these complexes requires highly sensitive approaches. Most 
commonly the proteins separated by PAGE are digested in-gel and identified by MALDI 
mass fingerprinting (Mann et al., 1993; Pappin et al., 1993), although the identification rate 
can be increased if tandem mass spectrometry methods are used. The first large scale 
analyses of this type used a single FLAG-tag or a TAP-tag to generate tagged proteins of 
10% of the predicted yeast proteome followed by immunopurification, gel electrophoresis 
and mass spectrometric identification of the protein complexes (Gavin et al., 2002; Ho et 
al., 2002). The comparison between this approach and large scale yeast two hybrid screens 
showed discrepancies. The immunopurification approach identified three times more 
interacting proteins, which is not surprising given that the proteomics approach is not 
confined to the detection of binmy interactions, but can identify all the proteins in a 
complex regardless whether their interaction with the bait is direct or indirect. However, 
the proteomics approaches failed to identify about 50% of the proteins found in the yeast- 
two-hybrid approaches, indicating that both methods are complementary (Ito et al., 2002; 
von Mering et al., 2002).
More recently gel-less approaches have been used for complex analysis. Multidimensional 
Protein Identification Technology (MudPIT) (Link et al., 1999), a form of 2D liquid 
chromatography, uses a strong ion-exchange matrix as first and reverse phase LC as
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second dimension in order to separate tryptic peptides that then can be online injected into 
a mass spectrometer for identification. MudPIT has been used in combination with the 
TAP-tag technology in yeast to analyse protein complexes involved in mitosis, identifying 
over 300 potential interactions (Graumann et al., 2004).
1.8 Analysis of phosphopeptides by mass spectrometry
Post-translational modifications are processing events that include either cleavage of the 
protein by proteases to change its properties or the covalent binding of modifying groups to 
one or several amino acids. These modifications can change the protein’s activity, cellular 
location and stability, as well as inducing or disrupting protein-protein interactions. In 
signalling processes, reversible phosphorylation is probably a major determining factor, as 
kinases can be turned on and of by these modifications. Knowledge of the particular 
residues that are phosphorylated can provide insights into the working of a signalling 
cascade, specifically how and when the kinases are activated and which kinases are 
responsible for this action. So it is not surprising that protein phosphorylation is possibly 
the most studied post-translational modification. Protein phosphorylation is one of the 
most ubiquitous modifications of proteins, with approximately 2% of the human genome 
encoding for kinases and possibly up to a third of all proteins being phosphorylatable. 
However, despite the large prevalence of phosphorylation events the identification of the 
specific amino acid which is modified is labour intensive and not always successful 
(Cohen, 2000; Mann et al., 2002).
1.8.1 Radioactive -labelling
The typical procedure used to identify phosphorylation sites involves labelling of a 
substrate protein with radioactive using an appropriate kinase in-vitro. The labelled 
protein in then digested with a protease to obtain peptides that are more amenable to 
further analysis than the full-length proteins. The peptides are then separated by either thin-
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layer-chromatography (TLC) or more recently by high-performance liquid chromatography 
(HPLC) (Boyle et aL, 1991; van der Geer and Hunter, 1994). The collected radioactively 
labelled purified peptides are then generally sequenced by Edman degradation using a 
sequencer. The amino acid composition and the position of the radioactive aminoacid can 
be determined as the loss of radioactivity is monitored after each cycle and the nature of 
the amino acid is determined by their characteristic HPLC retention times. However this 
method can be insensitive, and successful identification requires large amounts of 
phosphopeptides that are challenging to obtain. The detection of the labelled amino acid on 
the other hand requires little material, therefore the sensitivity of the method can be 
improved vastly by omitting the sequencing step and relying on mass spectrometric 
methods to determine either the mass or the sequence of the phosphorylated peptide (Ben- 
Levy et al., 1995). Instead of submitting the entire HPLC fraction containing the labelled 
peptide to the Edman sequencer, the Edman degradation is only used to determine the 
position of the phosphorylated amino acid by monitoring at which degradation cycle the 
^^P labelled phosphoamino acid is released. The majority of the fraction is analysed by 
mass spectrometry in order to determine the identity of the peptide. The masses of the 
peptides are generally determined by MALDI-TOF mass spectrometry and the presence of 
a phosphorylation site can be further confirmed by post-source decay (PSD) and a neutral 
loss of 90 Da. The Edman sequencing reveals the position of the labelled amino acid and 
the mass spectrum reveals the mass of the peptide. Comparing these findings with a 
theoretical digest of the proteins then reveals the exact position of the phosphorylation site 
in the protein. This method is probably the most successful method used to date and 
thousands of phosphorylation sites have been determined using this set-up.
1.8.2 Affinity purification o f  phosphopeptides
Other methods to determine phosphorylation sites have been used that do not rely on in- 
vitro or in vivo radioactive phosphorylation. These methods attempt to detect
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phosphorylation sites by enriching phosphorylated peptides by affinity purification, by 
modifying phosphorylated amino acids through chemical or biological reactions or by 
specifically detecting phosphorylation sites by “marker ions” with mass spectrometric ions.
To date the preferred enrichment method for phosphopeptides is by immobilised metal ion 
affinity chromatography (IMAC). In this technique, metal ions such as Fe^^ and Ga^^ are 
bound to a chelating support. Agarose or silica gel usually forms the matrix and 
nitrilotriacetic acid (NTA) or iminodiacetic acid (IDA) are the chelating groups (Ficarro et 
al., 2002; Muszynska et al., 1992; Neville et al., 1997; Scanff et al., 1991). 
Phosphopeptides are selectively bound to the chelated metal ion because of the phosphoric 
acid segment. The phosphopeptides are bound at a low pH and can be released by either 
high pH or phosphate buffer. The latter requires further desalting prior to mass 
spectrometric analysis. Limitations to this approach are the possible loss of 
phosphopeptides unable to bind to the matrix, unspecific binding o f unphosphorylated 
peptides and difficulty in eluting multiply phosphorylated peptides. Attempts have been 
made to address all three problems, albeit not completely satisfactorily. Some studies have 
suggested that IDA is less specific than NT A resins while other reported little difference 
(Neville et al., 1997; Nuhse et al., 2003). Moreover Ga^^ ions were reported to be more 
specific than Fe^  ^ ions (Cleverley et al., 1998). Seemingly the specificity of the method is 
highly dependent on the specific binding and elution conditions, but to date no uniquely 
successful method has been suggested and confirmed. Methyl estérification of peptide 
mixtures with methanolic HCl has been reported to enhance selectivity in some systems 
and a high degree of enrichment was obtained in a large scale analysis of the complete 
yeast proteome (Ficarro et al., 2002). The benefit of this modification has been disputed 
more recently as no added benefit was detected. Seemingly the benefit of masking 
carboxyl groups through estérification is dependent on the stringency of the subsequent 
IMAC purification and on the nature of the metal ion and the chelator. Prefractionation by 
strong ion exchange chromatography prior to IMAC was recently reported to enhance the
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enrichment of phosphopeptides and also to increase the proportion of singly 
phosphorylated peptides in the purification (Nuhse et al., 2003). A large scale study 
looked at overall binding and recovery of radiolabelled phosphopeptides derived from in- 
vivo labelled plasma membranes and found that prefractionation and optimisation of 
elution and binding conditions increased the overall level of mono-phosphorylated peptides 
that were detectable. This finding can be explained by the possible out-competition of 
weakly binding phosphopeptides by stronger binding multiply phosphorylated peptides. 
Overall IMAC methodology has improved dramatically over the past years but additional 
method development is still required. Several reports have been published where IMAC 
prefractionation enabled the authors to identify several hundred phosphopeptides in one 
analysis, which although impressive, amounts to only a small fraction of the total 
phosphorylation sites in a whole cell system (Ficarro et al., 2002). It also has to be taken 
into account that these large scale analyses have been performed using large amount of 
material that would not always be available.
In addition to IMAC, immobilised anti-phospho-amino acid antibodies have been used to 
purify phosphopeptides and phosphoproteins. The use of phosphoserine or 
phosphothreonine antibodies for immunoprécipitations has been reported but is not as 
widely used as the corresponding phosphotyrosine based purification. 
Phosphoserine/threonine antibodies have been shown to perform reasonably well in 
immunoprécipitation of whole proteins (Gronborg et al., 2002), but so far have not been 
used as a tool to purify phosphopeptides in order to facilitate phosphorylation site 
mapping. In contrast, phosphotyrosine immunoprécipitations have been used widely in 
phosphorylation mapping approaches, both on protein and peptide level. In some 
approaches phosphotyrosine immunoprécipitations were performed as an initial 
purification of either the complete phosphotyrosine proteome or of a specific protein. The 
enrichment of the phosphoprotein then facilitated the subsequent mapping of the 
phosphorylation site greatly. Normally the first purification step is followed by other
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purifications, either IMAC or PAGE and the analysis of the phosphorylation site is then 
performed by mass spectrometric methods. Anti-phosphotyrosine antibodies have also 
shown to be able to enrich phosphopeptides that were derived from purified tyrosine 
phosphorylated proteins (De Corte et al., 1999). The phosphopeptide was then detected by 
mass spectrometry, either by directly mixing the matrix with the antibody/phosphopeptide 
beads and MALDI analysis, or by eluting the peptide and then analysing it. So far this 
method, although looking promising, has not been exploited to map global phosphorylation 
changes in whole cell lysates.
1.8.3 Modification o f phosphorylation sites
Recently chemical and biological modifications of phosphorylation sites have been utilised 
to map phosphorylation sites in proteins. Three distinctive methods have been utilised to 
convert phosphoserine/threonine amino acids into moieties that are more amenable for 
enrichment and subsequent analysis. All three methods exploit the tendency of alkyl 
phosphate esters to undergo (3-elimination under basic conditions, converting serine into 
dehydroalanine and threonine into 2-amino-2,3-dehydrobutyric acid. The unsaturated 
sidechain can then undergo Michael addition, normally performed by a sulfhydryl moiety. 
This reaction then allows conversion of the former phosphoaminoacid into either a “hook”, 
such as biotin or a sulfhydryl group that can be affinity purified, or a residue similar to 
lysine (Goshe et al., 2001; Jaffe et al., 1998; Knight et ah, 2003; Oda et al., 2001). The 
inclusion of a sidechain similar to lysine changes the tryptic digest pattern and enables the 
detection of the former phosphorylated aminoacid without the need for sequencing, i.e. 
peptide mass fingerprinting. Although these methods have been shown to work with 
purified protein standards, such as casein, they have yet to be proven to be feasible for 
detecting phosphorylation sites involved in signalling pathways. It has to be noted that 
only very simple and efficient chemical derivatisation techniques can be used. If any 
heterogeneity is introduced through these reactions the task of identifying modified amino
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acids becomes more challenging, and only abundant phosphorylation sites might be 
detected. A further drawback of this method is the inability to detect phosphotyrosine 
residues, as these do not undergo ^-elimination.
Dephosphorylation by alkaline phosphatase is one of the most established methods used 
for detecting phosphorylation sites of biological samples (Larsen et al., 2001; Stensballe et 
al., 2001; Zhang et al., 1998). The general procedure is that the sample set is divided into 
two aliquots, one is treated with the phosphatase and the other one is left untreated. The 
mass spectra are then compared to each other. If a shift of 80Da (or multiples of 80Da) is 
detected in the phosphatase treated sample this is regarded as proof of a phosphorylation 
site. This method enables laboratories without MS/MS capabilities to perform at least 
rudimentary phosphopeptide mapping. This general method has been more recently 
combined with IMAC enrichment to obtain a purified phosphopeptide sample. The 
phosphopeptides are then dephosphorylated either prior to or after IMAC. Comparison of 
the non-treated samples with the dephosphorylated ones then reveals the phosphorylation 
sites (Stensballe et al., 2001). This method was recently reported to have been miniaturised 
and performed on a compact disc, where all the steps, from IMAC to MALDI are 
performed on the same surface (Hirschberg et al., 2004). Although method development 
has improved the performance and reliability of this method, the major drawback of this 
method is that without MS/MS data from the phosphorylated peptide, it is impossible to 
detect the exact phosphorylation site if  several potential phosphorylation sites are present 
in the peptide. Further problems arise if isobaric peptides are present and if the exact 
sequence of the protein to be analysed is unknown.
1.8.4 Precursor ion and neutral loss scanning
Phosphopeptides behave atypically after being ionised in the mass spectrometer. Peptides 
containing unmodified amino acids fragment under low energy collision induced 
dissociation (CID) conditions normally around the peptide bond of the peptide backbone.
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Side-chain fragmentations occur only at very high collision energies and are not normally 
observed under these conditions. Quite the opposite occurs with peptides that carry a 
phosphorylated amino acid. The phosphate group is quite unstable and the phosphoester 
group is more likely to fragment upon CID, rendering it possible to scan for the 
phosphospecifrc marker ions.
The hallmark of phosphorylated aliphatic amino acids is the tendency to P-eliminate 
phosphoric acid upon CID and under basic conditions. This lability is not only exploited 
for chemical modifications, but is also utilised to produce a marker of phosphorylation in 
mass spectrometry. The ionised peptide undergoes CID and phosphoric acid is eliminated 
resulting in loss of 98Da. The charge of the ion does not change upon dissociation of this 
fragment, therefore the loss is called neutral. The analysis is normally performed using 
mass spectrometers that contain two analysers. The first analyser, typically a quadrupole, 
scans through the mass range, while the second analyser scans at an offset of -98Da, the 
mass shift resulting from the loss of phosphoric acid (Figure I.5B). The ions undergo CID 
between the analysers and therefore only peptides that produce a product ion with a mass 
difference of 98Da, equalling the loss of phosphoric acid, are recorded. Ions identified can 
then be scanned to obtain complete MS/MS data that then ideally reveal the sequence and 
the site of the phosphorylated amino acid. This method has been widely used for 
phosphopeptide mapping, initially using triple quadrupole mass spectrometers (Schlosser 
et al., 2001), but more recently using Q-TOFs (Bateman et al., 2002). The enhanced 
resolution and mass accuracy of the TOF analyser has been reported to enhance this 
scanning method by reducing false positive identifications. As the scan is performed in 
positive-ion mode and no switching is required for a subsequent MS/MS scan, which is 
also performed in positive-ion mode, this facilitates automated method development. Thus 
this method has been widely used in conjunction with HPLC separation of the peptide 
mixtures (Hunter and Games, 1994). Problems arise from the fact that the value of the 
neutral loss depends on the charge state of the precursor, i.e. 49 for doubly charged and
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32.33 for trip ly  charged ions, thus both losses have to be scanned. T his not on ly  increases 
the scan time, thus lim iting the sensitivity, but also increases the likelihood o f  false 
positive identifications.
Precursor ion scan
Q1 Q2/CID 0 3
Scanning X
01
CID
Neutral loss scan
Q2/CID
Scanning for -79D a
0 3
Scanning X CID Scanning m/z= X -(98Da)/z
Figure 1.5: Schem atic draw ings of precursor-ion  and neu tra l loss scans used for phosphopeptide 
analysis using a trip le  q u ad rupo le  mass spectrom eter. A) Q1 is in RF/DC mode and scans the whole mass 
range, Q2 induces CID o f the ions selected by Q l, Q3 scans in RF/DC mode for m/z 79. B) Q1 is in RF/DC 
mode and scans the whole mass range, Q2 induces CID of the ions selected by Q l, Q3 scans in RF/DC with 
an offset to Ql equalling the mass o f phosphoric acid.
N eutral loss is not the only  m ass spectrom etric m ethod used to scan for phosphopeptides. 
A precursor ion scan is a m ass spectrom etric m ethod that is used to identify  the m ass o f  the 
precursor o f  a fragm ent. Tw o distinctive p recursor ion scans have been used for 
phosphopeptide m apping. T he first and m ore w idely  used m ethod  scans for the p recursor 
o f  PO3 and the second scans for the precursor o f  the phosphotyrosine-im m onium  ion.
The P O 3" precursor ion scan has been w idely  used for several years and is p robab ly  one o f  
the m ost successful m ass spectrom etry  based m ethods for phosphory lation  site m apping  
(C arr et al., 1996; N eubauer and M ann, 1999; W ilm  et al., 1996) (rev iew ed in (N eubauer
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and Mann, 1999). The method requires a mass spectrometer with two analysers, similar to 
neutral loss scanning, and is in performed in negative-ion mode. The first analyser scans 
through the whole mass range and the second analyser screens for a fragment of -79Da, the 
mass of PO3 . If the -79Da fragment is detected after the second analyser this indicates that 
the precursor ion contained a phosphorylated amino acid (Figure 1.5A). As there are few 
CID induced negatively charged peptide fragments that are isobaric, this method is highly 
specific and only few false positive identifications are expected. However this type of scan 
is not without difficulties. The pH of the spray is required to be basic to obtain optimal 
sensitivity, a condition unsuitable for HPLC separations. Thus, prefractionation is normally 
performed off-line. Furthermore it is quite challenging to obtain a stable spray in negative 
ion mode as this is frequently hampered by discharges from the tip of the capillary, further 
complicating matters. In addition, peptide sequencing in negative ion mode is not feasible 
and an additional positive ion MS/MS spectrum has to be acquired. This involves 
rebuffering the solvent to lower the pH or the use of another aliquot, further increasing 
sample handling time. Initially this method was not used in conjunction wdth HPLC 
because of the mentioned limitations, but recent publications have shown that using a 
multidimensional approach LC separation is feasible and enables to analyse more complex 
samples (Annan et al., 2001; Zappacosta et al., 2004; Zappacosta et al., 2002).
With the appearance of Q-TOF mass spectrometers another precursor ion scan method has 
been reported that takes advantage of the superior resolution of the TOF analyser. Unlike 
aliphatic phospho-amino acids, the phosphorylation residue of the tyrosine side chain is 
stable under positive-ion CID conditions and the intact phosphotyrosine immonium ion, 
with a mass of 216.04Da, is detectable in product ion scans. Unfortunately several 
theoretical fragments possess a similar mass to the immonium ion and would so increase 
false positive identifications. With the advent of hybrid mass spectrometers and the high 
resolution TOF analyser this did not represent a challenge anymore as the resolution is 
high enough to distinguish between the different ions (Steen et al., 2001a). The feasibility
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of the method was shown in studies o f EGF induced tyrosine phosphorylation (Steen et aL,
2002) and to map Abl phosphorylation sites (Steen et al., 2003). The main advantage of 
this method in comparison to the -79 precursor ion scan is that it is performed at low pH in 
positive ion mode, therefore sequencing can be done in the same experiment.
1.9 Concluding remarks
A relatively small number of signalling pathways in the cells enables the cell to react 
appropriately and with a high degree of specificity toward a multitude of extracellular 
signals. This high degree of flexibility and fidelity requires a high degree of spatial and 
temporal control of the kinase cascade and it is becoming increasingly accepted that the 
interplay of protein-protein interactions in combination with phosphorylation events 
substantially determine the final outcome of the signal, would it be differentiation, 
proliferation or cell death. To fully understand signalling pathways it is therefore not 
sufficient to determine the outcome of the signal but also to analyse the individual 
complexes and the regulation of their formation and turnover. As mentioned beforehand 
phosphorylation events do not only effect enzymatic activities but play also a crucial role 
in assembling these multiprotein signalling entities, such as linking receptors to their 
substrates.
We are interested in Raf-1 mediated signalling and therefore decided to use proteomic 
techniques to gain a deeper understanding of Raf-1 regulated signalling. We decided not 
only to determine the effects Raf-1 has on a whole cell system, but wanted also to detect 
and identify changes in Raf-1 protein complexes that are dependent on specific 
extracellular signals. Furthermore, as phosphorylation plays a pivotal role in signalling 
events, we wanted to analyse the phosphorylation status in these complexes and determine 
their effects.
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Chapter 2
Materials & Experimental Procedures
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2.1 Materials
2.1.1 Antiserum:
All antiserum was used at a concentration of 1:1000 unless otherwise stated
BD Transduction Labs
Anti Raf-1 (R19120)
Anti PP5; used at 1/500 
Calbiochem
Anti pS621 Raf-1 
Cell signalling
Anti pS338 Raf-1 
New England Biolabs
Anti phospho-ERK (9101)
Anti MEKl/2 (9122)
Anti phosphoMEKl/2 (9121)
Anti pS259 Raf-1 
Santa Cruz
Anti GST: used at 1:5000 
Anti-Raf-1 C12 
Anti G al2
Sigma
Anti ERKl/2 (M5670)
Anti phosphoERKl/2
2.1.2 General reagents
All reagents were purchased from Sigma, unless listed here.
Amersham Pharmacia: ^^P-ATP, GST-Sepharose, protein A-Sepharose, protein G- 
Sepharose, Cy2, Cy3, Cy5 DIGE dyes, PVDF blotting membrane, SDS gel caster, SDS gel 
running tank. Western blotting tank, Ettan 2D gel equipment, Typhoon laser scanner, IPG- 
strips, Pharmalytes
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Becton Dickinson, Collaborative Research: 10cm tissue culture dishes 
Biorad: agarose tanks and agarose gel casters 
Calbiochem: Nonidet P-40
Cell Signalling/New England Biolabs: mouse secondary antibody (HRP conjugate), 
rabbit secondary antibody (HRP conjugate)
Costar: plates for tissue culture
Fisher Scientific: glycerol, glycine, KCl, MgClz, MgS0 4 , NaCl, SDS 
Invitrogen: LipofectAMlNE and LipofectAMlNE 2000 transfection reagent 
Kodak: Ammonium Persulphate
Life Technologies/Gibco: BL21 (DE3) competent cells, DH5a competent cells, DMEM, 
Hepes, I^glutamine, MBP, trypsin 
Melford Laboratories: IPTG, Tris base 
Nunc: tissue culture flasks
Qiagen: Effectene transfection reagent, plasmid purification kits (mini and maxi),
Roche diagnostics/Boehringer Mannheim: blocking reagent, ECL (enhanced
chemiluminescence) system, EDTA, EGTA, leupeptin, Tris-HCl,
Stratagene: Mutagenic PCR kit
Severn Biotech Ltd: 30% Acrylamide (37.5:1 bis-acrylamide)
Sterilin: dishes for agar plates
2.1.3 Plasmids
FLAG-Raf-1; obtained from D. Morrison; vector: pCDNA3 purchased from Invitrogen; 
promoter: CMV (all Raf-1 mutants were produced by site specific mutagenesis using this 
plasmid as a template)
HA-PP5; obtained form T. Cohen; vector CMV; promoter CMV 
Gal2 and Gal2QL; a gift from Silvio Gutkind
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2.1.4 Primers
All primers were made by technology services staff at the Beatson Institute. All primers 
are written 5 ’ to 3’
PP5 mutation of 304 H to A- forward
CCT TCG AGG CAA CGC CGA GAC AGA CAA CAT G
PP5 mutation of 304 H to A
CAT GTT GTC TGT CTC GGC GTT GCC TCG AAG G 
Raf-1 SS338/339DE -  forward
GGC CTC GTG GAC AGA GAG ATG ACA GCT ATT ATT GGG AAA TAG 
Raf-1 SS338/339DE -  reverse
CTA TTT CCC AAT AAT AGC TGT CAT CTC TCT GTC CAC GAG GCC 
Raf-1 K375M -  forward
GGA GAT GTT GCA GTA ATG ATC CTA AAG GTT GTC 
Raf-1 K375M -  reverse
GAC AAC CTT TAG GAT CAT TAC TGC AAC ATC TCC
2.2 Cell culture and transfections
2.2.1 Maintenance o f 1 COS-1 cells and 3T3 fibroblasts
Cos-1 were maintained in complete media (DMEM supplemented with 1:100 L-Glutamine 
and 10% PCS). Cells were grown in a 37°C/5% CO2  incubator. Upon reaching 90% 
confluency, cells were washed in 5mls PBS and trypsinised in 1ml Trypsin (1:10). Cells 
were incubated with trypsin for no longer than 5 min. until cells appeared rounded and 
detached from the plastic tissue culture dish. 1 ml of suspended cells was diluted into 
lOmls fresh complete media. 1ml of the diluted cell suspension was placed into a new 
tissue culture flask with lOmls fresh complete media. Cells were “split” in this way 2-3 
times per week.
2.2.2 Transfection o f COS-1 cells
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Cos-1 cells were transfected using Effectene transfection reagent (Gibco) according to 
manufacturer’s instructions. Briefly 2x10^ cells were seeded per well of a 6 -well plate. 
The following day 0.3-1.0pg K-Ras/EXV or 50ng-0.3pg H-Ras/EXV was mixed with 
lOOpl Buffer EC. Vector only was used to equalise total DNA content. 4.0pl enhancer 
was added to each mix, mixed thoroughly and incubated for 2 mins at room temperature. 
6.0pl of Effectene reagent was then added, pipetted up and down 4-5X and incubated at 
room temperature for 15-30mins. Meanwhile cells were washed Ix  PBS and over laid 
with 1.5ml semm free DMEM. Complexes were over-laid onto the cells and incubated for 
5-6 hours at 3 7 °C/5 %C0 2 . Cells where then washed Ix PBS and fresh 10% FCS/DMEM 
added. 30 hours post transfection cells washed Ix PBS and starved overnight in 0.2% 
FCS/DMEM. The following day cells were washed 3 times ice cold PBS and either store 
at -70  °C or lysed directly.
23  DIGE preparation
2.3.1 Mammalian cell lysate preparation for DIGE
Cells were seeded in 10% FCS/DMEM at 800.000 per 10cm dish. Cells were let to attach 
for 4h and then either lysed or washed with PBS and overlaid with 0.1% FCS 
supplemented DMEM. Cells were starved for 16-20hours. Cells were lysed in 20mM 
Tris-HCl pH8.0, 2mM EDTA, 1% Triton, supplemented with protease inhibitors and 
phosphatase inhibitors (ImM PMSF, 2mM NaF, ImM Na vanadate, 5ug/ml leupeptin and 
2.2ug/ml aprotinin). Plates were scraped using a disposable cell scraper and incubated on 
ice for 5-lOmins. Lysates were collected in pre-cooled 1.5ml eppendorf tubes and clarified 
by centrifugation at 13000rpm for 15mins at 4°C. Supernatants where transferred to fresh 
pre-cooled eppendorfs and assayed for protein concentration using the BCA protein 
concentration assay KIT (Pierce). Proteins where then precipitated by TCA.
2.3.2 TCA precipitation
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Lysate or proteins eluted from FLAG-beads were incubated for 30 min on ice with 0.002% 
sodium deoxycholate in dH%0. 22% of 100% TCA solution was added and rested on ice for 
15 min. Precipitated proteins were pelleted by centrifugation at 13000rpm for 15 min at 
4°C. The supernatant was removed and the pellet was washed twice with ice-cold acetone 
for 30 min. Pellet was allowed to air-dry for 5 min and either digested or dissolved in SDS- 
loading buffer or DIGE labelling buffer.
2.3.3 DIGE labelling
Labelling of the protein samples was performed according to the manufacturer’ protocols. 
Briefly the protein samples were dissolved in 20mM Tris-HCl, pH 8.5, 2M thiourea. 6 M 
urea and 4% CHAPS in dH2 0  to a concentration of lOmg/ml. The pH was checked by 
spotting 0.5pi onto pH-paper. If the sample was too acidic the pH was adjusted with 2M 
Tris-HCl pH 8.9. Per 50pg of protein Ipl of diluted Cy2, Cy3 or Cy5 NHS activated ester 
(Amersham Pharmacia) was added. Samples were placed in an ice-bucket for 30min. The 
remaining unreacted esters were blocked by adding 1 pi of a lOmM lysine solution and 
incubated on ice for 30min. The labelled samples were then mixed and diluted to a total 
volume of 450pl with 2M thiourea, 6 M urea and 4% CHAPS in (IH2 O. DTT and 
Pharmalytes 3-10 (Amersham Pharmacia) were then added to a final concentration of 0.5% 
each.
2.3.4 Casting large gels for 2D-gel electrophoresis
Gels were cast in an EttanDALT6  gel caster and low fluorescence Ettan DALT gel glass 
plates were used (Amersham Pharmacia). Gels were bound to the backplate of the gel by 
treating it with bind silane solution made out of 1 Opl Bind Silane (Amersham Pharmacia), 
8 ml ethanol, 200pl acetic acid, 1.8ml dH2 0 . The prepared solution was applied onto the 
backplate with a lint-free cloth at let to air-dry for two hours. Then two reference markers 
(Amersham Pharmacia) were stuck to the backplate and the gels were assembled in the gel
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caster. The gel solution consisting of 10% acrylamide (Acrylamide/Bis-acrylamide 37.5), 
0.1% SDS, 350mM Tris-HCl pH 8.9 was filtered through a 0.2um filter. ). 0.05% TEMED 
and 0.05% APS was added and the solution was poured into the gel caster. 2ml water 
saturated n-butanol was placed on top of the gel solution and the gels were let to 
polymerise for 2h. The gels were stored in 0.1% SDS, 350mM Tris-HCl pH 8.9 at 4°C.
2.3.5 Running 2D gels
For the first dimension a 24cm strip 3-10 immobilised pH gradients (IPG) strips were used 
(Amersham Pharmacia). A total sample volume of 450pl containing 150pg (DIGE gels) or 
500pg (preparative gels) were transferred into IPGPhor (Amersham Pharmacia) coffins. 
The protective covering was removed from the IPG-strip and the strip was placed gel-side 
down on the sample. It was ensured that the sample was spread evenly and that no air 
bubbles were trapped underneath the strip. The strip was covered with 2ml of IPG cover 
fluid (Amersham Pharmacia) and placed on an IPGPhor unit Amersham Pharmacia). The 
following settings were used for DIGE gels: after 12h of rehydration a maximum voltage 
of 500V was applied for Ih, followed by an additional hour at lOOOV and further 9h at 
8000V. To prevent burning of the strip a maximum current of 60pA was allowed per strip. 
After the program was finished the strips were removed from the coffins the excess fluid 
was drained and the strips were rinsed briefly under a stream of dHzO. The strips were 
incubated with lOOmM Tris-HCl, 6 M urea, 30%glycerol 2% SDS,0.5% DTT in dH2 0  
under shaking for 15min. The strips were removed, briefly rinsed with dH2 0  and incubated 
with lOOmM Tris-HCl, 6 M urea, 30%glycerol 2% SDS, 4.5% iodacetamide in dH2 0  under 
shaking for 15min. Meanwhile the PAGE gels were stacked in an upright position and 
excess fluid was blotted away using Whatman 3MM paper. 0.5% Agarose in running 
buffer (see PAGE) with 30% glycerol was melted in a microwave. The strips were 
removed from the alkylating buffer, briefly rinsed with dH2 0  and placed on top of the gel. 
Precautions were taken not to damage the strip and not to trap air bubbles between the gel
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and the strip. The strip was sealed in place with the agarose solution. The gel was placed in 
an Ettanl2 gel-tank (Amersham Pharmacia) and run at fixed 1.5W (no limit of V or A) per 
gel over night until the dye-front just had run off the gel.
2.3.6 Scanning o f DIGE and Sypro-Orange gels
The gels were scanned using a Typhoon 9400 (Amersham Pharmacia) laser scanner with 
an external blue laser source. Following settings were used:
Dyes Excitation Filter Laser energy
Cy2 Blue; 488nm 520nm width 40nm 500-550
Cy3 Green; 532nm 580nm width 30nm 500-550
Cy5 Red; 633nm 670nm width 30nm 500-550
SyproOrange Blue, 488nm 580nm width 30nm 480-530
First the settings for the optimal laser energy were determined by using a quick scan at a 
low resolution (1000 micron pixel size). The laser energy was adjusted so that the most 
intensive spot was below saturation at around 80000 when visualised using ImageQuant 
(Molecular Dynamics). The final scan was performed at high resolution (lOOmicrons pixel 
size). Gel images were then cropped using the ImageQuant software before being analysed.
2.3.7 Analysis o f DIGE gels
Gels were analysed using the DeCyder software package (Amersham Pharmacia). The spot 
number was set to 2500, artefacts were deleted by filtering using following settings: 
Area<200; Peak height<200; Volume<10000. The settings were determined using one gel 
as a template. The number was set to a value where spots were neither split nor merged. 
Area, peak height, volume were set to values which excluded most artefacts without 
eliminating true protein spots. The slope was not used as an exclusion parameter as it 
eliminated true protein spots that colocalised with dust particles
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The master gel was selected as the Cy2 gel with the highest number of identified spots 
after filtering. All gels were matched to the master by landmarking an average of 50 spots 
manually, matching was then performed by the software. Spots matched erroneously by 
the software were corrected manually. Protein spots were picked that showed a variation of 
>1.7 fold between either set.
2.3.8 Spot-picking, tryptic digest and MALDI-plate spotting by robotic workstation 
The robotic workstation was used in conjunction with 2D-gels. The spot picking was 
controlled by a “pick-list”, in essence a file containing X,Y coordinates for the spots to be 
picked. The spot-picker was calibrated using two reference marker on the gel. Spot 
picking, digest and MALDI spotting were performed according to the manufacturer’s 
recommendations. Briefly the spots were excised and destained by washing with 50% 
methanol 50mM NH4CO3H in dHzO and 75% acetonitrile in dHzO. The digestion used 
modified porcine trypsin (Promega) at a concentration of 20ng/pl in 50nM 
Ammoniumbicarbonate in water and was conducted for 4h at 37°C. Peptides were 
extracted, dried and resolubilised in 3 pi of 50% acetonitrile, 0.1% TFA in FIPLC grade 
H2 O and 0.5pl were spotted on a MALDI plate and mixed on target with a 90% saturated 
solution of recrystallised a-cyano-4- hydroxyciimamic acid in 50% acetonitrile, 0.1% TFA 
in HPLC grade H2O.
2.4 Tryptic digests
2.4.1 In-gel digest
The coomassie stained bands were cut out using a scalpel and placed in eppendorfs. The 
gel slices were 2x washed with 50% methanol 50mM NH4CO3H in dHzO for 5min. lOmM 
DTT, 50mM NH4CO3H in dHzO was added and heated to 60®C for 15min. The supernatant 
was removed and replaced by 50mM iodacetamide, 50mM NH4CO3H in dHzO and 
incubated for 30min in the dark. The supernatant was removed and the gel slices were
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washed 2x with 50% methanol 50mM NH4CO3H in dHzO and Ix with 75% acetonitrile in 
dH2 0  for 5min at each step. Gel slices were dried by speedvac and were either kept at - 
20°C or directly digested.
Ice-cold modified porcine trypsin (Promega) was at a concentration of 12.5ng/pl was 
added to the gel slices until covered. Eppendorfs were placed in ice for 15min until the gel 
slices were rehydrated. Excess buffer was removed and replaced by 50mM NH4 CO3 H in 
dH2 0  until gel slices were covered. The gel slices were incubated overnight at 37°C. The 
supernatant was replaced into a fresh eppendorf and peptides were extracted from the gel 
by shaking it for 5min with 50% acetonitrile 5% formic acid in dH2 0 . The supernatant was 
removed, pooled with the previous one and lyophilised by speedvac.
2.4.2 In-solution digest
The washed pellet was solubilised in 4pl of 8 M Urea, 0.1% n-octyl-glucoside, 200mM 
NH4 CO3 H in dH2 0  by shaking for 30 min. 0.5pl of IM DTT was added and shaken for 30 
min at 37°C. 32pl of dH2 0  and 2pi of 125ng/pl porcine trypsin (Promega) were added and 
incubated over night at 37°C. The reaction was stopped by adding 2pl of formic acid.
2.5 Analysis of Raf-1 complexes
2.5.1 FLAG-Raf-1 immunoprécipitation for mass spectrometric analysis 
3 X 10cm plates of COS-1 cell were transfected with the Raf-1 constructs. After 24h the 
cells were washed with PBS and either overlaid with 0.1%, 10% FCS/DMEM or taxol 10% 
FCS/DMEM. After 24h the cells were washed 3 times with PBS and lysed with 3 times 
500pl Cells were lysed in 20mM HEPES pH8.0, 2mM EDTA, 0.5% NP-40, supplemented 
with protease inhibitors and phosphatase inhibitors (ImM PMSF, 2mM NaF, ImM Na 
vanadate, 5ug/ml leupeptin and 2.2ug/ml aprotinin). Plates were scraped using a disposable
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cell scraper and incubated on ice for 5-lOmins. Lysates were collected in 3 pre-cooled 
1.5ml eppendorf tubes and clarified by centrifugation at 13000rpm for 15mins at 4°C. 60pl 
of FLAG-Agarose and ProteinA-agarose was washed in the lysis buffer, then O.IM glycine 
pH2.5 in dHzO and then lysis buffer. The pooled supernatants were incubated with 60pl of 
washed ProteinA-agarose for 15min. The agarose was pelleted by centrifugation and the 
supernatant removed and incubated with 60pl of washed FLAG-agarose for 2-4h. The 
beads were pelleted by centrifugation and washed 3 times with 20mM HEPES pH8.0, 
2mM EDTA, 0.1% NP-40. The proteins were then eluted form the beads by incubating 
them 3 times for 5min with O.IM glycine pH2.5 in dH2 0 . The combined eluates were then 
neutralised with 2M pH 8.9 Tris-HCl buffer. TCA precipitated as described and in-solution 
digested as described.
2.5.2 2D-LC MS/MS
The peptides were separated using a UltiMate Nano LC System (LC Packings) using a 
strong cation exchange (SCX) column in the first dimension and nano reversed phase in 
the second dimension and detected using a Q-Star mass spectrometer (Applied 
Biosystems). 40pl of the digest were injected onto the column in two injections of 20 pi. 
The digest was firstly run over an strong cation exchange column (BioX-SCX, 0.5mm ID x 
15mm, LC Packings) with a flow rate of 30pFmin. Peptides that did not bind to the first 
column were run over a CIS reverse phase (RP) cartridge (PepMap, 300pm ID x 5mm, LC 
Packings) functioning as a trap. The peptides bound to the C18 RP cartridge were then 
eluted from the trap and separated using a 75pm ID CIS RP column (PepMap, 15cm, LC 
Packings) with a 60min gradient from 0-40% acetonitrile 0.1% formic acid with a flow rate 
of 200nl/min. The peptides bound to the SCX column were eluted with increasing 
concentrations of KCl and run over the CIS RP cartridge at 30pl/min. The peptides bound 
to the RP cartridge were then eluted from the trap and separated using the 75um ID C18 
RP column. The elution form the SCX and subsequent RP separation was repeated 8  times
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up to a concentration of lOOOmM KCl (50, 100, 150, 200, 250 400, 600, lOOOmM). The 
eluted peptides were sprayed through a nano-LC needle (Pico emitter, 20pm ID, 10 pm 
orifice. New Objectives) and analysed using a data-dependent acquisition program on the 
Q-Star. The four most intensive multiply charged ions with an ion-count of >50 were 
selected by the software for further MS/MS analysis. Ions were excluded from MS/MS 
analysis for 120s after analysis, collision energy was set automatically by the software. The 
scan time was set to 3s in MS mode and 10s in MS/MS mode.
2.6 Peptide purification
2.6.1 C18 ZipTip peptide purification
If necessary peptide samples were desalted using ZipTips (Millipore) according to the 
manufacturer. Briefly the tip was washed with 50% Acetonitrile in HPLC grade H2 O by 
pipetting lOpl up and down. The matrix was then equilibrated with 1% formic acid in 
HPLC grade H2 O by pippetting lOpl up and down. The peptides were then loaded on the 
matrix by pipetting the solution slowly up and down for 10 times and then washed 3 times 
with 1% formic acid in HPLC grade H2 O by pipetting up and down. The peptides bound to 
the matrix were then eluted by pipetting 3 pi of 30% Acetonitrile, 1% formic acid in HPLC 
grade H2 O up and down into a clean eppendorf. The peptide mixture was then analysed by 
mass spectrometric methods.
2.6.2 IMAC purification o f peptides
IMAC purification of the casein digest and of the synthetic peptides was performed using 
ZipTipMc (Millipore) according to the manufacturer’s instructions. Briefly the tips were 
washed 3 times with 0.1% acetic acid with 50% acetonitrile in HPLC grade H2 O. Then the 
matrix was charged with iron(lll) ions by 10 aspirate and dispense cycles with 10 pL 200
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mM of Ferric Chloride in HPLC grade H2 O with 10 mM HCl. The tip was washed 3 times 
with HPLC grade H2 O and 3 times with 1.0% acetic acid with 10% acetonitrile in HPLC 
grade H2 O. The tip was then equilibrated by washing 5x with 0.1% acetic acid with 10% 
acetonitrile in HPLC grade H2 O. The lyophilised sample was dissolved in 0.1% acetic acid 
with 10% acetonitrile in HPLC grade H2 O and loaded onto the matrix by 10 aspirate and 
dispense cycles. And then washed 3 times with 0.1% acetic acid with 50% acetonitrile in 
HPLC grade H2 O and 3 times with HPLC grade H2 O. Bound peptides were eluted with 0.3 
N ammonium hydroxide solution in HPLC grade H2 O into an eppendorf and lyophilised by 
speedvac.
2.6.3 Crosslinking o f 14-3-3 andphosphospecific antibodies
We used cyanogen bromide activated agarose (Sigma) to cross link proteins to be able to 
perform the peptide-pull-down experiments. We crosslinked the proteins according to the 
manufacturers instructions. Briefly we dialysed the proteins against 0.1 M NaHCOg buffer 
containing 0.5 M NaCl, pH 8.3 to ensure that no free amino groups were present in the 
buffer. Then we washed the cyanogen-bromide activated resin in cold 1 mM HCl for 30 
min. The resin was washed with distilled water and then with the NaHCOg /NaCl coupling 
buffer and afterwards the protein solution was added immediately. The slurry was mixed 
for 2 hours at room using a rotation mixer. The reactive groups were then blocked with 0.2 
M glycine, pH 8.0 for 2 hours at room temperature. The slurry was then washed 
extensively to remove the blocking solution, first with 0.1 M NaHCOg buffer containing 
0.5 M NaCl, pH 8.3 and then with acetic acid 0.1 M, NaCl 0.5 M, pH 4. This wash cycle 
was repeated 5 times. The resin was then washed with PBS containing 0.02% sodium azide 
and stored at 4°C.
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2.6.4 Phosphopeptide pull-downs
The phosphopeptides were dissolved in PBS, 0.05% Tween-20 and incubated with the 
either 14-3-3 or anti-phospho Ser/Thr agarose overnight. The slurry was then loaded into a 
home-made spin column and washed 3 times with PBS, 0.05% Tween-20 and 3 times with 
PBS. The peptides were eluted by incubating the beads 3 times for 5min with 5% acetic 
acid in H2 O. The eluates were then lyophilised and desalted by ZipTips prior to MALDI 
analysis.
2.7 Mass spectrometric methods
2.7.1 MALDI mass spectrometry
All MALDI mass spectrometric analysis was performed using a Voyager-DE mass 
spectrometer (Applied Biosystems). Peptide samples were either previously de-salted with 
ZipTips or solubilised in 50% acetonitrile, 0.1% TFA in HPLC grade H2 O. A saturated 
solution of recrystallised a-cyano-4- hydroxyciimamic acid was freshly prepared in 50% 
acetonitrile, 0.1% TFA in HPLC grade H2 O and mixed on target with the peptide solution. 
Typically O.Spl was spotted. Positive-ion mode was performed using the reflector to 
enhance resolution, in negative-ion mode the reflector was switched off and the mass 
spectrometer was used in linear mode. Acceleration voltage was 20kV and laser intensity 
was set at around 2300. The data was calibrated either internally by using the trypsin auto­
digest peaks or by near-point calibration using a peptide mixture.
If the samples were spotted by the robotic workstation (Amersham Pharmacia) the 
acquisition was performed automatically controlled by the Voyager software.
73
2.7.2 ESI mass spectrometry, product-ion scan
Electrospray ionisation (ESI) was done on either a Q-STAR or QTRAP (Applied 
Biosystems). Ions were scanned in a mass range of 400-1200Da. Scan time was 3s. 
Multiply charged peptides were selected by the software in an information dependent 
acquisition mode (IDA) and subjected to further MS/MS analysis. Scan time was 10s. If an 
LC interface was used the ions were excluded for 120s after analysis, otherwise for the 
whole length of the analysis. Collision energy settings were set by the software in 
accordance of mass and charge state. MS/MS spectra were analysed by the Analyst 
software package (Applied Biosystems) and Mascot (Matrix science)
2.7.3 -79precursor ion scan single-shot Q-Star
3pi of the desalted casein digest was pipetted into a nano-spray needle (Protana). The 
needle was centrifuged to ensure that the sample was at the sharp end of the needle. 
Backpressure was applied using a glass syringe and if needed the needle was opened by 
tapping it gently against the metal plate surrounding the orifice. When a droplet appeared 
the backpressure was reduced and the needle was brought into position in line with the 
orifice. The appropriate voltage was applied that resulted in a steady spray without plasma 
formation at the tip. Typically the voltage was set between -600 and -lOOOV. The ion spray 
was checked in MS mode and if ions were visible the mass spectrometer was switched to 
precursor ion mode for the -79Da ion with the pulsing function active. The mass window 
on the TOF analyser was set to 0.5Da. Collision energy was set at 50eV. If precursors were 
identified the charge was determined by analysing the previously recorded MS spectrum. 
The mass spectrometer was then switched to positive ion mode and the appropriate 
MS/MS spectrum was recorded. The collision energy was adjusted to generate high and 
low molecular weight fragments.
74
2.7.4 -79precursor ion scan Q-Trap
Needle was prepared as in 2.7.3. The ion spray was checked in MS mode and if ions were 
visible the mass spectrometer was switched to precursor ion mode for the -79Da ion. The 
resolution of the first and third quadmpole was set to “low” and the step-size was set to 
IDa. The collision energy was set to 70eV. If precursors were identified the mass 
spectrometer was switched to positive-ion mode and the charge and mass of the precursor 
was determined by an “enhanced resolution” scan at a scan-rate of 250Da/s. If the ion 
identified was multiply charged it was subjected to an MS/MS scan. The collision energy 
was adjusted to generate high and low molecular weight fragments and the mass range was 
scaimed at a scan-rate of 4000Da/s.
2.7.5 216.04precursor ion scan Q-Star
The mass spectrometer was calibrated using GluFib peptide fragmentation. The mass 
spectrometer had to be calibrated just before the analysis was performed because to the 
high mass accuracy needed for this specific experiment. After the calibration the needle 
was prepared similar to 2.7.3 Typically the voltage was set at 1000V. The spray was 
checked first in MS mode, if ions were visible then the machine was switched into 
precursor-ion scan with the pulsing function active and a step-size of 0.5Da. The mass 
window was set to 216.04Da with a width of 0.04Da. The collision energy was either 
varied between 40 and 80eV. Identified precursor were then further analysed by MS/MS. 
The collision energy was adjusted to generate high and low molecular weight fragments.
2.7.6 -79 precursor ion scan LC MS/MS
The peptides were separated using a UltiMate Nano LC System (LC Packings) and 
detected using a Q-Trap mass spectrometer (Applied Biosystems). A 30min gradient from 
0-40% acetonitrile and 0.1% formic acid was used as reverse-phase separation condition. A 
data-dependent acquisition program was used. The precursor ion scan was set at the same
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values as used in the single-shot analysis. If the precursor scan detected an ion of >1000 
counts an enhanced resolution scan was performed on the peak-area. Settings for this scan 
were equivalent to the values set in the single shot analysis. The charge state of the most 
abundant peak was determined automatically and the ion was then selected for MS/MS 
analysis. The optimal collision energy was calculated by the software and the scan rate was 
set at 4000Da/s.
2.7.7Neutral loss scan LC MS/MS
The peptides were separated using a UltiMate Nano LC System (LC Packings) and 
detected using a Q-Trap mass spectrometer (Applied Biosystems). A  30min gradient from 
0-40% acetonitrile and 0.1% formic acid was used as reverse-phase separation condition. A 
data dependent acquisition program was used. The first scan was a neutral-loss scan in 
positive-ion mode for loss of 49 and 33Da, the equivalent of loss of a phosphate for doubly 
and triply charged ions. The collision energy was rolled and the step-size was set to IDa. 
The resolution of the first and third quadrupole was set to “low”. If a neutral loss was 
detected the mass and charge-state of the ion was determined by an enhanced resolution 
scan at a scan-rate of 250Da/s. The most abundant peak was then selected for MS/MS 
analysis. The optimal collision energy was then calculated by the software by taking m/z 
and the charge state into account.
2.8 Database searching
2.8.1 MASCOT based protein identification by peptide mass fingerprinting 
The MALDI spectra were processed by the MASCOT Demon (Matrix science) software in 
conjunction with the Voyager Dataexplorer (Applied Biosystems) software. The internally 
calibrated spectra were smoothed, the base-line was corrected and the peaks were de­
isotoped. The masses over 1000 were selected for peptide mass fingerprinting searches. 
Cysteins were selected as modified by carbamylation and methionines were selected as
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variably oxidised. Mass accuracy was set at 50ppm and searches were conducted using an 
in-house version of MASCOT searching against the rodent subsection of the NCBI 
database.
2.8.2 MASCOT based protein identification ofMSIMS data
The MS/MS data was processed using a MASCOT script downloaded form 
http://www.matrixscience.com/help/instmments_analyst.html. The spectra were smoothed 
and centroided. Distanced below O.lDa were merged. The mass accuracy was set 
according to the accuracy of the calibration. Typically the settings were 200ppm in MS 
mode and 0.4Da in MS/MS mode. If the calibration was performed on the same day the 
values were lower. The resulting compressed data files were searched against the NCBI 
database using an in-house MASCOT server.
2.9 3T3 cell line characterisation
2.9.1 Phalloidin staining
Cells were seeded onto 15mm glass coverslips in 12-well plates at a density of Ix  10"^  cells 
per well. 3T3 fibroblasts were fixed for 30mins in 4% paraformaldehyde (final 
concentration) in phosphate buffered saline (PBS), washed 3 x in PBS and permeabilised 
with 0.05% Triton X-100, 50mM glycine for 20mins. Cells were washed 3 times in PBS 
cells and blocked (10% PCS, 0.5% BSA in PBS) for 20mins. Cells were then incubated 
for 45mins with FITC-conjugated Phalloidin (O.llg/ml in blocking solution) in the dark. 
Cells were then washed 2 times in blocking solution, with a final two washes in PBS. 
Coverslips were mounted onto glass slides, overlaid with a drop of Vectashield and glass 
rectangular 30mm coverslip. Slides were sealed to protect from drying out using clear nail 
varnish.
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2.9.2 Wound Assays
Cells were seeded into 35mm/6-well tissue culture dishes. Cells were plated at a suitable 
density so that in two days the cells would be 100% confluent. Using a sterile cell scraper 
a straight wound was pressed down the middle of the layer of cells. Fresh media was 
added to the cells. Wounds were then examined and suitable areas, marked using a cloning 
ring and photographed using a digital camera. Wound assays were incubated overnight at 
photographed again the next morning.
2.9.3 Cell-cycle profiling
After induction of cell death the cell culture medium was pipetted of the plates and placed 
into 15ml falcon tubes. The cell were then washed, trypsinised and pooled with the 
medium in the falcon tubes. The cells were pelleted by centrifugation and washed 2x with 
PBS. The cells were resuspended in lOOpl PBS and fixed with 900pl of ice-cold 70% 
ethanol in H2 O for Ih on ice. The cells were sedimented by centrifugation and incubated in 
300pl PBS containing 250ug/ml RNAse and lOug/ml propidium iodide for 30min at room 
temperature. Fluorescent assisted cell sorting (FACS) analysis was performed on a Becton 
Dickinson FACScan. The FACS data was analysed using the CellQuest (Becton 
Dickinson) software package.
2.9.4 Annexin stain
After induction of cell death the cell culture medium was pipetted of the plates and placed 
into 15ml falcon tubes. The cell were then washed, trypsinised and pooled with the 
medium in the falcon tubes. The cells were pelleted by centrifugation and washed 2x with 
PBS. Annexin-V-Alexa 568 (Roche) was mixed 1/50 with lOmM Hepes pH 7.4, 140mM 
NaCl, 5mM CaCb in H2 O. The cell pellet was resuspended in this solution and incubated 
for 15min. The suspension was diluted with PBS to 300pl and analysed using a FACScan
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machine (Becton Dickinson). The FACS data was analysed using the CellQuest (Becton 
Dickinson) software package.
2.10 Polyacrylamide gel analysis
2.10.1 PAGE
Lysates were resolved on SDS-polyacrylamide gels by SDS-PAGE gel electrophoresis. 
Resolving gels of an 10-12% acrylamide concentration were cast using Amersham 
Pharmacia mini-gel gel caster. Prior to pouring of either resolving (acrylamide 10-12%, 
2mM EDTA, 0.35mM Tris-HCl pH 8.9) or stacking gels (acrylamide 4.5%, 125mM Tris- 
HCl pH6 .8 ,1%SDS, 4mM EDTA), ammonium persulphate and TEMED were added. For 
resolving gels, 500pl APS and 50pl TEMED were added per 30ml solution, mixed by 
inverting 3-4 times, poured and overlaid with butan-2-ol. Resolving gels were allowed to 
set at room temperature for 1-2 hours. Once set, butan-2-ol was removed and gels were 
rinsed with dH2 0 . Excess water was blotted away using Whatman 3MM paper. 
Appropriate comb was inserted into the gel apparatus and stacking gels prepared. 15pl of 
APS and 4pl TEMED were added per ml of gel solution, mixed by pipetting up and down, 
poured and allowed to set for lOmins at room temperature. Both reservoirs were then 
filled with Ix SDS-PAGE running buffer (lOx SDS-PAGE running buffer: 24.2g/L Tris, 
144.1g/L glycine, 1% (w/v) SDS), the comb was carefully removed and wells rinsed with 
running buffer prior to loading samples. Proteins were denatured prior to loading by 
heating to 100°C for 5 min. in 5x Laemmli (Laemmli, 1970) sample buffer (62mM Tris- 
HCl pH 6 .8 ,2%  SDS, 10% Glycerol, 0.1% Bromophenol blue, 4% P-mercaptoethanol) and 
cooled on ice. Protein extracts where resolved together with the appropriate molecular 
weight markers (Gibco).
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2.10.2 Coomassie staining
SDS-gels were stained with colloidal coomassie stain (Sigma) according to the 
manufacturer for 2 hours -  overnight. Gels were destained (50% methanol, 10% acetic 
acid in dHzO and 50% methanol in dHiO) until proteins bound to coomassie appeared blue 
against a clear background. Gels were stored in 5% acetic acid at 4°C.
2.10.3 Western Blotting
Following electrophoresis, resolved proteins were transferred to PVDF membranes 
(Hybond-P, Amersham Pharmacia biotech UK) by wet blotting method. Membranes where 
cut to the size of the gel and soaked in methanol. Membranes where briefly soaked in 
water and the gel was then transferred onto the membrane. Two pieces of Whatmann 
3MM paper were used to sandwich the membrane and gel. This sandwich was then placed 
in a blotting cassette (Bio-rad) and wet blotted (25mM Tris, 130mM glycine in dH2 Û) in a 
Transblot wet blotting apparatus (Bio-rad) for overnight at 8V.
2.10.4 Western analysis
Western blots where rinsed in PBS-T (0.05% Tween) and blocked for a minimum of 1 
hour in blocking buffer (5% BSA, PBS-T supplemented with 0.2% sodium azide). Blots 
where probed with primary antibodies diluted in blocking solution generally at a dilution 
of 1:1000 unless otherwise stated. Membranes where washed 3 x 10 min. in PBS-T and 
incubated for 45min at room temperature with the appropriate peroxidase-conjugated 
secondary antibody (1:5000). After 3 x 10 min washes in PBS-T, bands where visualised 
by exposure to Fuji Medical X-Ray film. Immunoblots were stripped (0.2M Glycine pH 
2.5,1% SDS) for between 10-30min at room temperature with agitation. Membranes were 
subsequently washed with water and re-blocked prior to incubating with primary antibody.
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2.11 Enzymatic activity assays
2.11.1 Immunoprécipitation for western blot analysis.
Protein A (for rabbit antibodies) or Protein G beads (for mouse antibodies) were washed 2x 
with lysis buffer. The cleared lysates were incubated over night with the beads and the 
antibody. The beads were washed 3 times with lysis buffer and either denatured with SDS- 
loading buffer or washed with kinase dilution buffer (50mM Tris-HCl pH7.5,5mM EGTA, 
75mM NaCl, 5mM MgClz) and frozen for kinase assays.
2.11.2 Raf-1 radioactive2-step kinase assay
The Raf-1 immunoprécipitation was adjusted to lOpl with kinase dilution buffer (50mM 
Tris-HCl pH7.5, 5mM EGTA, 75mM NaCl, 5mM MgCli) and incubated with 0.2pg of 
purified bacterial expressed GST-MEK-1 and with 0.4pg of bacterial expressed GST- 
ERK-2 and dilution buffer to a total volume of 20ul. 5pi of start buffer was added (50mM 
MgClz, 0.8mM ATP). The mixture was incubated for 20min at 32°C with agitation,. 
Afterwards the reaction was placed in ice and lOOpl of assay buffer (ImM DTT, ImM 
Na3V0 4  in dilution buffer) was added. 25pl of the dilution was placed in a fresh tube with 
15pg of MBP in 25pl dilution buffer. 2.2pl of radioactive reaction start mix was added 
(37.5mM MgClz, 1.25mM ATP and 0.2pl ^^P-ATP in dilution buffer). The mixture was 
incubated for lOmin at 32°C with agitation and stopped by addition of SDS sample buffer. 
Each sample was electrophoresed by SDS-PAGE on a 12.5% gel, western blotted for Raf-1 
and exposed to a phosphoimager.
2.11.3 Raf-1 ‘"cold” kinase assay
The Raf-1 immunoprécipitation was adjusted to lOpl with kinase dilution buffer (50mM 
Tris-HCl pH7.5, 5mM EGTA, 75mM NaCl, 5mM MgC^) and incubated with 0.2pg of 
purified Sf9 expressed GST-MEK-1. 5pi of start buffer was added (50mM MgCl2 , 0.8mM 
ATP). The mixture was incubated for 30min at 32®C with agitation. The reaction was
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Stopped by adding SDS sample buffer. Each sample was electrophoresed by SDS-PAGE 
on a 10% gel and western blotted for pMEK and Raf-1.
2.11.4 In-vitro phosphatase assay
GST proteins for full-length PP5 (GST-PP5) and the truncation mutant lacking the 
phosphatase domain(GST-APP5) were purified as described using glutathione-Sepharose 
beads. COS-1 cells transfected with Flag-Raf-1 and RasV12 were lysed. The lysates were 
immunoprecipitated with anti-Flag antibodies as described. The beads containing Flag- 
Raf-1 washed in a final step with phosphatase assay buffer (50 mM Tris-HCl pH 8.0, 2 
mM MnClz, lOmM DTT) and then incubated with GST-PP5 or GST-APP5 in the presence 
of 100 mM arachidonic acid, and reaction mixtures were incubated at 30°C for 30 min. 
Phosphatase reaction was stopped by adding SDS sample buffer. The beads were then 
resolved on SDS-PAGE followed by electroblotting onto PVDF membranes and analyzed 
by immunoblotting with ECL.
2.12 Recombinant protein expression
2.12.1 Purification o f GST-Fusion proteins from E. coli
BL21 cells were transfected with GST-PP5 or GST-PP5A construct, resultant clones were 
used to prepare 50ml overnight culture supplemented with lOOlg ampicillin. Overnight 
culture was diluted to 500mls LB-broth and left to grow to CD at 600nm 0.4-0.6. Protein 
expression was induced (0.2mM IPTG, 4h 37°C). Cells were re-suspended in 20ml GST- 
lysis buffer (PBS, 1% Triton, ImM DTT, llg/m l leupeptin, ImM aprotinin, ImM Na 
vanadate, ImM PMSF) and lysed by sonication (3 times 5 sec). Lysates were incubated 
with Glutathione Sepharose beads (ovemight/4lC) to purify the fusion proteins. Beads 
were washed 5 times with PBS and eluted by incubation with glutathione. Eluates were
82
dialysed over against 30% glycerol PBS with ImM PMSF over night. Purified proteins 
were stored at -20°C.
2.12.2 Sf9 (Spodoptera frugiperda 9 cells) expression o f GST tagged proteins (GST-MEK)
Sf9 cells were grown in suspension at 27°C in TClOO media (Gibco) that was 
supplemented with 50ml of heat treated FCS, 0.5ml pluronic l%solution (Sigma) and 
0.5ml Amphotericin B solution (Sigma). Cells were centrifuged and the medium was 
replaced prior to been seeded. The cells were seeded at 20Mio/14cm dish and let to set 
down for Ih. 2ml of GST-MEK virus were pipetted into each dish. The cells were kept at 
27°C for 48h and then lysed in 2ml/14cm dish with GST-lysis buffer (PBS, 1% Triton, 
ImM DTP, llg/m l leupeptin, ImM aprotinin, ImM Na vanadate, ImM PMSF). Plates 
were scraped using a disposable cell scraper and incubated on ice for 5-lOmins. The 
lysates were cleared by centrifugation and the supernatant was incubated with Glutathione 
Sepharose beads (ovemight/4lC) to purify the fusion proteins. The beads were washed 3 
times with the lysis buffer. The proteins were eluted by incubation with glutathione. 
Eluates were dialysed over against 30% glycerol PBS with ImM PMSF over night. 
Purified proteins were stored at -20°C.
2.13 Mutagenesis and plasmid DNA isolation
2.13.1 Mutagenic PCR
Generation of 338/339 FLAG-Raf-1 and HA-PP5 (H304A) mutant
Mutagenic PCR kit (Stratagene) was used according to the manufacturer's instructions. 
The primers stated in section: 2.1E, were used to generate the mutations:
PCR reaction samples were digested with Dpnl enzyme for Ihour at 37 °C and 
transformed into DH5a (section 2.2H.2). All constructs were checked by complete 
sequencing of the insert (Agowa sequencing service)
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2.13.2 Bacterial Transformation
Following addition of DNA, cells were incubated on ice for 30 min.. Cells were heat 
shocked for 45secs at 42 °C and incubated on ice for 5 min. 0.5ml of room temp LB was 
added and cells were left for 1 hour, shaking at 37 °C to allow expression of ampicillin 
resistance gene. 1 OOpl were then plated onto solid agar (+antibiotic) and left overnight at 
37 °C. Colonies were picked the next day and overnight cultures set up. 1.5ml of 
overnight culture was minipreped (Qiagen) to isolated plasmid DNA.
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Results and D iscussions
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Chapter 3
Proteomic Analysis of Raf-1 knock-out Fibroblasts
and Complexes
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Chapter 3: Introduction
Growing evidence suggests that Raf-1 has cellular functions that are distinct from its well 
documented role in MARK signalling. Studies using knockout mice have indicated that the 
three Raf isoforms play different roles in vivo and that some of their functions are non- 
redundant (Huser et al., 2001; Mikula et al., 2001) (Baccarini, 2002). Raf-1 is essential 
during mouse development and Raf-1 ' mice die in midgestation due to massive apoptosis 
in the liver and placenta. As MAPK signalling was not impaired cells derived from these 
mice, these studies concluded that Raf-1 was not required for activation of MEK-ERK 
signalling during development. However, when the wild-type Raf-1 gene was replaced by 
a Raf-1 mutant, RafYY340/lFF, which possesses basal activity but caimot be activated by 
growth factors, the mice were bom with no apparent phenotype indicating that kinase 
activity is not needed for the unique survival role of Raf-1. Previous studies have also 
suggested that Raf-1 has an anti-apoptotic function, which may be mediated partly by its 
ability to translocate to the mitochondria and increasing phosphorylation of the pro- 
apoptotic BH3 protein Bad (Wang et al., 1996a; Wang and Reed, 1998). More recent 
studies have shown that Raf-1 can prevent apoptosis through inhibiting the activity of the 
pro-apoptotic kinases, ASKl (Chen et al., 2001; Yamaguchi et al., 2004) and MST2 
(O’Neill et al., in press). From these studies it becomes clear that Raf-1 may use several 
different signalling pathways and mechanisms to regulate apoptosis. Therefore, we want to 
use an unbiased proteomic approach to discover such pathways.
The aim of the studies described in this chapter was to characterise the anti-apoptotic 
function of Raf-1. To do this we compared the protein expression profiles and post- 
translational modifications in immortalised Raf-1 knock-out fibroblasts with cells that were 
reconstituted with either wild-type Raf-1 or a kinase-dead mutant of Raf-1. Using this 
approach we hoped to be able to distinguish between changes that were related to kinase 
activity and those that occurred because of kinase independent functions. As the method of 
analysis we chose two-dimensional gel electrophoresis combined with mass spectrometry.
87
The method has the unique ability to detect post-translational modifications such as 
phosphorylations and truncations which play a pivotal role in the induction and execution 
of apoptotic pathways.
One of the most challenging aspects of detecting differences in protein patterns using 2D 
gel electrophoresis is the necessity to obtain reproducible spot patterns to enable cross gel 
analysis. Furthermore, standard methods to visualise protein spots such as Coomassie and 
silver staining have very limited ranges of linearity between staining intensity and protein 
content, making an accurate assessment of changes very demanding, if not impossible. 
Therefore we decided to utilise a novel method that involves covalently labelling the 
proteins prior to separation with fluorescent dyes, typically Cy3 and Cy5 (Unlu et al., 
1997). The differentially stained proteins are then mixed and separated using one gel 
thereby avoiding any ambiguities arising from the necessity to compare samples run on 
different gels. Because these fluorescent dyes retain the sensitivity of silver staining 
protocols but have a linear relationship between fluorescence and concentration across a 
wide range, they enable the detection of even small changes in protein expression. 
Additionally an internal standard, a mixture of equal amounts of both samples, is labelled 
with a third dye, Cy2, and included into the mixture, further benefiting the experimental 
design. As each spot contains its own internal standard changes in protein spot 
concentration can be identified with even higher accuracy and reproducibility (Alban et al., 
2003; Friedman et al., 2004; Knowles et al., 2003).
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Chapter 3: Results
3.1 Phenotypic characterisation of Raf and reconstituted cells
3.1.1 Wild type Raf-1 and kinase-dead Raf-1 protect from starvation- induced cell death 
Primary and immortalised fibroblasts derived from Raf-1 knock-out mice have been shown 
to be hypersensitive to cell death inducing stimuli (Huser et al., 2001; Kolbus et al., 2002; 
Mikula et al., 2001). Since only a subset of the phenotypic characteristics of the Raf-1  ^
fibroblasts was dependent on its kinase function, we used Raf-1" '^ fibroblast cell lines 
stably reconstituted with either vector alone (control), wild-type or kinase dead Raf-1 for 
our experiments (Fig. 3.1 A). We induced cell death by starving the cells in medium 
containing 0.1% FCS. Afterwards we analysed the cell cycle distribution and identified the 
percentage of cells in the sub-Gl phase, an indication of DNA fragmentation occurring in 
apoptotic cells. Whereas cell lines reconstituted with wild-type or kinase-dead Raf-1 were 
unaffected by starvation for 24 hours, cells reconstituted with the vector alone showed 
increased cell death (Figure 3.IB), confirming that these vector-containing cells are 
hypersensitive to starvation-induced cell death in comparison to the other two cell lines 
used.
■O
CO
0)
?
0)
(/)
(0c
0>a
> s
□ □
9is
3
<n
c
(A:
O
o
c
o
jO
3ao
Q.
( / )
U
r
o
00
<D
2a.
COa:
(U '= 
O  CO
a -s
o
ÛÛ
OJ■a
” 3
V
T )
u
3
■ o
^ 3
C
O
X )oc
3
£
_ £
>%JC
I
(U
" O
s
c/5
<D
O
" O
u
0  
3 
' O
_ c
c
_ o
1
0
<u
>
ccg
c/5
1 
1
i  ^I g
S -1— (U 3
2a.
3
0 :
■a
3
(U•o
" 3
C
3
U
O .
Æ  i
on 3
I I
f  ^T  73 
^  ■§ 
0^  .-£
II
(D
6° -  
O  cA ^  <U
ë |
^  o
f-§c ^ 
'£ c
I =
o (U u
I °II
3  D -
' i l
& H
I d
■5 2
l . f
li
g
3
C
Co
o
2
3
D £
k
l i
I S
; ;
'£ GO2  •
^ (U 
2  3
(D 
CL
C/5cd
c/5
s I 
-  :
1 Î
» i  .g o  X
(U
^ a0 Û
90
3.1.2 Raf-1 ''' cells have less actin stress fibres and are less motile 
In addition their hypersensitivity to apoptosis, we noticed that Raf-1" ' cell were also 
morphologically different from their parental counterparts, indicating that cytoskeletal 
rearrangements had taken place. To visualise if these changes were due to reorganisation of 
the actin cytoskeleton, we stained cells with FITC-phalloidin, a toxin that binds 
specifically to F-actin. The cells exhibited remarkable differences. Wild-type cells seemed 
to be more polarised and showed pronounced actin stress fibres. The knock-out cells on the 
other hand were less polarised, more rounded and contained less stress fibres (Figure 
3.2A). To test if these changes in actin cytoskeleton affected the motility of the cells, 
wound assays were performed. To do this a wound was scratched in confluent monolayers 
of the two cell types and the extent to which the wound had closed was measured after 16 
hours later measured. During this period, the wild-type cells closed the wound almost 
completely whereas the knock-out cells were much slower (Figure 3.2B). This result shows 
that deletion of Raf-1 impairs the motility of cells.
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3.2: DIGË method development
3.2.1 Minimal labelling ofTCA precipitated cell lysate
The three fluorescent labelling dyes that were used in DIGE experiments (Cy2, Cy3 and 
Cy5) have an activated ester as the reactive group. This NHS-ester reacts with primary 
amines to form an amide bond. This reaction is used to link the fluorophors to the primary 
amine of the lysine side chain and therefore to the proteins in the lysate. The efficiency of 
the labelling reaction depends on several parameters. Firstly the pH of the lysate has to be 
basic between 8 and 9. Lower pH hinders the labelling reaction because primary amines 
tend to be protonated and therefore lose the nucleophilic character needed for the 
formation of the amide bond. However, at higher pH values hydrolysis of the ester is the 
predominant reaction. Secondly the protein concentration has to be between 5 and 10 
mg/ml to ensure that enough lysines are labelled before the NHS-ester hydrolyses. Thirdly, 
the ratio between dye and protein has to be such that on average only one lysine per protein 
is labelled, otherwise quantitative comparisons between different proteins would be 
compromised as they would depend on the number of lysines labelled. Thus, under typical 
conditions only 3-5% of total lysines are labelled reducing the amount of multiply labelled 
proteins to a minimum (Marouga et al., 2005). In addition to the changes of electrophoretic 
mobility, especially for low-molecular proteins by multiple labelling,, ’’overlabelling” can 
negatively affect protein solubility (Shaw et al., 2003; Unlu et al., 1997). The general 
scheme of the experimental design of our DIGE experiments is shown in Figure 3.3. The 
total study included three individual clones of Raf-1 knockout fibroblasts reconstituted 
with an empty vector, kinase dead and wild type Raf-1. The cell lysates were harvested 
form growing cells and one biological repeat was run, resulting in a total of 6 DiGE gels 
containing 4 gel-images per clone. The internal standard was an equal mixture of all 6 
samples.
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Figure 3.3: Schematic display of the DIGE experiments. Raf-1 knock-out MEFs were stably transfected with an 
empty vector, wild-type Raf-1 or kinase-dead Raf-1, Raf-1 The lysates were labelled in the following way: 
Vector with Cy3, Raf-1'''' with Cy5 and R a f - 1 w i t h  Cy3 and Cy5. A mixture of all three lysates was labelled 
with Cy2 to form the internal standard. Labelled vector, wild-type and standard lysates were mixed and separated 
by 2D-gel electrophoresis (Gel 1). Gel 2 and 3 consisted of either vector/Raf-1 *^” ^^/standard or Raf-1'^'’^'^/Raf- 
1''^^/standard. Two biological repeats were performed.
In initial studies, w e trypsin ised  cells p rio r to lysis to achieve the desired  pro tein  
concentration. H ow ever, w e later abandoned this m ethod  because o f  concerns that 
detaching the cells from  the plates w ould  alter their p roperties including protein 
abundance, m odifications and processing. It w as also d ifficu lt to determ ine the exact 
protein concentration  using pro tein  assays because o f  in terference from  detergents and 
thiourea. W e thus decided  to  use non-denaturing  lysis cond itions and to lyse cells on the 
plates w ithout detaching them . A fterw ards the protein  concen tration  o f  the cleared  lysates 
w as determ ined using a protein  assay before p recip ita tion  o f  the pro teins w ith  TC A , 
assum ing total recovery  o f  the m aterial. A certain  degree o f  pro tein  loss w ill occur, 
especially  for proteins w ith  m olecu lar w eights <20kD a but the loss o f  pro teins should  have 
been equal betw een all the sam ples and the fluorescent labelling  reaction  is robust enough 
to cope w ith a slightly  reduced protein concentration. A fter ex tensive w ashes w ith acetone 
to rem ove residual acid, w e solubilised  the pellet in the labelling  buffer. W e then
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determined the pH and if necessary increased the pH by adding Tris-base to the buffer. The 
samples were then labelled and run on a standard ID-SDS gel to determine if the labelling 
reaction was satisfactory. All samples appeared to be correctly labelled as no apparent 
double bands were visible in the low molecular region of the gel and the intensity of the 
fluorescent signal corresponded to the values reported in the manufacturer’s protocols. All 
three samples showed similar patterns on the one dimensional gel (see Figure 3.4). The 
Cy2 samples generally needed a higher laser intensity to achieve similar signal strength 
and hence resulted in higher background fluorescence. This could indicate reduced 
labelling efficiency but was probably associated with different quantum efficiency of the 
fluorophor.
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3.2.2 Identification o f differences
As we wanted to use fluorescence as means of detection we had to cast gels using low 
fluorescent glass plates. We were not able to use pre-cast gradient gels as these gels are 
bound to a polymer film that itself is fluorescent and would increase the background. 
Since we were not able to cast highly reproducible gradient gels ourselves we decided 
instead to determine an optimal acrylamide concentration which would enable the best 
separation for the cell lysates for the purposes of our studies. A high gel reproducibility is 
paramount in 2D-gel analysis as this facilitates inter-gel matching of protein spots, 
permitting to compare multiple sets of samples. Our initial studies were performed using 
12.5% acrylamide gels which showed an optimal separation for small proteins. 
Unfortunately the majority of protein spots were present in the top quarter of the gel and 
the separation for the bulk of spots was unsatisfactory. Therefore we decided to use 10% 
gels although they compromised on the detection of small proteins. These gels improved 
the overall separation and increased the number of protein spots that were detected. Figure 
3.5 shows representative examples of 2D-gels that we obtained. The proteins had 
molecular masses of between 20 to over 200 kDa. The majority of protein spots were 
present between pi 4-7 and 40-70kDa in a region of the gel that was also the most 
reproducible. The basic pi and the high molecular weight region of the gels showed the 
highest variability. The pi region between 7-11 was the least resolved, a problem 
commonly encountered in 2D gel electrophoresis as the cysteines contained in the proteins 
tend to reform S-bonds, leading to “streaking” of proteins spots in the basic pH region. 
High molecular weight proteins sometimes did not focus into single spots and some 
proteins with a very high molecular weight were only present in a subset of gels indicating 
that these proteins did not readily enter the gel and poorly resolved in the second 
dimension. Additional variation occurred because some gels, although cast at the same 
time and in the same caster, had regions of lower density resulting in vertical distortions.
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After the gels were imaged spot detection was performed using the Decyder software 
package. An average of 1800 individual protein spots was detected after artefacts were 
deleted. The status of master gel was then assigned to the image of the standard gel with 
the most detected protein spots. Thereafter all gel images, resulting form 6 individual gels 
containing sets of comparisons between all 3 clones (see Figure 3.3) and one biological 
repeat, were matched to the master. Automatic matching using the software was erroneous, 
especially in the border regions of the gels. Consequently we matched an average of 50 
protein spots manually and assigned these matches as landmarks. The succeeding matching 
of the remaining spots was done by the software and the accuracy was satisfactory. We 
routinely matched between 900 and 1700 spots, averaging at around 1100. In a preceding 
study we assessed the influence of biological variation on protein changes in mouse 
fibroblasts. Two biological repeats of Raf-1 knock-out fibroblasts were analysed using 6 
DiGE gels. Using a t-test value of 0.05, indicating a 95% chance of the mean difference 
being significant, no protein spots showed a change in the mean spot intensity with a fold 
change of >1.7 (see Figure 3.7). We therefore decided to use these thresholds for our 
studies, thus eliminating variances that are likely to arise from technical and systematical 
errors as well as from biological variances. Hence protein spots showing a >1.7 fold 
increase or decrease within at least one of the three sets (i.e. vector/wt; vector/kinase dead, 
kinase dead/wt) with a t-test value of <0.05 were picked for further analysis. To increase 
the chances of identifying proteins by mass spectroscopy we ran an additional preparative 
gel with a high protein load. The higher loading negatively affects resolution, but improves 
the chance of protein identification by mass spectrometry. We were able to match 877 
spots from the preparative gel to the master gel. The protein spots were then cut out and 
processed by a robotic workstation, spotted on a MALDI plate and analysed. Only a 
limited number of spots could be identified using peptide mass fingerprinting. Some 
samples contained only the trypsin autodigestion peptides but all samples where additional 
masses were detected and mass fingerprinting failed to return a significant identification
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with a confidence level of >95% were further analysed using LC-MS/MS. In total 63 
differentially expressed protein spots were positively identified, containing 55 individual 
proteins. In 13 spots we identified mixtures containing up to four different proteins. All 
proteins identified were identified with a confidence of 95% or greater. In case of multiple 
proteins within one spot there is no certainty which protein changes, therefore an additional 
quantification has to occur, possibly by immunoblotting.
A
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Figure 3,6: Number of protein spot changes above certain thresholds: The x-axis represents the number of protein 
spots that change, the y-axis represent the fold changes. A) analysis of biological variation of 2 biological repeats of - 
/- Raf-1 MEFs. If p is set to <0.05 all protein spots that change, change <1.7 fold B) analysis of changes of two 
biological repeats between Vector and Wild type Raf-1 reconstituted MEFs.
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33: Protein expression profiles of Raf '^ and reconstituted ceils
A list of the proteins identified using DIGE is shown is Tables 3.1 and 3.2. Table 3.1
contains the protein names, means and confidence of the identification, molecular weights 
and isoelectric points. The proteins are listed in sequenced according to the master gel 
number (see Figure 3.7). If a mixture of proteins was identified then all proteins are listed 
according to the Mascot score. The protein accession numbers relate to the protein entries 
in the NCBI non-redundant database (http:Hwww. ncbi. nlm. nih. govf). The theoretical 
molecular weight and pi were calculated using a web tool
(http:Hus.expasv.org/toolslpi toolhtml), the peptide number indicate how many peptides 
were identified and if peptide mass fingerprinting was used to identify the protein, the 
sequence coverage is given. The Mascot score indicates the confidence in the
identifications, the threshold was set to >95%.
Table 3.2 lists the properties of the individual protein spots. All spots listed in the table 
have a increased or decrease in volume >1.7 between at least two of the three sample sets. 
If the spots were detected and matched in several gels a p value of <0.05 in at least one 
sample pair indicating a 95% confidence of a change in the spot volume was used as an 
additional threshold.
<uT3
(2
I -A
o
<D 0Ûc
o. o 
O 13
S *(N (U
73 "5ÛÛ §
u rs
cn O)i IOJ o 
■£ a(+-4 (4-,o o
tl
O
£ SU eg
■tï >-O  <L)
Î1(/) g? C8 O C O,
t :  (u
g i
•3 c
OJD (U
1 = 
I I
••  CLr~ (u 
^  hQj <U■- Xi
S) § 
E  z
Table 3.1:
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Master No. Name Protein pi Mw peptides# mascot identificatic
AC (coverage) score
115 procollagen, type I, alpha 1 34328108 5.65 138032 20 366 MS/MS
120 Procollagen, type 1, alpha 1 29476768 5.65 138032 27(33%) 157 MALDI
123 ProcoUagen, type I, alpha 1 29476768 5.65 138032 31(34%) 210 MALDI
125 tubulin alpha-3 chain 90217 4.93 50095 2 51 MS/MS
128 beta tubulin 49481 4.85 49741 1 44 MS/MS
134 thromboqwndin 511869 4.72 129647 1 52 MS/MS
144 Endosome-associated protein pl62 38090688 5.59 160914 15(14%) 48 MALDI
326 ALG-2 interacting protein AIPl 4633515 6.27 96151 16(21%) 165 MALDI
(34) (1149) (MS/MS)
374 Gsn protein 38014369 5.52 80762 7 198 MS/MS
palladin 38089265 5.87 152131 7 191
375 Gsn protein 38014369 5.52 80762 8 196 MS/MS
palladin 38089265 5.87 152131 5 91
alpha-macroglobulin 2144118 6.32 163614 1 56
Alpha-l-inhibitor m 112893 5.70 163773 1 45
376 Gsn protein 38014369 5.52 80762 10(21%) 48 MALDI
382 Gsn protein 38014369 5.52 80762 10(21%) 63 MALDI
386 Gsn protein 38014369 5.52 80762 10 (21%) 43 MALDI
387 Gsn protein 38014369 5.52 80762 12 (22%) 114 MALDI
396 heat shock protein 1, beta 194027 4.95 83232 3 31 MS/MS
428 heat shock protein 1, beta 194027 4.95 83232 10 328 MS/MS
435 zyxin 1430883 6.47 60790 5 102 MS/MS
448 thimet oligopeptidase 11385994 5.77 77994 5 110 MS/MS
451 Thimet oligopeptidase 1 21619359 5.67 78026 10 184 MS/MS
461 caldesmon 1 21704156 6.98 60452 10 338 MS/MS
moesin 6754750 5.94 66481 9 276
492 moesin 6754750 5.94 66481 13 (18%) 55 MALDI
498 moesin 6754750 5.94 66481 11 (16%) 76 MALDI
581 Asparaginyl-tRNA synthetase 31127138 5.62 63190 4 93 MS/MS
635 Calreticulin 13097432 48136 11 (31%) 113 MALDI
654 Heat shock protein 1 (diaperonin) 16741093 5.91 60955 7 (19%) 54 MALDI
719 Prolyl 4-hydroxylase, beta polypeptide 14250251 4.77 57058 8 (20%) 98 MALDI
731 tubulin alpha 223556 4.94 50241 10 (37%) 60 MALDI
757 tubulin, beta 46237656 4.78 49670 17 (36%) 181 MALDI
758 beta tubulin 49481 4.85 49741 10 210 MS/MS
794 beta tubulin 49481 4.85 49741 7 152 MS/MS
798 Calreticulin 13097432 4.33 47994 10 (21%) 70 MALDI
817 ATP synthase, H+ transporting, mitochondrial FI 6680748 9.22 59752 6 69 MS/MS
complex
945 calumenin isoform 1 6680840 4.49 37063 5 133 MS/MS
946 annexin A7 6753062 5.91 49939 10 (23%) 84 MALDI
958 Adenosine kinase 16307144 5.84 40148 6 (14%) 67 MALDI
1011 Serpinb6a protein [Mus musculus] 34784412 5.53 42598 8 (23%) 68 MALDI
1024 phosphoglycerate kinase 987048 8.02 44562 8 (21%) 45 MALDI
1038 serine (or cysteine) proteinase inhibitor, clade B, 15826842 6.28 42733 3 76 MS/MS
1045 Septin 2 6754816 6.1 41525 8(19) 81(625) MALDI
serine (or cysteine) proteinase inhibitor clade B 15826842 6.28 42733 15 485 MS/MS
Hsp40 13278364 5.92 40555 9 371
mCBP 495128 8.48 35016 3 70
1058 Serpinbla protein 15029834 5.85 42574 17 515 MS/MS
1153 annexin A1 6754570 6.57 38691 13 (45%) 207 MALDI
1158 annexin A1 6754570 6.57 38691 7 (23%) 84 MALDI
1180 eukaryotic translation elongation factor 1 delta 26336931 4.96 31292 10 297 MS/MS
TPR containing protein 21313588 4.99 34322 5 120
vacuolar adenosine triphosphatase subunit D 3955100 4.89 40319 3 89
1202 annexin A1 6754570 6.57 38691 12 (42%) 212 MALDI
1271 Annexin A2 13097099 7.55 38676 9 (34%) 114 MALDI
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1272 Annexin A2 13097099 7.55 38676 8 (27%) 78 MALDI
1273 G-protein beta subunit 51116 5.6 37376 2 56 MS/MS
pyrophosphatase 27754065 5.37 32667 12 321
1276 Annexin A2 13097099 7.55 38676 10 (38%) 151 MALDI
1428 glutathione S-transferase omega 1 6754090 6.91 27497 9 315 MS/MS
methyithioadenosine phosphorylase 45544618 6.71 31061 4 104
1438 Platelet-activating factor acetyUiydrolase IB beta 3024348 5.78 25492 5 176 MS/MS
translation initiation factor eIF-4E 110568 5.79 25053 1 68
death domain protein FADD 1167559 5.77 23004 1 43
1476 Pgaml protein 12805529 6.67 28831 8 193 MS/MS
platelet-activating factor acetylhydrolase, isoform 6679201 6.42 25853 4 119
lb, a^hal
1492 peroxiredoxin 4 7948999 6.67 31052 7 262 MS/MS
1-Cys peroxiredoxin protein 4139186 5.98 24840 6 193
Smfn protein 13097411 5.84 23613 1 40
1518 triosephosphate isomerase 1864018 5.62 22505 10 412 MS/MS
glutathione S-transferase, mu 2 6680121 6.91 25716 3 93
1554 smooth muscle protein SM22 homolog 321246 8.53 22490 9 (46%) 47 MALDI
Table3.1: Proteins differentially expressed in Raf-1 knock-outs and reconstituted 
fibroblasts. Lane 1: Master gel number (compare Figure 3.7) Lane 2: Protein name from 
NCBI database, Lane 3: Accession number of the identified proteins. Lane 3 and 4: 
theoretical pi and molecular weight of proteins. Lane 5: peptides identified and sequence 
coverage in brackets and %, Lane 6: Mascot score, Lane 7: method of identification, 
MS/MS indicates identification using LC-MS/MS analysis with QSTAR, MALDI 
indicates an identification based on peptide mass fingerprinting.
Table 3.2:
Master # T-test Av. Ratio ev/wt T-test Av.Ratio ev/kd T-test Av. Ratio kd/wt
115
20
ev/wt
0.24
1.18
-1.4
ev/kd
0.24
1.77
1.27
kd/wt
0.039
0.027
-1.5
-1.77
123 0.039 -1.96 0.93 -1.01 0.053 -1.94
125 0.028 -1.8 0.19 -1.36 0.018 -1.32
128 0.015 -1.85 0.51 1.09 0.0012 -2.01
134 0.048 -2.27 0.38 -1.25 0.089 -1.82
144 0.011 -1.45 0.027 -1.39 0.74 -1.04
326
374
0.00031
0.052
-1.73
-1.85 0.22
-1.58
-1.54 0.26
-1.1
-1.2
375 0.0085 -2.32 0.27 -1.42 0.047 -1.63
376 0.089 -1.77 0.17 -1.42 0.083 -1.25
382 0.0052 -1.86 0.08 -1.52 0.4 -1.23
386 6.00E- -1.77 0.0075 -1.43 0.082 -1.24
387
05
4.40E- -2.01 0.00083 -1.58 0.019 -1.27
396
06
0.038 -3.08 0.15 -1.72 0.11 -1.79
428 0.017 2.14 0.075 2.11 0.83 1.01
435 0.0048 -1.95 0.0073 -1.64 0.027 -1.19
448 0.00066 1.72 0.018 1.46 0.15 1.18
451 0.0003 1.81 0.012 1.37 0.045 1.32
461 0.0036 -1.77 0.016 -1.61 0.23 -1.1
492 0.00029 -2.53 5.50E- -2.43 0.52 -1.04
498 l.OOE- -2.19
05
0.00013 -2.04 0.45 -1.07
581
05
0.0041 1.8 0.23 1.39 0.22 1.29
635 0.0098 -2.24 0.82 -1.1 0.0035 -2.03
654 0.00032 2.12 0.0098 1.64 0.16 1.29
719 0.0083 1.61 0.0051 1.91 0.1 -1.19
731 0.012 -1.75 0.58 -1.13 0.001 -1.55
757 0.07 -1.75 0.95 -1.05 0.0084 -1.68
758 0.015 -1.89 0.16 -1.4 0.11 -1.35
794 0.056 -1.82 0.9 -1.02 6.50E-05 -1.77
104
798 0.016 -2.67 0.81 -1.09 0.0074 -2.44
817 0.0049 2.02 0.0076 2.11 0.83 -1.04
945 0.022 -2.64 0.031 -1.71 0.1 -1.55
946 0.00011 -1.81 0.0006 -1.48 0.045 -1.22
958 4.70E- -2.07 0.00013 -1.8 0.0098 -1.15
05
1011 0.00068 -1.8 0.00045 -1.71 0.48 -1.05
1024 0.0012 -1.52 0.00013 -2.16 0.0027 1.43
1038 0.0083 -2.72 0.0041 -3.13 0.69 1.15
1045 0.065 -1.99 0.061 -2.15 0.69 1.08
1058 0.26 -1.43 0.024 -2.55 0.12 1.78
1153 1.07 0.046 -1.6 1.71
1158 0.95 1.03 0.011 -1.78 0.058 1.84
1180 0.014 1.43 0.004 1.71 0.15 -1.19
1202 0.061 -1.8 0.0023 -2.73 0.18 1.51
1271 0.81 -1.05 0.057 -1.72 0.044 1.65
1272 0.053 -1.55 0.0087 -2.1 0.19 1.35
1273 0.00031 -2.02 0.0001 -1.74 0.15 -1.16
1276 0.0082 -2.19 0.0081 -2.53 0.53 1.15
1428 0.37 -1.1 0.00013 -2 0.0097 1.82
1438 0.059 1.69 0.042 1.77 0.76 -1.05
1476 0.00062 1.89 0.22 1.13 0.0013 1.67
1492 0.0003 2.1 0.013 1.73 0.073 1.22
1518 0.0023 1.9 0.11 1.25 0.019 1.53
1554 0.00032 -2.07 0.0017 -2.03 0.81 -1.02
Table3.2: Differences between protein spots volumes and confidence in these changes.
Lane 1: master number, Lane 2: p values from T-test between empty vector and Raf-1 wild 
type fibroblasts, Lane 3: Changes in volume between empty vector and Raf-1 wild type 
fibroblasts. Lane 4: : p values from T-test between empty vector and Raf-1 kinase dead
fibroblasts, Lane 5: Changes in volume between empty vector and Raf-1 kinase dead
fibroblasts. Lane 6: : p values from T-test between kinase dead and Raf-1 wild type
fibroblasts. Lane 7: Changes in volume between kinase dead and Raf-1 wild type
fibroblasts.
3.3.1 Proteins involved in apoptosis
We identified several anti-apoptotic proteins, a large proportion of which were cysteine- 
protease inhibitors, which can inhibit caspases. In vector-reconstituted cells, three 
apoptosis inhibitory proteins were identified as being expressed at elevated levels. These 
were the serine (or cysteine) proteinase inhibitor, clade B (Figure 3.8C), Serpin B la  and 
Serpin|B6a (Ekert et al., 1999). Amongst the other proteins in this group, 
Alix/Programmed cell death 6 interacting protein (Figure 3.8A), an ALG-2 binding protein
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that has been reported to both inhibit and promote apoptosis and cell proliferation was 
found at elevated levels only the vector-reconstituted cells (Chatellard-Causse et al., 2002; 
Missotten et al., 1999). The expression of FADD, the FAS-associated death domain- 
containing protein, was specifically reduced in the vector-containing cells. FADD is an 
adaptor that recruits caspase-8 or caspase-10 to the activated Fas receptor (Wajant, 2002). 
The resulting complex is called the death-inducing signalling complex (DISC). This 
complex when assembled on the activated Fas receptor induces the activation of caspase-8 
through proteolytic cleavage. Activated caspase 8 then mediates apoptosis by cleaving and 
activating Bid or directly activating other caspases, such as caspase 3 (Wajant, 2002). It is 
uncertain though if this change was accurate as it was only identified in a protein spot 
containing a mixture of four proteins. We attempted to validate the differentially expressed 
proteins by quantification via western blots, unfortunately the antibodies we used did not 
recognise mouse-FADD, nor could we quantify proteins downstream of the Fas receptor, 
such as cleaved Caspase 8 and truncated Bid.
Proteins involved in cell motility, adhesion and actin dynamics
Zyxin, moesin (Figure 3.8C) and gelsolin were all identified in protein spots that were 
unregulated in the vector-reconstituted cells. All four proteins are involved in motility, 
adhesion or actin dynamics. Zyxin (Franco et al., 2004; Wang and Gilmore, 2003) is 
present in focal adhesions whereas moesin is a linker between the actin cytoskeleton and 
the plasma membrane, a function that is possibly regulated by RhoGTPases (McClatchey,
2003). Gelsolin on the other hand is involved in capping actin filaments and so preventing 
monomer exchange (McGough et al., 2003). The changes in these proteins are consistent 
with the altered actin cytoskeleton and motility in cells lacking Raf-1.
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3.3.2 Calcium binding proteins
Several annexin isoforms were detected as differentially distributed proteins. We identified 
annexin A l, A2, A4 and A7 in several protein spots. In general, these differences were not 
detected in all annexin containing spots, therefore it is likely that they are related to post- 
translational modifications. Other calcium binding proteins that were down-regulated 
included calreticulin (Figure 3.9B) and calumenin. Little is known about the function of 
calumenin, but we have also identified it as a potential Raf-1 interacting protein in 
immunoprécipitations experiments. Calreticulin has been proposed to be an upstream 
regulator of calcineurin, a protein that is involved in ER-dependent apoptosis (Groenendyk 
et al., 2004).
3.3.3 Changes o f proteins involved in reducing peroxides
Two enzymes involved in deactivating peroxides were detected at reduced levels in the 
vector cells. The 1-Cys peroxiredoxin protein was present in a spot mixed with 
peroxiredoxin 4 (Figure 3.10A). It has been shown that 1-Cys peroxiredoxin requires 
glutathione to reduce and recycle the oxidised cysteine (Manevich et al., 2004). This 
reaction is mediated by glutathione S-transferase (GST) that forms a hetereodimer with 
peroxiredoxin. We additionally found one GST isoform (Figure 3.IOC) at elevated levels 
in the vector and another isoform was elevated in the kinase dead cells indicating a 
possible connection between the identified changes.
3.3.4 Changes in potential Raf-1 binding proteins
In addition to the decrease in calumenin expression, we identified a G-protein beta subunit 
as a protein whose expression was altered. We had previously identified this protein as a 
potential Raf-1 interaction partner in serum-stimulated cells using our 2D-LC-MS/MS
108
approach. The expression of G-protein beta seemed to be strongly increased in the vector 
cells whereas no difference could be detected in the kinase-dead cells. Once again we 
could not be certain if the amount of this G-protein really had changed as it was detected in 
a mixture, further validation was impeded by non-availability of an appropriate antibody. 
In vector-reconstituted cells we also found a two-fold reduction in the expression of 
chaperonin, a protein previously reported to bind to the N-terminus of Raf-1 in a yeast- 
two-hybrid screen (Yuryev and Wennogle, 2003).
5.5.5 Changes in protein expression not rescued by kinase dead Raf-1 
We identified four protein spots whose expression was altered in a manner dependent on 
Raf-1 kinase activity. These changes included spots containing collagen type I, beta 
tubulin, thrombospondin and calreticulin (Figure 3.9). The changes in the spot intensity of 
both the collagen and the tubulin spot only occurred in one specific spot suggesting that the 
change is specific to one isoform.
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Chapter 3: Discussion
Initially we desired to use pools of reconstituted cells, unfortunately we were unable to 
detect stably reconstituted Raf-1 in our pools and therefore had to resort to use single 
clones, where Raf-1 expression was detectable. Because of these limitations some of the 
differences we detected might be due to clonal variation. It is quite encouraging though 
that the majority of the identified differentially expressed proteins were either elevated or 
reduced in both clones that were reconstituted with either kinase dead of wild type Raf-1, 
therefore indicating that these alterations might not be due to previously mentioned clonal 
variation..
We successfully analysed changes in protein expression induced by reintroducing Raf-1 or 
kinase-dead Raf-1 into immortalised Raf-1  ^ fibroblasts. Use of DIGE methodology 
enabled us to detect numerous differentially expressed proteins in these cell lines. 
Unsurprisingly the biggest differences were detected between the vector and the wild-type 
Raf-1 reconstituted cells. The protein expression profile of cells reconstituted with kinase- 
dead Raf-1 generally resembled those of the wild-type Raf-1 reconstituted cells indicating 
that Raf-1 kinase activity plays only a minor role in inducing the identified changes. In 
some cases the kinase-dead Raf-1 reconstituted cells showed changes in protein expression 
that were intermediate between the vector and wild-type reconstituted cells. One 
explanation of this observation is that Raf-1 protein levels were higher in the wild type 
cells and the effects could be dependent on the total amount of Raf-1 present in the cells. 
The exceptions from these general trends were annexin A l, one GST isoform, tubulin, 
calreticulin, thrombospondin and collagen. The latter two proteins are involved in cell-cell 
and cell-matrix adhesion (Sid et al., 2004). These results suggest that the kinase activity of 
Raf-1 is required for some aspects of adhesion but further experiments should be 
performed to confirm this hypothesis. The changes observed in annexin A l and the GST
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isoform were not matched by the vector reconstituted cells, suggesting that these 
differences were due to clonal variations. Some of the biggest differences detected were in 
proteins that inhibit caspases and this is probably due to cells adapting to higher basal 
levels of protease activity, a likely consequence of the proapoptotic phenotype. The 
differential expression of Alix is possible another protection mechanism as overexpression 
of the C-terminus of this protein protects neuronal cell from apoptosis by blocking 
caspases, whereas overexpression of the full length is sufficient to induce apoptosis in the 
same cells (Trioulier et al., 2004). Further experiments, especially a siRNA knock-down 
experiment, are needed to elucidate the effect Alix has in Raf-1  ^ fibroblasts.
The detection of the differences using DIGE increases the understanding of some aspects 
of the phenotype of the Raf-1 knock-out cells such as hypersensitivity to apoptosis, 
impaired mobility and a defective actin cytoskeleton. On the other hand we were not able 
to elucidate how Raf-1 protects from apoptosis, Though we identified numerous proteins 
that are involved in apoptosis such as FADD and the caspase inhibitors, it is likely that 
these responses are adaptive features of cells that are hypersensitive toward apoptotic 
stimuli and therefore are selected to contain higher levels of anti-apoptotic proteins. Thus 
the cells have to adopt mechanisms to survive such as overexpressing potent inhibitors of 
caspases or by reducing Fas receptor signalling. Thus the DIGE analysis seems to have 
identified the consequences of cells adapting to the loss of Raf-1 rather than direct targets 
of Raf-1 involved in protecting cells from apoptosis. The possible exception is Alix but 
further experiments will be required confirm this.
From a technical point of view, use of the novel DIGE approach was highly satisfactory. 
The method was robust and spot patterns on gels were reproducible and it was possible to 
identify differences between samples with ease. This is a great improvement over other 2D 
gel staining techniques as it is comparatively quick and easy to identify intensity changes 
and provide accurate quantification. To achieve a similar comparison using other modem
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fluorescent staining methods such as SyproRuby staining would have involved running a 
larger set of gels, as it is possible to run three samples on one gel using DIGE. 
Furthermore, the workload would have increased because matching all gels to one master 
gel is essential for cross-gel comparisons. It is far easier to match 6 gels, as we used in 
each of our conditions, than to match 18 gels. The use of an internal standard further 
reduced the need to run additional gels as it was possible to compare samples from 
different sets to each other. In the case of our experiments, we were able to compare the 
vector samples against vector/wild type samples and to a kinase-dead sample from a kinase 
dead/wild type gel as the standards in all the samples were identical. Therefore running 6 
gels with three different cell lines resulted in a quadruple set of cross-comparisons. By 
using DIGE we managed to circumvent several drawbacks that the 2D gel approach 
inherently possesses. Unfortunately, we still did encounter problems that are the hallmark 
of this type of approach. Though we reproducibly were able to match more than 1000 
protein spots to the master gel we were still looking at only a small subset of the total 
proteome.
Taking into account that several proteins are present in multiple spots we were only 
comparing a small set of proteins, possibly derived from as few as 400 genes. To further 
increase the uncertainties a large proportion of the spots contained a mixture of up to four 
proteins, frequently making it impossible to assign the detected changes to one protein. 
The problem of resolution can be partially overcome by using narrow pi range lEF strips 
and gradient gels, but on the other hand this increases the workload and is costly as the 
dyes cost £100 per gel. Furthermore, even though MALDI mass fingerprinting was able to 
identify a substantial number of protein spots, it would be desirable to analyse all peptide 
samples with a mass spectrometer capable of acquiring MS/MS data to be more confident 
about the identifications. Because we were only able to acquire MS/MS data using an LC- 
system coupled to a Q-TOF the throughput was limited to approximately 30 samples per 
24 hours. We therefore decided to analyse only the samples that failed in the MALDI but
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Still contained ions that were not of trypsin origin. The limiting factor of this type of 
approach is no longer the sensitivity of the mass spectrometer, as we were able to identify 
proteins in spots that were hardly visible, but the overall resolution of the 2D gels resulting 
in multiple identifications of proteins in individual spots.
Because of these disadvantages it would be preferable to conduct similar comparisons 
using methods that do not rely on 2D gel electrophoresis. Several methods have been 
developed recently that enable comparisons between samples using isotope tags. Most 
notably SILAC (Ong et al., 2002) and ICAT (Gygi et al., 1999; Zhou et al., 2002) are two 
methods that could be used for these comparisons, especially when combined with high 
resolution LC methods such as 2D-LC or gel-assisted LC. These methods are capable of 
analysing several thousand peptides in one run and have been shown to be able to detect 
several hundred individual proteins or even over 1000 if pre-fractionation is used (lin k  et 
al., 1999; Washburn et al., 2001). 2D gels still retain one advantage over these methods, it 
the most practical method to detect post translational modifications, but especially when 
changes in phosphorylations are involved (Hinsby et al., 2004), new gel-less approaches 
are emerging and will probably replace 2D gel electrophoresis as the preferred method of 
choice.
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Chapter 4
Analysis of Raf-1 com plexes
116
Chapter 4: Introduction
Proteins involved in signal transduction act mostly as part of multiprotein complexes 
(Kolch, 2000; Pawson and Scott, 1997). These complexes can contain adaptors, 
chaperones, linkers, effectors and regulators of the core proteins. Raf-1 has been shown to 
exist as a complex of ~500kDa (Wartmann and Davis, 1994). The core complex seems to 
consist of several heat shock proteins and 14-3-3, while adaptors such as KSR and CNK 
enhance the interaction of Raf-1 with regulators, effectors and substrates in response to 
extracellular signals (Kolch, 2000). In addition to these, proteins such as RKIP can bind 
Raf-1 and dismpt its interaction with its substrate, MEK (Yeung et al., 1999). The net 
effect of this multitude of protein-protein interactions is to control the signal flux through 
the pathway, regulate crosstalk with other pathways, and ensure signalling specificity and 
fidelity.
The analysis of the components of protein complexes is crucial to the understanding of 
how signalling processes are regulated. Conventional approaches for identifying protein- 
protein interaction such as yeast-two-hybrid screens focus on binary and direct interactions 
in the nucleus of a yeast cell, which is a rather artificial environment for mammalian 
proteins (Fields and Song, 1989). Proteins that do not bind or may only bind weakly 
without scaffolding molecules may not be identified using these methods. More recently, 
several methods based on the ability of mass spectrometric analysis to identify proteins 
have been used to analyse protein complexes on a large scale (Ho et al., 2002; Rubio et al.,
2004). Firstly, interacting proteins can be purified by firstly cross-linking the “bait” to a 
matrix and then incubating it with a protein lysate. Proteins that bind to the bait are then 
eluted and identified using mass spectrometry. Secondly, intact multi-protein complexes 
can be isolated from cell lysates by immunoprecipitating the bait and identifying the bound 
proteins by mass spectroscopy. We decided to use the latter method to purify complexes
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because it presented several advantages over other methods. Immunoprecipitating intact 
protein-complexes ensures that these have formed in their “natural” environment and not 
in-vitro on a column or inside a yeast cell nucleus. Secondly it possible to analyse changes 
in the composition of the complexes in response to different stimuli. Thirdly it enables us 
to study the entire complex and not only direct one to one interactions between the bait and 
the protein. Standard analysis of proteins involves separating them using PAGE, cutting 
out the stained bands and using peptide mass fingerprinting to identify them. Though 
powerful, peptide mass fingerprinting is problematic when the proteins are not isolated 
with high resolution as it is virtually impossible to identify mixtures as are often present in 
1-dimensional gels. Additional problems arise from separating proteins by PAGE. Several 
amino acids can be modified by the running conditions. For example, methionines are 
oxidised and cysteines can be modified by unpolymerised acrylamide. Moreover, the 
proteins have to be digested in gel, adding several wash and elution steps. This potentially 
decreases the total amount of material available to be injected into the mass spectrometer, 
as especially hydrophobic peptides tend to be retained in the gel matrix and a proportion of 
eluted peptides will adhere to the tubes used. Finally, contamination from keratins and 
polymers can arise more readily because more manual handling is needed. We therefore 
decided to use a gel-less method to study protein complexes, combining in-solution tryptic 
digests with a 2-dimensional LC approach coupled to a QTOF mass spectrometer able to 
generate MS/MS data. We used FLAG-tagged human Raf-1 overexpressed in COS-1 cells 
as a model.
As the interactions between proteins can be regulated by their phosphorylation status, we 
also wanted to develop new methods that would enable us to identify phosphorylated 
peptides in the immunoprecipitated Raf-1 complexes. Reversible protein phosphorylation 
is a major mechanism of regulating protein function (Cohen, 2002; Manning et al., 2002). 
For example, the biological functions of key signalling molecules such as Raf-1, are 
regulated through multisite phosphorylation at activating and inhibitory sites (Dhillon and
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Kolch, 2002). Mass spectrometry is a powerful technique to identify and sequence 
phosphorylation sites. Even with the introduction of new and more sensitive mass 
spectrometers, sequencing of phosphopeptides still remains a demanding task due to the 
nature of the modification. The acidity of phosphorylations impedes efficient ionisation in 
positive ion mode. Therefore the signal intensity of the modified peptide in comparison 
with the unmodified one is greatly reduced. In complex mixtures, the ion of the 
phosphorylated peptide is quite frequently not detectable in the positive ion mode, but 
identification of modified peptides can be greatly improved through prior purification and 
fractionation of the peptide pool. Standard phospho-specific purification methods involve 
immobilised metal affinity chromatography (IMAC) and chemical modification to 
transform the phosphor group into a modification that would facilitate the purification 
(Mann et al., 2002). In this chapter, we attempted a different approach by utilising 
phosphorylation-dependent binding proteins and antibodies to purify serine- and threonine- 
phosphorylated peptides from complex mixtures. Another method that was chosen to 
tackle the problem was to perform precursor ion scans on either the 216Da phospho- 
tyrosine immonium-ion or the 79Da phosphoric acid ion (Steen et al., 2001a; Steen et al., 
2001b). These results were also compared with a neutral loss scan of 98Da to find the most 
sensitive and practical method to identify in vivo phosphorylation sites of Raf-1 and its 
binding partners.
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Chapter 4: Results
4.1 Identification of proteins which co-immunoprecipitate with Raf-1
4.1.1 MALDI peptide mass fingerprinting o f SDS-PAGE separated Raf-1 multiprotein 
complexes
To assess if our method of identifying proteins was an improvement over standard 
methods, we initially used the well established gel electrophoresis protocol to separate 
proteins. FLAG-Raf-1 was expressed in COS-1 and immunoprecipitated by incubating the 
cell lysate with anti-FLAG-antibody coupled to agarose beads (Ho et al., 2002). The 
antibody used was covalently linked to the agarose to minimise contamination of the 
sample by co-elution of immunoglobulin. We decided to use a pH drop (glycine pH 2.5) to 
elute FIAG-Raf-1 and interacting proteins instead of using a more specific elution by 
incubating the beads with an immunoreactive peptide. We were concerned that large 
amounts of the peptide in the eluate might impede subsequent analysis, particularly when 
the proteins would be digested in solution prior to separation by 2D-LC. The eluted 
proteins were TCA precipitated, washed extensively with acetone and then resolubilised 
with SDS-PAGE loading buffer. The proteins were then separated by gel electrophoresis 
and stained with Coomassie. The complete lane was cut into 40 strips and after extensive 
destaining and washing we performed in-gel digestion with trypsin. The digests were 
subsequently analysed by MALDI-TOF peptide mass fingerprinting using the MASCOT 
search engine to identify the proteins.
Although most samples contained multiple ions that did not correspond to tryptic auto 
digested peptides of contaminants such as keratins, we were only able to identify 9 
individual proteins. We assumed that the majority of the samples contained multiple 
proteins and therefore rendered it impossible to identify the proteins without obtaining 
MS/MS data. Most proteins identified were well known Raf-1 interacting proteins, such as
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HSP90, HSP70 and 14-3-3 isoforms. Three of the identified proteins, a G-protein, a 
hypothetical protein and a histone had not been reported to bind to Raf-1 (see Figure 4.1).
4.1.2 2D-LC MS/MS o f whole cell lysates
It has been reported that 2D-LC MS/MS coupled to a mass spectrometer can identify up to 
500 individual proteins with one run. These studies were performed using 120pg of a yeast 
lysate (Link et al., 1999). As we did not expect to be able to generate an 
immunoprecipitated sample of such high a concentration of protein, we wanted to test the 
performance of our 2D-LC MS/MS setup (Figure 4.2) and our in-solution digest protocol 
using 50pg of a mammalian cell lysate. We precipitated the lysate with TCA to mimic the 
protocol used for our eluates and resolubilised the pellet in urea and n-octylglucoside. By 
adding the detergent we hoped to facilitate the resolubilisation of the proteins. 
Additionally, it has been reported that adding suitable detergents enhances the tryptic 
digest and reduces sample loss (Erdjument-Bromage et al., 1998). As this is a non-ionic 
detergent it should not bind to the ion-exchange column and, and as it elutes at a higher 
acetonitrile concentration than most peptides from a C18 reverse phase column, will not 
affect peptide identification on the first HPLC run. The proteins were then incubated with 
DTT at 37°C to reduce the cysteine bonds. Increasing the temperature further was avoided 
to minimise carbamylation of side chains. Trypsin has a low reactivity at high urea 
concentrations, therefore we diluted the urea to under 0.5M before adding trypsin. We 
incubated the solution at 37°C overnight. To avoid sample loss through concentration steps 
the digest was only acidified and subsequently injected into the LC. We used 8 salt step- 
gradient elutions and a 90 minute acetonitrile gradient to separate the peptides. The LC 
was coupled to a Q-TOF (Q-STAR Pulsar) mass spectrometer that acquired MS/MS 
spectra of all multiply charged ions, as peptides tend to carry 2 or more charges when 
electrospray is used as means of ionisation. The mass spectra were then analysed using 
MASCOT.
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We were able to identify 70 individual proteins. No oxidised methionine was found and 
only one peptide was carbamylated. The tryptic digest was successful as no increase in the 
number of missed cleavages in comparison to typical in-gel digests was found. These 
results confirmed that our in-solution digest protocol worked and that our 2D-LC setup 
would be powerful enough to analyse samples of medium complexity, such as 
immunoprecipitated protein complexes..
4.1.3 2D-LC analysis o f wild-type FLAG-RAf-1 and FLAG-Raf-1^^^^^
Although we expected to increase the sensitivity of the analysis using our gel-less protocol 
we were concerned that we would not be able to generate information that can be derived 
from visualising proteins bands on gels before analysing them by mass spectrometry. We 
expected to lose apparent molecular weight information and also information about 
changes in absolute protein amounts. To test the ability of our set-up to detect known 
changes in composition of protein complexes, we compared wild-type Raf-1 against Raf- 
|S259A iiYimunoprecipitates. Unlike the wild-type protein, Raf-1 is known to bind 14-3- 
3 protein poorly. This difference in 14-3-3 binding can be easily detected when wild-type 
and Raf-1^^^^ immunoprecipitates are run in parallel on a ID gel. Additionally the Raf- 
lS259A has other interesting characteristics. Despite its ability to constitutively
activate MEK to a level comparable to the oncogenic v-Raf protein, this mutant is unable 
to transform cells. One possible explanation for this observation is that the mutant impedes 
signalling pathways important for transformation, possibly by interacting with other 
proteins (Dhillon et al., 2003; Dhillon et al., 2002a). Thus, comparing complexes formed 
by Raf-1 and Raf-1^^^^"  ^ is an ideal test for the method, as some changes in complex 
partner proteins are known while further changes are expected.
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We immunoprecipitated FLAG-wild-type and FLAG-Raf-1 and identified the proteins
in the complexes by 2D-LC MS/MS. A comparison of the proteins identified showed that 
several were unique to either the wild-type or mutant Raf-1 (Figure 4.3). A more detailed 
functional study of one of the associated proteins, protein phosphatase 5 (PP5), will be 
reported in a subsequent chapter. Most notable of these was the presence of five 14-3-3 
isoforms in the wild-type sample but only one in the Raf-1 sample, confirming the 
reduced binding of 14-3-3 proteins to the mutant. The ability to detect differences in 14-3- 
3 binding to Raf-1 suggests that our approach was sensitive enough to identify absolute 
changes in the composition of protein complexes.
In FLAG-Raf-1'^ only In FLAG-Raf-1^^^^  ^only
14-3-3 protein beta/alpha: PP5
14-3-3 eta DNA damage binding protein 1
14-3-3 protein gamma AHNAK-related protein
14-3-3 epsilon Nucleophosmin
FKBP51 47 kDfl hfiat Rhnrk
similar to Frizzled-? protein
G protein beta polypeptide 2-like 1
erbB3 binding protein EBP1
SIP
Figure 4.3: Proteins identified only in FLAG-Raf-l"^^ or FLAG-Raf-1 im m unoprecipitates by 2D LC 
MS/MS analysis.
4.1.4 2D-LC MS/MS analysis o f  Raf-1 complexes isolated from starved, serum-stimulated 
and taxol-treated cells
Based on the results described above we next wanted to test if  we could identify changes in 
the composition of Raf-1 complexes under different conditions. We decided to use the Raf-
K375M mutant as bait. This mutation of the essential lysine in the ATP binding pocket of
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Raf-1 prevents ATP binding, hence destroys kinase activity. This kinase-dead Raf-1 may 
bind more strongly to prospective substrates by functioning as a “substrate trap”. To 
compare dynamic changes in Raf-1 complexes, we compared the composition of 
complexes formed after serum-starvation, serum-activation (a mitogenic stimulus) and 
taxol-treatment (an apoptotic stimulus). We transfected Cos-1 cells with FLAG-Raf- 
|K375M^  and after 24 h starved the cells in medium containing 0.1% PCS or treated them 
with taxol overnight. One set of serum-starved cells was also stimulated for 15 minutes 
with 10% FCS. The Raf-1 complexes were immunoprecipitated and analysed using 2D-LC 
MS/MS as described previously. We identified 98 proteins in immunoprecipitates from the 
serum-stimulated cells, 82 in serum-starved cells and 63 in taxol-treated cells. Most of the 
proteins were chaperones, adaptors and ribosomal proteins, but we also identified low 
abundance proteins, such as kinases, phosphatases, transcription factors and G proteins. 
Several proteins were uniquely present in Raf-1 complexes from either serum- 
activated or serum-starved cells, and two proteins were exclusively present in the taxol- 
treated samples (Figure 4.4).
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In starved cell only
EBP1
were GA17/dendritic cell
protein
Torsin
R A k /l a n H  a n r i  a  H P l H n m a ir
In serum-starved and 
taxol-treated cells
Calumenin
TIM50
In serum-activated cells only
G-protein beta WD-40 repeats 
containing protein 
guanine nucleotide binding protein 
(G protein), beta polypeptide 2-like 
1
Serine/threonine protein 
phosphatase 2A
similar to EG:95B7.3 gene product 
[Homo sapiens]
transcription factor ARF6 chain B 
Collagen alpha 1(1) chain precursor 
filamin
HIV-1 Nef interacting protein 
HSPC029
mitochondrial matrix protein p32 
PNAS-12.5
Figure 4.4; Proteins identified in FLAG-Raf-l'^^^'^ immunoprecipitates by 2D-LC MS/MS analysis. 
A) Proteins interactions lost upon activation o f starved cells with 10% FCS Üiat were not present in the 
taxol treated sample B) Protein interactions induced by treating cells with taxol overnight and present in 
starved cells; C) Proteins interactions induced by treating cells with 10% FCS for 15min.
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We evaluated the validity of our approach by comparing the strength of one individual ions 
belonging TIMM50, a protein identified in the serum starved and taxol treated Raf-1 
immunoprécipitation. A doubly charged ion with m/z 559.9 was identified by the Mascot 
search engine as being a tryptic peptide derived from TIMM50. The ion was present at a 
strength of 70 and 55 counts at its maximum in the 50mM salt step of the serum starved 
and taxol treated immunoprécipitation but only with a count of 20 in the serum activated 
Raf-1 immunoprécipitation. A  direct comparison with the co-eluting ions additionally 
confirms that the ion is relatively reduced (Figure 4.5).
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Table 4.1 gives a list of all proteins identified from the Raf-1 interaction studies. The first 
column contains proteins that have been previously described to be either binding to Raf-1 
or a core members of the HSP90/70 complex, therefore likely to be contained in the Raf-1 
core complex that contains Raf-l/HSP90/HSP70/CDC37/14-3-3/BAG-l. The second 
column contains proteins that have not been described to be binding to Raf-1 previously 
but are likely to be specific interaction partners as these proteins were not identified in 
immunoprécipitations form unrelated proteins. Finally column three contains likely 
contaminants, as these proteins are regularly found in immunoprécipitations and seem to 
be precipitating regardless of the nature of the bait. Additionally to the listed proteins 
keratin, BSA and trypsin were identified.
Table 4.1: Proteins identified in FLAG-Raf-1 co-immunoprecipitations
Raf-1 and HSP90 Interacting 
proteins
14-3-3 epsilon
14-3-3 eta
14-3-3 protein beta/alpha 
14-3-3 protein tau 
14-3-3 zeta 
14-3-3gamma
BAG-family molecular chaperone
regulator-2
calmodulin
CDC37 homolog
chaperonin containing t-complex 
polypeptide 1, delta subunit 
chaperonin containing TCP1, 
subunit 2
chaperonin containing TCP1, 
subunit 3
chaperonin containing TCP1, 
subunit 4
chaperonin containing TCP1, 
subunit 8
DnaJ (Hsp40) homolog, subfamily
A,
DnaJ (Hsp40) homolog, subfamily
B, member 4
DnaJ subfamily A member 2
dnaK-type molecular chaperone 
grp78
dnaK-type molecular chaperone
HSPA5 precursor
FKBP51
FKBP54
heat shock 27kD protein 1 
Heat shock 70 kDa protein 1
heat shock 70kD protein 9B 
(mortalin-2)
Likely Interacting proteins
52-kD SS-A/Ro autoantigen
ADP,ATP carrier protein T2
annexin A2
calumenin
CBP-50 protein
erbB3 binding protein EBP1
filamin
fission yeast Skbl protein homolog -
human
GA17 protein
gi|12857398
G-protein beta WD-40 repeats containing 
protein
guanine nucleotide binding protein (G 
protein), beta polypeptide 2-like 1 
H+-transportlng ATP synthase
HI histonefamily, member 3; histone H ie
H3 histone famiiy, member T
Heterogeneous nuclear ribonucleoprotein 
K (hnRNP K) 
histone HI .c - human
histone H2B, testis -
histone H4 [Homo sapiens
HIV-1 Nef interacting protein
HSPC029 
KIAA1279 protein 
mitochondrial matrix protein p32
PNAS-125
Likely contaminants
26S proteasome regulatory 
chain 12 - human 
40S RIBOSOMAL PROTEIN 
P40
408 ribosomal protein 810 
408 ribosomal protein 812 
408 ribosomal protein 813 
408 ribosomal protein 814 
408 ribosomal protein 815a
408 ribosomal protein 816
408 ribosomal protein 817
408 RIBOSOMAL PROTEIN 
819
408 ribosomal protein 82
408 ribosomal protein 820
408 ribosomal protein 821
408 ribosomal protein 824
408 ribosomal protein 825
408 ribosomal protein 828
408 ribosomal protein 83 
408 ribosomal protein 830
408 ribosomal protein 83a
408 RIBOSOMAL PROTEIN 
84
408 ribosomal protein 87
408 ribosomal protein 89
408 RIBOSOMAL PROTEIN 
8A (P40)
608 ACIDIC RIBOSOMAL 
PROTEIN PI
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Heat shock cognate 71 kDa 
protein
heat shock protein 27
heat shock protein 70
heat shock protein 90-beta - 
human
Heat shock protein HSP 90-alpha
mortalin mot-2=hsp70 homolog 
perinuclear form 
Serine/threonine protein 
phosphatase 2A 
stress-induced-phosphoprotein 1 
(Hsp70/Hsp90-organizing protein 
t-complex 1 ; T-complex locus TCP- 
1 ; t-complex 1
T-complex protein 1, epsilon 
subunit
telomerase binding protein p23 
TIM50
v-raf-1 murine leukemia viral 
oncogene homolog 1 ; Oncogene 
RAF1 
PP5
ribosomal protein SI 8
RuvB (E coli homolog)-like 1 [Homo 
sapiens]
RuvB-like protein 1 ; Pontin 52
SAM domain and HD domain 1 ; 
DKFZP564A032 protein; SAM domain and 
HD domain
serine/threonine kinase 38 
similar to dendritic cell protein
similar to EG:95B7.3 gene product [Homo 
sapiens]
similar to Frizzled-7 protein - human
similar to T-complex protein 1, epsilon 
subunit (TCP-1 -epsilon)
SKB1 homolog; SKB1 (S. cerevisiae)
homolog
spindlin
transcription factor ARF6 chain B 
SIP1
DNA damage binding protein 1 
AHNAK-related protein 
Nucleophosmin
60S ACIDIC RIBOSOMAL 
PROTEIN P2
60S RIBOSOMAL PROTEIN 
LI 2
60S ribosomal protein L23 
actin beta
actin, skeletal muscle 
Alpha-81 casein precursor
Alpha-82 casein precursor
beta-actin
beta-lactoglobulin
Collagen alpha 1 (I) chain 
precursor
elongation factor 1-aipha
Elongation factor 1 -alpha 1 
(EF-1-alpha-1)
Eukaryotic translation initiation 
factor 3 subunit 9
eukaryotic translation initiation 
factor 3, subunit 10 theta 
eukaryotic translation initiation 
factor 3, subunit 2 beta 
eukaryotic translation initiation 
factor 3, subunit 3 gamma 
eukaryotic translation initiation 
factor 3, subunit 4 
eukaryotic translation initiation 
factor 3, subunit 4 delta 
eukaryotic translation initiation 
factor 3, subunit 5 epsilon, 
eukaryotic translation initiation 
factor 3, subunit 6 
eukaryotic translation initiation 
factor 3, subunit 6 interacting 
protein
eukaryotic translation initiation 
factor 3, subunit 8 
Eukaryotic translation initiation 
factor 4 gamma 
eukaryotic translation initiation 
factor 4B
phosphoribosyl pyrophosphate 
synthetase 1
phosphoribosyl pyrophosphate 
synthetase-associated protein 2 
phosphoribosylphosphate 
synthetase (PRP82) 
small nuclear ribonucleoprotein 
D3 polypeptide 18kDa 
translation initiation factor elF- 
4A
Tubulin alpha-2 chain
tubulin alpha-3 chain
tubulin beta 5
tubulin beta chain
tubulin beta chain 15
tubulin, alpha 4; tubulin alpha 4 
[Mus musculus] 
tubulin, beta, 2
T a b l e  4 .1 :  P r o t e i n s  i d e n t i f i e d  b y  2 D - L C - M S / M S  o f  F L A G - R a f - 1  i m m u n o p r é c i p i t a t i o n s :  All proteins 
listed were identified with >95% certainty using the Mascot search engine and comprise the cumulative 
number of proteins identified from FLAG-Wild type, FLAG-S259A and FLAG-K375M(serum
starved/taxol/serum activated)_Raf-l co-immunoprecipitations.
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4.1.5 Proteins unique to Raf-1 complexes from serum-starved or taxol-treated cells
As Raf-1 protects cells from cell death induced by both serum-starvation and by taxol 
treatment we hypothesized that Raf-1 would bind to proteins under these conditions that 
could explain its anti-apoptotic function. Two proteins were specifically found in FLAG- 
Raf-1^^^^ complexes under these conditions (Figure 4.4B). One of these was calumenin, a 
calcium-binding protein that we also identified by DIGE as one of the proteins whose 
expression differed in vector/kinase-dead Raf-1 reconstituted fibroblasts in comparison to 
wild-type Raf-1 reconstituted cells The second protein was TIM50, a mitochondrial 
membrane protein that, at least in yeast, links the outer membrane translocator complex to 
that of the inner membrane (Yamamoto et al., 2002). Recent studies in human cell lines 
have shown that human TIM50 is also an integral part of the mitochondrial membrane. 
Down-regulation of TIM50 was found to increase the sensitivity of the cells towards 
apoptotic stimuli by accelerating cytochrome c release from the mitochondria (Guo et al., 
2004). Interestingly, TIM50 was also identified in a yeast-two-hybrid screen using the N- 
terminus of Raf-1 as bait, indicating that TIM50 and Raf-1 bind directly (Yuryev and 
Wennogle, 2003). Taken together, the results from the published literature and our 2D-LC 
data suggest that the TIM50 could play a role in Raf-1-dependent protection from 
apoptosis, possibly by acting as a mitochondrial anchor for Raf-1.
4.1.6 Proteins unique to Raf-1 complexes from serum-starved cells
Four proteins were exclusively present in the Raf-1 complexes isolated from serum-starved 
cells (Figure 4.4A). One is EBPl, originally found as an erbB3 binding protein (Yoo et al., 
2000). It binds to erbB3 in starved cells and was also reported to bind to Rb and suppress 
E2Fl-mediated transcription (Xia et al., 2001). Interestingly, Raf-1 has also been reported 
to bind to Rb but this binding correlated with an enhancement of E2F-mediated
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transcription, contrary to EB Pl’s effect (Wang et al., 1998). Further studies are required to 
determine whether the binding of Raf-1 and EBPl to Rb is mutually exclusive or whether 
the three proteins form a ternary complex. The remaining proteins specifically identified in 
complexes from starved cells were GA17/dendritic cell protein, Torsin and a protein 
containing a SAM and HD domain. Unfortunately no further information is currently 
available on these proteins.
4.1.7 Proteins unique to Raf-1 complexes stimulated with serum
Several proteins were identified specifically in complexes from cells stimulated with 
serum. A few of these appeared to be contaminants, mostly from serum proteins. However, 
PP2A was one of the proteins identified unique to these samples. PP2A has been shown to 
dephosphorylate pS259 on Raf-1 and was reported to bind to Raf-1 upon activation 
(Abraham et al., 2000). Our results confirm these observations and show that we are able 
to detect dynamic changes in Raf-1 complexes using the 2D-LC/MS approach. Lastly, we 
identified two G proteins in these complexes, G-protein beta WD-40 repeats containing 
protein and G-protein beta polypeptide 2-like 1 (aka RACKl), suggesting that membrane 
localised Raf-1 might interact with to these two proteins. RACKl is particularly interesting 
because it was reported to anchor active PKC and Src to the cells membrane (Chang et al., 
1998; Ron et al., 1994). In addition several other proteins were unique to serum activated 
Raf-1 complexes (Figure 4.4 C)
4.1.8 PP5 and SIP co-immunoprecipitate with Raf-1
Having identified over 100 proteins as potential components of Raf-1 signalling 
complexes, we decided to further validate two of these, PP5 and SIPl. We chose these 
proteins for further analysis as they are known to be expressed at moderate and low levels, 
respectively, and had not previously been reported to interact with Raf-1.
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PP5, PP2A and PPl are members of a family of serine/threonine phosphatases (Chen et al., 
1994). Both PP2A and PPl have been implicated in dephosphorylating Raf-1 at S259 and 
S621. However, it is still unknown which phosphatases dephosphorylate the other 
regulatory sites on Raf-1. The identification of PP5 in Raf-1 complexes suggested that PP5 
may be one such phosphatase. Therefore we decided to verify the interaction between Raf- 
1 and PP5 by co-expressing them in cells and testing their ability to form a complex. Both 
wild-type Raf-1 and the Raf-1 specifically co-immunoprecipitated PP5. Conversely 
PP5 was able to precipitate both wild-type Raf-1 and the mutant, confirming that Raf-1 and 
PP5 form a complex in-vivo (Figure 4.6 A & B).
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SIPl is an adaptor protein involved in a novel pathway regulating p-catenin degradation, 
independently of its phosphorylation by GSK3. In this pathway, SIPl links p-catenin to 
Siah, a ubiquitin ligase whose expression is induced by p53 (Matsuzawa and Reed, 2001). 
Our identification of SIPl as a potential Raf-1-interacting protein raised the exciting 
possibility that SIPl may be a link between Raf-1 signalling and this novel pathway of p- 
catenin degradation. Once again by co-immunoprecipitation experiments, we found that 
both kinase-dead and wild-type Raf-1 formed a complex with SIPl in cells. Curiously, 
kinase-dead Raf-1 consistently demonstrated an enhanced ability to interact with SIPl in 
these experiments. We also found that GST-Raf-1 bound to glutathione-Sepharose beads 
was able to “pull-down” SIPl expressed in Cos-1 cells suggesting that the interaction 
between these two proteins was a direct one (Figure 4.6 C & D).
4.2 Purification of phosphopeptide standards with antibodies and 14-3-3: a comparison with 
established methods
4.2.1 Anti phospho-serine/threonine antibodies only purify a subset o f synthetic 
phosphopeptides
The use of anti-phosphotyrosine antibodies to immunoprecipitate proteins has been very 
successful due to the high affinity and specificity of these antibodies and their ability to 
bind phosphotyrosine with little dependence on the surrounding amino acid sequence. 
Unfortunately the antibodies that recognise phosphorylated serine and/or threonine are of 
poorer quality. The surrounding amino acids influence the affinity of the antibody for its 
target, presumably because of the smaller size of serine and threonine side chains in 
comparison to the bulkier aromatic ring of tyrosine. To test if phospho-specific antibodies 
could be used to enhance the identification of phosphopeptides prior to MALDI-MS, a 
mixture of anti-phosphoserine/threonine antibodies was first cross-linked to agarose beads 
to cover the largest possible variation of phosphopeptides. A mixture of synthetic peptides.
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comprising 3 phosphorylated peptides from Raf-1 containing the pS621, pS259 and pS338 
sites and an excess of a non-phosphorylated peptide, Raf-1 S43, were incubated with the 
antibody beads overnight, washed and eluted using a pH drop. The eluted peptides were 
then identified by MALDI mass spectrometry. In most cases the eluted peptides had to be 
further purified with C18 Zip-Tips in order to be detected by mass spectrometry. Very 
hydrophilic peptides might have been lost in this purification step. Using this approach, we 
were able to enrich the pS338 phosphopeptide from the mixture but the purification was 
not completely compatible with subsequent mass spectrometric analysis, even using a 
MALDI source with its high tolerance towards contaminants such as salts or detergents 
(Figure 4.7A & B). Thus the eluted peptides had to be further purified in order to be 
ionised and visible in the mass spectrum.
4.2.2 14-3-3P agarose beads enrich the Raf-1 pS621-containing synthetic phosphopeptide 
The ability of 14-3-3 proteins to bind to serine/threonine phosphorylated proteins was 
exploited in this approach. 14-3-3 proteins show a strong affinity to a specific recognition 
motif (R-S-X-pS/T-X-P or R-X-X-X-pS/T-X-P) in which binding occurs only when the 
central serine or threonine are phosphorylated. Several approaches have been published 
that utilise this phosphospecific protein-protein interaction domain to isolate and identify 
14-3-3 binding proteins (Basu et al., 2003; Milne et al., 2002; Rubio et al., 2004). We 
wanted to test if 14-3-3 bound to agarose would be a suitable affinity purification matrix 
for phosphopeptides containing 14-3-3 recognition sites. Raf-1 contains two 
phosphorylation-dependent 14-3-3 binding sites, one at serine 259 and the other at serine 
621. Both phosphorylated peptides were incubated with agarose-14-3-3 beads, alongside 
the non-phosphorylated control peptides (S43) and one phosphorylated peptide that is not 
able to bind 14-3-3 proteins (pS338).
The binding peptides were eluted by dropping the pH of the buffer. As was the case with 
immunoprécipitations using the phosphospecific antibodies, the eluted peptides had to be
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further purified with Zip-Tips for them to be detected by MALDI mass spectroscopy. This 
additional purification step is a major disadvantage in comparison to EMAC based 
purifications, as these can be eluted in a mass spectrometry compatible solvent and the 
IMAC resin does not seems to retain less contaminants than the agarose matrix. The 14-3-3 
P protein beads were able to enrich, but by no means purify, only the phosphopeptide 
containing the pS621 site. The other peptide containing the pS259 14-3-3 binding site was 
not found to bind to the beads specifically (Figure 4.7C & D).
4.2.3 IMAC purification o f  synthetic phosphopeptides and fi-casein derived tryptic peptides 
We wanted to compare our “biological” affinity purifications to well established 
phosphopeptide enrichment methods. Therefore we chose to use IMAC affinity 
purification (Flotow et al., 1990; Muszynska et al., 1992; Neville et al., 1997; Scanff et al., 
1991) using a P-casein digest and our mixture of phosphopeptides. Phosphorylated amino 
acids, their peptides and even whole proteins can be purified with IMAC matrices. This 
affinity purification relies on the affinity of the strongly acidic nature of the phosphor ester 
group. The advantage of this “chemical” affinity is that the influence of the side chains of 
the surrounding amino acids is smaller than in the other methods described above. The 
binding of some peptides might be inhibited through formation of hydrogen bridges and 
ionic interactions with amino acids containing nucleophilic groups which can lead to 
masking of the phosphor ester group. The biggest disadvantage of this approach is the poor 
specificity of the interaction since acidic peptides tend to be co-purified and can make up 
the bulk of the isolated peptides when a complex mixture of peptides, such as a digest of a 
whole cell lysate, is used as starting material.
Using a p-casein tryptic digest with Fe^^IMAC we were able to purify the mono- 
phosphorylated 2060Da casein peptide with little contamination of the non-phosphorylated 
peptide. In negative ion mode even the quadruply phosphorylated peptide at 3186Da was 
visible (Figure 4.8). Using the Raf-1 phosphopeptide mixture IMAC was only able to
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enrich pS338 (Figure 4.7E & F). The method was fully compatible with subsequent 
MALDI analysis and no additional de-salting step had to be performed.
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4.3 Identification of phosphopeptides from mixtures
The first method tested was a precursor ion scan for a phosphite ion that can be observed 
after fragmentation of a phosphate-containing peptide in negative ion mode. This method 
is able to identify modifications present on serine, threonine and tyrosine. The first 
quadrupole screens in negative ion mode through the mass range, the second quadrupole, 
or TOP analyser, is set at 79Da to screen for the phosphite ion. If an ion of a mass of 79Da 
was detected in the fragmentation spectrum the precursor of this ion was then further 
analysed in positive ion mode. The voltage was switched and the charge state and exact 
m/z of the precursor was determined. The ion was then further analysed by MS/MS.
A second method was used to specifically identify phosphotyrosine containing peptides. 
The ion scanned is the immonium ion of phosphotyrosine with a mass of 216.04Da. The 
scan is performed like the 79Da scan but in positive ion mode
Additionally a neutral loss scan for loss of 49 and 33Da was performed on the Q-Trap 
spectrometer. These masses represent the often observed ^-elimination of the phosphate- 
ester from the side chain of serine or threonine. Phosphotyrosine does not undergo p- 
elimination and cannot be detected using this method. The first quadrupole screens through 
the mass range set, the second screens at an off-set of 33Da for triply charged peptides, and 
for 49Da, for doubly charged peptides. If ions were detected at the specified off-set mass 
the ions from the mass range of origin were further analysed to determine charge state and 
the exact mass of the precursor. The precursor was then subjected to a MS/MS analysis to 
determine the amino acid sequence and location of the phosphorylation site.
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4.3.1 Precursor ion scans for 79 and 216.04Da are able to identify phosphopeptides 
The ability of the Q-Star and the Q-Trap spectrometers was first tested to identify 
phosphorylated peptides using P casein as a standard for the 79Da and a synthetic 
phosphotyrosine-containing peptide for the 216.04Da precursor ion scan. The 79Da 
precursor ion scan was performed using both the Q-Star and Q-Trap, whereas only the Q- 
Star was used for the 216.04Da scan because of the higher mass accuracy and resolution of 
the second analyser.
lOpmol of a tryptic digested P-casein peptide mixture was desalted using a C18 Zip-Tip 
and eluted within 3pi of 50% Acetonitrile/Water, filled into a nano tip and analysed in 
negative ion mode. Both mass spectrometers were able to identify the singly 
phosphorylated p casein peptide (Figure 4.8A). The Q-Trap identified the phosphorylated 
peptide within seconds whereas the Q-Star needed more than a minute to identify the 
peptide. Therefore all further experiments involving the 79Da scan were performed on the 
Q-Trap due to its higher sensitivity in this application.
We used lOpmol of a pY340 Raf-1 synthetic peptide to test the phosphotyrosine 
immonium-ion scan. The width of the precursor scan was set at 0.04 mass units to 
minimise false identifications. As the precursor ion scan was able to detect the peptide with 
ease (Figure 4.8C), we further wanted to test the selectivity of the method using a trypsin 
digested PDGF tyrosine kinase receptor purified from Sf9 cells. The precursor ion scan 
identified several ions whose fragmentation showed presence of a mass equivalent to the 
phosphotyrosine immonium ion (Figure 4.9A). Further MS/MS analysis of these ions was 
not able to identify the sequence of the precursors. Most of the peptides showed the same 
fragmentation pattern, indicating that the ions did not represent a peptide but originated 
from contaminants (Figure 4.8B-F). Due to the poor specificity and lack of sensitivity, the 
phosphotyrosine immonium-ion scan method was abandoned.
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4.3.2 LC-MSIMS -79Da precursor ion scan is more sensitive and specific than neutral loss 
We wanted to combine our precursor ion scan with a LC to increase the robustness and 
performance of the analysis. The mass spectrometric analysis of peptides using an ESI 
source is very sensitive towards contaminating molecules. In particular, detergents such as 
SDS, salts or polymers can sometime render it impossible to detect peptides even when 
they are present at a relatively high concentration. Therefore all samples have to be 
purified prior to analysis, typically using CIS reverse phase resin. If this purification is 
performed using a one step elution contaminating salts are generally removed successfully. 
Contaminating polymers, such as poly-ethylene glycols (PEG), that are frequently present 
in samples derived from in-gel digests, can still be present and hinder the subsequent 
analysis. Another disadvantage of eluting all the peptides in one fraction is that the 
complexity of the sample is not reduced and co-eluting peptides will suppress the 
ionisation of the phosphopeptides. Furthermore the fraction volume typically used in a 
one-step elution is around 1-3pL whereas the volume at which peptides elute from a nano 
LC column is between 100 and 200nL, thus increasing the concentration of the eluting 
peptide around 10-fold and increasing detectability. Using in solution digested casein two 
different LC-MS/MS approaches to identify phosphorylation sites were tested.
lOOpmol of peptides derived from a casein digest were separated on a nano-LC and 
directly analysed by mass spectrometry. Firstly we used a neutral loss scan of 98Da and 
secondly a -79Da precursor ion scan to detect phosphorylated peptides. Upon detection of 
a phosphorylated peptide the mass spectrometer switched automatically to an enhanced 
resolution scan to determine the peptide mass and charge and then selected the ion to be 
further analysed by MS/MS. Both the neutral loss scan and the 79Da precursor ion scan 
were able to detect phosphopeptides, although the neutral loss scan detected only one 
phosphopeptide and numerous non-phosphorylated peptides. The precursor ion scan on the
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other hand not only identified both phosphorylation sites of P casein but also identified 4 
other sites contained in two a casein proteins that were evidently present as a contaminant 
in the p casein sample (Table 5.1). The direct comparison between neutral loss scanning 
and precursor ion scaiming showed a higher specificity and higher sensitivity for the latter 
method, therefore the precursor ion scan was chosen as the method to be used for further 
analyses.
4.3.3 LC-MS/MS precursor ion scan detects 500finol o f  phosphorylated fi-casein 
To determine the sensitivity of our approach, four additional LC runs were performed 
using lOpmol, Ipmol, SOOfmol and lOOfmol of P-easein. One phosphorylation site was still 
detectable in the SOOfmol injection but no phosphorylation site was detected in the 
lOOfMmol injection, setting the sensitivity of the method between 100 and SOOfmol of 
injected phosphopeptide (Table S.2).
Table 4.2; Phosphopeptides identified from a p-Casein digest (90% purity) by LC-MS/MS 
using different concentrations and different detection methods
casein alpha-S2
beta casein
alpha-S1-casein
P - p e p t i d e s  id e n t i f ie d
lO O p m o i
p r e c u r s o r
lO p m o i
p r e c u r s o r
I p m o i p r e
c u r s o r
SOOfmol
p r e c u r s o r
s c a n
lO O p m o l
n e u t r a i
l o s s
N M A IN P p S K E N L C X - - - -
T V D M E pST E V FT K X X - - -
F Q p S E E Q Q Q T E D E L Q D K X X X X X
R E L E E L N V P G E iV E p S L p S p S p S E E S IT R X - - - -
D iG p S E p S T E D Q A M E D iK X X X - -
Y K V P Q L E iV P N p S A E E R X X X - -
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4.3.4 Identification o f four phosphopeptides derived from Raf-1 complexes 
Having established the sensitivity and specificity of our method, we then wanted to 
identify phosphorylation sites in Raf-1 complexes. Therefore a FLAG-Raf-1 co- 
immunoprecipitate was digested with trypsin in solution and the resulting peptides were 
analysed by a LC coupled to a Q-Trap in precursor ion scan mode. The resulting MS/MS 
spectra were processed by the MASCOT search engine and five peptides were identified 
over a significant threshold. Four peptides contained a phosphorylation site and in each 
peptide the position of the phosphorylated aminoacid was identified. Only one peptide 
originated from Raf-1, confirming the phosphorylation on the serine at the 259 position 
(Figure 4.11 A). The other phosphopeptides identified belong to proteins previously not 
identified to be interacting with Raf-1. ABP-7 has similarities to the translation initiation 
factor IF2. We identified translation initiation factors with our previous 
immunoprécipitations but no further analysis of the specificity of the interaction was 
performed. These proteins are among the most abundant proteins in the cell, therefore it 
carmot be ruled out that the interaction is unspecific.
Methylosome subunit plCln and Ac2-269 (similar to methylosome protein 50, MEP50) 
both play a role in arginine méthylation and have been found previously in the same 
complex (Friesen et al., 2002). MEP50 is a protein containing WD repeat domains which 
function as protein-protein interaction domains, indicating that the function of this protein 
is to act as a scaffold for the complex. The identification of two proteins from the same 
complex strengthens the possibility that the interaction with Raf-1 is functional although 
non-specificity cannot be ruled out without further investigations. Although these two 
proteins were not identified in our previous immunoprécipitations we were able to identify 
one additional protein involved in the same methyliosome complex (JBPl/SKB or Jakl 
interacting protein)(Friesen et al., 2002).
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The other peptides were from proteins that were present in the immunoprecipitate and 
could have been Raf-1 interacting proteins. The location of the phosphorylation carrying 
amino acid was identified by MS/MS in all peptides that were above the significant 
threshold (Figure 4.11). Several other peptides that could not be identified following the 
MASCOT search showed a neutral loss of 98 mass units, typical for phosphopeptides. 
However, the quality of the fragmentation data was not good enough to positively identify 
these peptides.
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C hapter 4: Discussion
We set out to improve methods of analysing multi-protein complexes by using more 
accurate and sensitive mass spectrometers combined with new separation techniques. By 
using two-dimensional liquid chromatography we were able to separate peptides generated 
from immunoprecipitated samples and identify them by an online mass spectrometer. By 
using this approach we increased the number of identified proteins by more than 10-fold 
when compared to our initial MALDI approach, demonstrating the increased sensitivity 
and accuracy of our improved methodology. We now have a powerful and robust tool that 
enables us to analyse protein complexes and have confirmed the validity of our approach 
by verifying two interactions with alternative methods.
Although this method is very useful, further improvements are needed to unlock the full 
potential of mass spectrometry-based approaches to study protein-protein interactions. One 
of the most surprising findings was that some well documented Raf-1 binding proteins 
evaded detection by our approach despite our increasing the sensitivity of the 
methodology. One possible explanation for these results is the lysis conditions used and the 
presence of detergent in the buffer. It is plausible that some proteins will detach from Raf-1 
complexes upon contact with detergents. Other proteins might detach from Raf-1 in a time- 
dependent manner For example, Ras would detach from Raf-1 if GTP hydrolysis occurred 
after prolonged buffer exposure. Other problems arise from non-specific binding proteins. 
Although they do not seem to hamper the detection of genuine interacting proteins, the 
presence of these non-specific binders can make it time consuming to sort out the wheat 
from the chaff. Tandem affinity purification tags have been proposed to solve the latter 
problem (Rigaut et al., 1999). Although using these tags will increase specificity these 
methods will inevitably increase sample handling times as two affinity purification steps 
and incubation with a specific protease are needed to cleave the tag and purify the protein
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complex. These extra steps could result in the loss of loosely and transiently bound 
proteins, rendering this method unsuitable for analysing dynamic changes in the 
composition of protein complexes. There is no easy solution to these problems, but using 
detergent free lysis buffer whenever possible and using highly specific antibodies 
preferably against endogenous proteins will most certainly improve the accuracy and 
validity of this approach.
Further improvements have arisen in recent years. In particular, the use of stable isotope 
labelling is set to revolutionise gel-less proteomics. We used a crude method to estimate 
changes in protein binding, an all or nothing approach. If we would have used methods like 
SILAC we would have been able to detect even slight changes in protein binding, making 
this method most suitable to detect transient interactions. SILAC (Stable Isotope Labelling 
in Cell culture) uses ^^C and substituted amino acids in cell culture. Cell grown in this 
medium will incorporate the modified aminoacids into newly synthesised proteins. 
Lysates from cells grown in “heavy” and “light” medium are mixed and further 
purification steps, such as immunoprécipitation, can be performed on the mixture. The 
protein mixture can is then analysed by mass spectrometric means and peptides derived 
from these proteins will elute at the same time from an LC and will have identical 
ionisation properties, despite having different masses. The comparison of the signal 
strength of the individual ions can therefore be used for relative quantitation. As recent 
publications have shown, use of these methods enables the identification of novel insights 
into well studied cellular systems (Blagoev et al., 2003; de Hoog et al., 2004).
In the second part of this chapter we attempted to improve phosphorylation site mapping of 
protein complexes by using specific purification and detection methods. None of the 
methods that were tried to enrich phosphopeptides was completely successful. Several 
reasons might explain this. IMAC, as shown several times before, is an efficient method to 
enrich tryptic phosphopeptides that originate form casein digests (Stensballe et al., 2001).
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We were able to highly enrich both the singly and the quadruply phosphorylated peptide. 
However, the purification was not satisfactory when even a simple mixture of synthetic 
phosphopeptides was used. Only one of the synthetic phosphopeptides was enriched using 
this affinity purification. The results were similar to the results achieved with the affinity 
matrices generated from either phosphospecific antibodies or 14-3-3. In recent years IMAC 
methods have been improved by introduction of new chelating matrices, the use of 
different ions and the modification of acid amino acids. Future improvements may render it 
possible for IMAC to be used more widely and initial attempts using yeast lysates have 
been reported (Ficarro et al., 2002).
Because the interaction between the peptides and their interacting proteins relies on a 
biological affinity all the incubations were performed in PBS. The peptide pull-down could 
only be efficient in a physiological salt-containing buffer that does not affect the tertiary 
structure of the proteins. The salt contained in the sample had to be removed using 
ZipTips, possibly resulting in sample loss. Additionally the elution with acetic acid might 
not have been complete, especially in case of the 14-3-3 affinity purification. This 
approach has been very successful in purifying whole proteins (Basu et al., 2003; Rubio et 
al., 2004). In these experiments the proteins were competed off the beads by using 
phosphopeptides containing the 14-3-3 recognition site. Therefore there is no reason why 
both the pS259 and pS621 peptide should not have been able to bind to the bait proteins. 
The most conceivable explanation is that we failed to elute the peptides from the 14-3-3 
beads. Instead of trying a pH drop maybe the use of a chaotropic elution buffer would have 
been more efficient. The use of these reagents is on the other hand is not compatible with 
subsequent mass spectrometry and extensive washes, with the possibility of sample loss, 
would have had to follow the elution.
Our antibody-based enrichment method failed presumably because of weak interactions 
between some of the peptides and the antibodies. More recent studies have shown that
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certain Ser/Thr phosphospecific antibodies perform quite well in immunoprecipitating 
phosphorylated proteins (Gronborg et al., 2002). Thus, with a broadening arsenal of 
antibodies recognising multiple phosphorylation sites, a more successful enrichment of 
phosphopeptides from a complex sample might become possible.
Specific detection of phosphopeptides by precursor ion scans has been more fruitful for the 
task of sequencing phosphorylated peptides from biological samples. Our initial method 
development showed that both machines, the Q-Star and the Q-Trap, were able to detect 
phosphopeptides by precursor ion scanning with a high sensitivity and high accuracy. In 
negative ion mode the phosphopeptides seem to fragment nearly exclusively into a 
fragment of 79 and 97Da mass units (Figure 4.7B), hence the high sensitivity of the 
method. Overall the linear iontrap had a higher sensitivity. The probable reason for the 
better performance is the design of the machine, having a linear iontrap as a second 
analyser that functions as a third quadrupole when used in precursor ion mode, as this 
analyser is built for a continuous ion stream as originating from the electrospray. The TOF 
analyser in the Q-Star could obviously not perform as well; one reason might be the 
pulsing nature of the TOF design.
The performance and the practicality of the phosphorylation mapping increased 
dramatically by use of an LC system coupled to the mass spectrometer. The sensitivity 
achieved with 500fmol of peptide is reasonable and comparable to methods published that 
utilised multidimensional LC analysis (Zappacosta et al., 2004; Zappacosta et al., 2002) 
and non LC-based precursor ion scanning (Neubauer and Mann, 1999). In contrast to other 
published methods the method is amenable to automation and the complete scan of a 
sample and sequencing of the detected peptides is achieved with one LC run of 40 minutes. 
Full automation though could not be achieved. Unfortunately the electrospray is unstable 
in the negative ion mode and plasma formation at the tip of the needle is quite frequent, so 
that the operator has to be present at all times to be able to adjust the needle.
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In total four phosphorylated peptides were identified in Raf-1 immunoprecipitates, quite a 
small number considering the large number of proteins identified in the complexes. This 
small number can be explained by the fully automated selection of ions designated to be 
further analysed by MS/MS. Firstly it is possible that the correct precursor ion might not be 
chosen accurately. The enhanced resolution scan that is executed in the mass range that 
contained the precursor of the 79Da fragment has a width of lODa and selects the ion with 
the highest intensity for analysis. This selection might not be accurate at all times, 
especially if the sample is complex and other peptides or contaminants elute in the same 
mass range. Additionally the analysis assumes that a peptide ion that carries a given 
amount of charges in negative ion mode will carry the same charge in positive ion mode, 
as only that mass range is selected for further analysis in positive ion mode. This 
assumption will not be correct for all peptides, especially since phosphopeptides tend to 
carry a lesser charge in positive ion mode due to the strong negative charge carried by the 
phosphorester. Confirming this assumption was the observation that the trace of the 79Da 
precursor ion scan showed several peaks that did not result in a positive identification of a 
phosphorylated peptide. Secondly co-eluting peptides could have suppressed the ion 
corresponding to the phosphopeptide rendering it invisible to the mass spectrometer. The 
feasible combination of precursor ion scan and 2D-LC might cure some of these problems 
and so possibly change the detection of phosphorylation sites in multiprotein complexes to 
a robust and easy technique.
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Chapter 5
Characterisation of the Raf-1/PP5 interaction
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Chapter 5: Introduction
Numerous studies have shown that phosphorylation plays a key role in regulating the 
activity and signalling by Raf-1 (Dhillon and Kolch, 2002; Kolch, 2000). While several 
kinases have been reported to phosphorylate some of the major regulatory sites in Raf-1, 
much less is known about how theses sites are dephosphorylated. Protein phosphatases 
PPl and PP2A have both been shown to dephosphorylate pS259 upon activation by 
mitogens (Abraham et al., 2000; Jaumot and Hancock, 2001; Mitsuhashi et al., 2003). 
Déphosphorylation of this inhibitory site is crucial for translocation of Raf-1 to the 
membrane and binding to active Ras, its phosphorylation on activating sites such as S338 
and its ability to activate MEK (King et al., 1998; Mason et al., 1999). While these studies 
have shown that dephosphorylation plays an important role in Raf-1 activation, the role 
and the identity of phosphatases involved in deactivating Raf-1 is poorly understood. We 
identified PP5 as a novel component of Raf-1 complexes and verified the interaction 
between PP5 and Raf-1 by co-immunoprecipitation experiments in COS-1 cells (see Figure 
5.4). The aim of the experiments described in this chapter was to characterise the role of 
PP5 in Raf-1 signalling. In particular, we wanted to test if PP5 directly dephosphorylated 
site(s) on Raf-1.
PP5 is a member of the PPP family of serine/threonine specific protein phosphatases which 
also includes PPl, PP2A and PP2B. PP5 was initially reported to be a predominantly 
nuclear protein, but more recent studies have confirmed that it is also cytoplasmic and can 
translocate to the cell membrane (Chen et al., 1994). PP5 comprises a catalytic domain 
which shows approximately 40% identity to the other PPP family members. PP5 can be 
inhibited by okadaic acid, but at higher concentrations to those required to inhibit PP l and 
PP2 (Brewis et al., 1993; Chen et al., 1994). A distinctive feature of PP5 is that it possesses 
an N-terminal tetratrico-peptide repeat (TPR) domain, which is found in numerous 
signalling proteins. As it is believed that the TPR domain is crucial for protein-protein 
interactions it is possible that it targets PP5 to its substrates. The process that leads to
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activation of PP5 is controversial. In contrast to PP l and PP2, PP5 has a very low basal 
activity and it seems that, whereas PPl and PP2 are regulated primarily by targeting to 
their substrates, PP5 can be activated by removing the N-terminus. PP5 can also be 
activated by long-chain polyunsaturated fatty acids, such as arachidonic acid, that interact 
with the TPR domain and protein-protein interactions mediated via the TPR domain 
increase PP5 activity, at least in-vitro (Chen and Cohen, 1997; Yamaguchi et al., 2002; 
Zeke et al., 2004; Zeke et al., 2005). These studies indicate that the N-terminal TPR 
domain shields the C-terminal active site from interacting with substrates and so regulates 
its activity. Although numerous proteins have been shown to interact with PP5, only a few 
have been shown to be genuine substrates. Thus far ASKl and DNA-PKcs are the only two 
bona fide substrates that have been identified (Morita et al., 2001; Wechsler et al., 2004). 
These studies reveal a remarkable specificity for PP5 in choosing its targets, quite in 
contrast to PPl and PP2.
Recent studies have shown that subcellular localisation of PP5 plays an important role in 
regulating its activity. Nuclear localisation appears to be dependent on the C-terminal 
region, whereas localisation to the membrane can be induced by activating the 
heterotrimeric G-proteins, G a l2 or G al3 (Yamaguchi et al., 2002). These results indicate 
that changes in PP5 localisation induced by extracellular signals may play an important 
role in regulating its signalling properties.
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Chapter 5: Results
5.1 Characterisation of the interaction between Raf-1 and PP5
5.1.1 Endogenous Raf-1 and PP5 form a complex in serum starved COS-1 cells
PP5 was identified as a potential Raf-1 interacting partner in a proteomic screen using Raf- 
lS259A as bait. This interaction was validated using co-immunoprecipitation analysis 
(Figure 4.6). Having verified the interaction using overexpressed proteins we then wanted 
to test if both proteins form a complex when expressed at endogenous levels. Therefore, 
we immunoprecipitated endogenous Raf-1 from COS-1 cells with an antibody that 
recognised the 12 C-terminal residues of Raf-1. We found that PP5 interacted with Raf-1 
specifically in serum-starved cells as less endogenous PP5 was found to co-precipitate with 
Raf-1 in growing cells (Figure 5.1 A). This result indicated that PP5 and Raf-1 form an 
endogenous complex which is regulated by extracellular signals.
5.1.2 PP5 binds specifically to the kinase domain o f Raf-1
Next we wanted to determine the region of Raf-1 that interacted with PP5. We coexpressed 
HA-PP5 with Flag-tagged versions of full-length Raf-1, the N-terminal regulatory domain 
and the C-terminal kinase domain in COS-1 cells. Analysis of Flag immunoprecipitates 
prepared from these cells showed that both full-length Raf-1 and its kinase domain 
coprecipitated PP5 (Figure 5.IB). These results show that PP5 interacts specifically with 
the kinase domain of Raf-1. They also raised the possibility that PP5 may dephosphorylate 
sites within this region of Raf-1.
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5.1.3 PP5 dissociates from Raf-1 upon stimulation with EGF
The poor binding of PP5 to Raf-1 in cells growing in medium containing 10% PCS 
prompted us to ask if the interaction between the two proteins was regulated by 
extracellular growth factor signals. Therefore we compared the interaction of PP5 with 
Raf-1 in serum-starved COS-1 cells with cells stimulated with EGF, a strong activator of 
the Raf-l-MEK-ERK pathway. EGF treatment led to the rapid dissociation of PP5/Raf-l 
complex, with little PP5 coprecipitating with Raf-1 after just 5 minutes (Figure 5.2). Thus, 
the interaction between PP5 and Raf-1 is disrupted by growth factor signalling.
5.2 Effect of PP5 on signalling via the Raf-l-MEK-ERK pathway
5.2.1 PP5 impairs serum-stimulated activation o f MEK
To explore the effect of PP5 on Raf-1 signalling, wild-type and catalytically-inactive 
(phosphatase-dead) PP5 were coexpressed in COS-1 cells with Raf-1 and HA-MEK. After 
serum-starvation overnight the cells were stimulated with 10% PCS for 5 minutes. HA- 
MEK was immunoprecipitated and immunoblotted with an antibody recognising the Raf- 
mediated phosphorylation sites on MEK. Phosphorylation of these sites is required and 
sufficient for MEK activation. Thus, MEK activation can be conveniently measured by 
determining the phosphorylation at theses sites. Active PP5 reduced MEK phosphorylation 
whereas phosphatase-dead PP5 had no effect on pMEK levels (Figure 5.3). These results 
show that PP5 negatively regulates activation of the Raf-MEK pathway.
5.2.2 PP5 reduces Raf-1 kinase activity o f wild type and activated Raf-1 mutants
To test if PP5 acts at the level of Raf-1 we assayed the effect of PP5 on serum-induced 
activation of Raf-1. We coexpressed wild-type Raf-1 with wild-type or phosphatase-dead 
PP5, then determined Raf-1 kinase activity using a two-step assay. Expression of wild-
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type PP5 reduced Raf-1 kinase activity, whereas the vector and phosphatase-dead PP5 had 
no effect of Raf-1 activity (Figure 5.4A). To rule out the possibility that PP5 might be 
acting on a protein required for the activation of Raf-1 by serum, we performed the same 
analysis in serum-starved cells on a mutationally activated mutant of Raf-1, Raf- 
Y^Y34o/34iDD again, wild-type PP5 inhibited the activity of this Raf-1 protein in
comparison to vector-transfected cells. Interestingly, phosphatase-dead PP5 was able to 
further enhance the basal activity Raf-1^2"^o/34iDD (Fig. 5.4B). These results
demonstrate that PP5 exerts a direct inhibitory effect on Raf-1, possibly by 
dephosphorylating an activating site.
o  sLU Q_
.E <
in
fO
CE
i
I
Q.
O
5U.
à
a;
& s
1  =  G g i?
*"■ to3
r ^ s g .
% V _ "S
l a f t  
l - G
l E lo
%
8
I f  
a ^
•^1
I  s
• i !W) o  .2 u
Ou ^
cd li
- ■ s i
§|.i
E .9-
(Q
IT) Q/
. 1 3b  üw
o
I i g 
§ 11
X
LJJ
2
Q.
UJ
V) S' %,uu_ V1 \
\
UJs
<X
(U c 73 73a. C C
r
3 3
2 U § "8
i < 1
3
'Oh
u
tii
z
TD § ‘oB
s "8 §■so ul iS 3
1
c/3 B
OC È B3% C c/3> u 3
1
c/3
B Ni
w
1 2 >c/3 S■o CLe X 13 <0> (U o z
s-
V
8
(/)
<u
•s c
m 3 c 1B .2 IT)
2 U-3 t3V Pu (U 2V) CL
s
1
(U73
U
1
c/3
CO
E£
u C/3 g o3 CL
Ou 3x: # •Sfiu CL (N
n Ox: (/)
>
73
CL
8
U
_3u
.1
O
U-3
CL
c/3o
3
B
CL U 00
0
1 3
e
B
Xi
73<U
0>
i
U
•3
I  
i
u
IÎ
II
(0oc
ÛQ
(0
o
o
(0
OC
JO )38A
Q.
m
s
CL
N
(0oc
in
Q. □ d 1 •û.
< lAA 1 1Z w
JO;03A 1 1
>.
Js s
1 1ca
□C
"O <u
CL CA
(U <u 
73 J=
I §
t lO CAjc c 
CL
r >
£
CL
CA
a
X:
CL (N 
T*
73 lO 73 (L> Ou (UI
1 1 ^  
Eü
"C „
_  CL (U
g  S ^
X: CA 
CL —
o ë£ I
0-, g
"% g  o
“ f i
S-
(N
i
C
(L> 3
Oû
C
1
3
^  U-,
2  ffl s
5 I I
ffl
2
I
8
c
>  JS
%
II
il
e  3 §
CL^
8
O
U
^  .S
s  a
sI.
S
l ' i l
Ï Ü
.BP.S U
li
a
I
I
a
<u
è
■8
2  
.# '3
Lu Oi
f  .SI"
(U CA 
CA 3
8
2
<uII
164
53 Identification of the PP5-regulated site(s) on Raf-1
5.3.1 PP5 dephosphorylates pS338 but notpS621 or pS259 in-vitro 
As PP5 appeared to directly reduce Raf-1 activity in cells we next tested if Raf-1 was a 
substrate for PP5 by assaying its ability to dephosphorylate several major Raf-1 
phosphorylation sites in vitro. In order to generate Raf-1 that was highly phosphorylated on 
activating sites we coexpressed FLAG-Raf-1 with Ras^^^^ , a GTPase inactive, therefore 
constitutively active Ras mutant, and immunoprecipitated Raf-1 using an anti-FLAG 
antibody coupled to agarose beads. The Raf-1 bound to the beads was subsequently 
incubated with purified recombinant wild-type GST-PP5 or a mutant lacking the 
phosphatase domain (GST-APP5). In order to increase the phosphatase activity of PP5 
lOOpM of arachidonic acid, a potent PP5 activator (Chen and Cohen, 1997), was added in 
the buffer. After 30 minutes the reaction was stopped and the Raf-1 immunoprecipitates 
were immunoblotted and probed with antibodies against three phosphorylation sites. Two 
of them, pS338 and pS621, are located in the kinase domain of Raf-1 while the other, 
pS259, is in the regulatory domain. Wild-type PP5 had no effect of the level of 
phosphorylation either S259 or S621 but dramatically reduced the level of S338 
phosphorylation. By contrast, the phosphatase-inactive PP5 protein did not affect the 
phosphorylation levels of any of the sites. These results show that PP5 has a remarkable 
specificity in-vitro for pS338 of Raf-1 (Figure 5.5 A).
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5.3.2 Expression ofPP5 reduces pS338 but not pS621 or pS259 levels in cells
To determine if PP5 could also dephosphorylate pS338 in-vivo FLAG-tagged R a f-1 ^  and 
were coexpressed with the empty vector, wild-type PP5 or phosphatase- 
dead PP5 in COS-1 cells. The FLAG-tagged immunoprecipitates were immunoblotted and 
probed with the Raf-1 phospho-specific antibodies described above. The result of this 
experiment was fully consistent with that obtained in the in-vitro experiments (Figure 5.5B 
& C). Both the pS259 and pS621 levels were not affected by coexpression of wild-type 
PP5 whereas pS338 levels were reduced in both Raf-1 proteins. The vector and 
phosphatase-dead PP5 mutant had no effect on the levels of phosphorylation on any of the 
sites. These results provide strong evidence that pS338 is a genuine in-vivo target of PP5.
5.3.3 The kinase activity o f the mutant is not affected by PP5
To further test if other sites on Raf-1 other than S338 were regulated by PP5 we mutated 
both serines 338 and 339 to either alanines to prevent phosphorylation or to 
phosphomimetic glutamic and aspartic acid and then assessed the effect of PP5 on Raf-1 
kinase activity. We used a one-step kinase assay to test the ability of Raf-1 to 
phosphorylate MEK. COS-1 cells coexpressing the Raf-1 mutants and PP5 were stimulated 
for 5 minutes with 10% FCS before Raf-1 was immunoprecipitated to determine its kinase 
activity (Figure 5.6). The Flag-Raf-l^^^^"^^^^^"  ^ mutant was devoid of kinase activity, 
confirming that the 338 site is essential for Raf-1 activity whereas the Flag-Raf-1^^^®°^^^^®  ^
mutant had a slightly higher activity than wild-type Raf-1. As shown previously in Figure 
6.4A, PP5 reduced the activity of FLAG-Raf-1^ whereas the phosphatase-dead PP5 
mutant had no effect (Fig. 5.6). By contrast, the activity of the Flag-Raf-1^^^^^^^^^® mutant 
was not affected by either wild-type or phosphatase-dead PP5. These results show that PP5 
inhibits Raf-1 activity by specifically dephosphorylating S338.
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5.4 Gal2-dependent regulation of Raf-1 S338 phosphorylation by PP5
5.4.1 Active G al2 binds PP5 in COS-1 cells
Recent reports have indicated that active G a l2 increases binds to PP5 and recruits it to the 
cell membrane (Yamaguchi et al., 2002). To verify this report we coexpressed HA-tagged 
PP5 and with wild-type G a l2 and or the activated mutant G a l2^^ in COS-1 cells. This 
mutant is defective in its GTPase activity and is so retained in an active conformation. We 
serum-starved the cells overnight and immunoprecipitated G al2 with a G a l2 specific 
antibody. We then blotted for co-precipitating PP5 and found that active G al 2 bound 
considerably stronger to PP5 confirming the previously published results (Figure 5.7A).
5.4.2 Active G al2 ^  impairs PP5 dependentpS338 dephosphorylation
Having established that PP5 is binds active G a l2 we wanted to investigate the effect of 
this interaction on the ability of PP5 to dephosphorylate pS338. We therefore coexpressed 
FLAG-Raf-l^^"^^"^^^*^ and G a l2^^ in COS-1 cells with either wild-type PP5 or the 
phosphatase-dead mutant. We used the F L A G - R a f - m u t a n t  for this experiment 
because it has a high basal level of S388 phosphorylation in starved cells and therefore no 
induction by growth factors was needed. Using growth factors to induce S338 
phosphorylation could also activate G a l2 signalling, therefore making the interpretation of 
the results less definitive. We immunoblotted the Raf-1 immunoprecipitates with 
antibodies against two phosphorylation sites, pS338 and pS621 (Figure 6.7 B). pS621 was 
not affected by either PP5 or G a l2^% On the other hand the PP5-mediated reduction in 
S33 8 phosphorylation was prevented by coexpressing G a l2 ^ \ Phosphatase-dead PP5 on 
its own, or when coexpressed with G a l2^% slightly increased pS338 phosphorylation. 
These results suggest that G a l2 signalling can positively regulate Raf-1 activity by
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antagonising PP5-mediated déphosphorylation of pS338. This effect o f active G al2 may in 
turn be mediated by its ability to sequester PP5 from Raf-1.
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Chapter 5: Discussion
The experiments described in this chapter were aimed at characterising the interaction 
between PP5 and Raf-1 and to decipher its functional consequences. We found that the 
interaction is regulated by growth factor signalling and have identified pS338 on Raf-1 as a 
genuine in-vitro and in-vivo substrate of PP5. S338 is one of the sites whose 
phosphorylation is induced by Ras and mitogens and is required for Raf-1 activation by 
these signals (Diaz et al., 1997). The identity of the kinase which phosphorylates S338 has 
been controversial, but several studies have suggested that this kinase is PAKl or PAK3 
(Chaudhary et al., 2000; King et al., 1998; Sun et al., 2000). The results presented here 
provide strong evidence that PP5 is the S338 phosphatase. We found that PP5 showed a 
remarkable specificity for dephosphorylating pS338 both in vitro and in vivo. Most 
importantly, phosphomimetic substitutions of S338 rendered Raf-1 no longer susceptible to 
inhibition by PP5. We could also show that Raf-1 dependent activation of MEK in cells 
was reduced through PP5-dependent inhibition of Raf-1 kinase activity.
While we have shown that PP5 associates with the catalytic domain of Raf-1, we did not 
identify the region of PP5 to which Raf-1 binds. Thus far, most proteins that interact with 
PP5 do so via its TPR domain (Chen et al., 1996; Galigniana et al., 2002; Kono et al., 
2002; Lubert et al., 2001; Ollendorff and Donoghue, 1997; Russell et al., 1999; Shao et al., 
2002; Silverstein et al., 1997; Yamaguchi et al., 2002; Zhao and Sancar, 1997). Further 
studies using a TPR domain truncated PP5 mutant are required to determine if Raf-1 also 
binds to this domain. We also did not determine if PP5 bound directly to Raf-1 or if it did 
so via an adaptor. It is possible that proteins that bind to both PP5 and to Raf-1 could 
function as linkers. These include the regulatory subunits of PP2A (Lubert et al., 2001), 
HSP90 (Chen et al., 1996), and possibly 14-3-3. However our finding that the Raf-1^^^^" ,^ 
which is deficient in its 14-3-3 binding capacity (Rommel et al., 1996), interacts equally 
well with PP5 as wild-type Raf-1 argues against 14-3-3 as being a potential adaptor.
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Another question to be resolved is the mechanism by which PP5 dissociates and re­
associates to Raf-1. One elegant way this could occur would be if the catalytic subunit of 
PP2A would replace PP5 from the two regulatory subunits of PP2A that are constitutively 
bound to Raf-1. It has been shown that PP5 can bind to these subunits (Lubert et al., 2001) 
and, though it could be coincident, PP5 dissociates from Raf-1 when the catalytic subunit 
of PP2A is reported to associate.
We identified G a l2 signalling as one pathway that could regulate PP5-dependent pS338 
dephosphorylation. This may provide a link between two distinct GTPase pathways (Ras 
and G a l2). Active G al 2 is an oncogene and strong inducer of cell transformation (Chan et 
al., 1993; Xu et al., 1993). It is thought that it main role is to activate the INK pathway 
through a Rho dependent mechanism. G a l2 and Gal 3 have been both found to interact 
and activate pllSRhoGEF (Hart et al., 1998), thus increasing Rho-GTP levels and 
inducing Rho-dependent signalling pathways. G al2 signalling has also been shown to 
increase Ras activity by binding to rasGAP (Jiang et al., 1998) and by activating 
PLCb(Lopez et al., 2001). Increasing both Ras and Rho activity in Ga 12^^-transfected 
HEK293 cells resulted in phosphorylation of JNK but not ERK (Collins et al., 1996). It 
was shown in the same cells that activation of JNK could be blocked by transfecting 
dominant negative Ras, demonstrating that both Ras and Rho are necessary for JNK 
activation. The lack of ERK phosphorylation is quite puzzling in respect to our results as 
we have found that active G a l2 inhibits PP5 dependent dephosphorylation of pS338 of 
Raf-1. This in combination with active Ras should result in increased signalling through 
the ERK pathway. This discrepancy can be partially explained by the finding that active 
G a l2 inhibits the Ras/RafiMEK/ERK pathway at the level of MEK in COS-7 cells 
(Voyno-Yasenetskaya et al., 1996). On the other hand studies assaying the transformation 
potential of G a l2 and known proto-oncogenes in rodent fibroblasts have shown that there 
is a striking cooperative effect on focus formation when G a l2 and Raf-1 are co-transfected 
into NIH3T3 cells (Zhang et al., 1996). Co-expression of these two proteins also results in
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the constitutive activation of ERK. These discrepancies in the outcome could be cell type 
dependent. It is possible that in a certain cell types MEK inhibition overrides the increase 
in Ras and Raf-1 activity and thereby prevents an increase of ERK phosphorylation. 
Clearly these discrepancies should be resolved by examining the effects of active G al 2 on 
Raf-1 activity and ERK phosphorylation in several different cell lines.
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